List of COVID-19 vaccine authorizations#Janssen
{{Short description|None}}
{{cs1 config|name-list-style=vanc|display-authors=6}}
{{for|COVID-19 vaccination policy by country|Vaccination policy#Table}}
{{Use dmy dates|date=October 2022}}
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.
Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi–GSK. Seven others are under assessment by the WHO: Sputnik V, Sinopharm WIBP, Abdala, Zifivax, Corbevax, COVIran Barekat, and SCB-2019.{{#invoke:Cite web||title=Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process|url=https://extranet.who.int/pqweb/key-resources/documents/status-covid-19-vaccines-within-who-eulpq-evaluation-process|publisher=World Health Organization (WHO)}}
Of the 40 vaccines, 16 have a full or emergency authorization in only one country, 12 in ten or fewer countries, and 12 in more than ten countries.
Note that in some countries, vaccines may be authorized solely for travel purposes. They may not be approved for the general population. For example, the CoronaVac, Covishield, BBIBP-CorV and Covaxin vaccines are not part of Australia's national vaccination program; however, they are recognized for the purpose of travel to Australia.{{cite web |title=International COVID-19 vaccines recognised by Australia |url=https://www.tga.gov.au/international-covid-19-vaccines-recognised-australia |website=Therapeutic Goods Administration |publisher=Australian Government Department of Health |access-date=12 January 2022}}{{cite web |title=COVID-19 and the border - Vaccinated travellers |url=https://covid19.homeaffairs.gov.au/vaccinated-travellers#toc-0 |website=Department of Home Affairs |publisher=Australian Government Department of Home Affairs |access-date=12 January 2022 |archive-date=14 March 2022 |archive-url=https://web.archive.org/web/20220314092238/https://covid19.homeaffairs.gov.au/vaccinated-travellers#toc-0 |url-status=dead }}{{cite web |url=https://www.smartraveller.gov.au/COVID-19/COVID-19-vaccinations#TGA-approved |website=Smartraveller |publisher=Australian Government Department of Foreign Affairs and Trade |access-date=12 January 2022|title=COVID-19 vaccinations }}
{{Horizontal TOC}}
Overview maps
class=center
| File:COVID-19 RNA and DNA vaccines authorization map.svg| RNA vaccines and DNA vaccines{{Legend|#800080|Pfizer–BioNTech (original)}}{{Legend|#8C00FF|Pfizer–BioNTech (omicron)}}{{Legend|#008800|Moderna (original)}}{{Legend|#8CFF00|Moderna (omicron)}}{{Legend|#666666|Others}}
File:COVID-19 adenovirus vaccines authorization map.svg| Adenovirus vector vaccines{{Legend|#000088|Oxford–AstraZeneca}}{{Legend|#008800|Janssen}}{{Legend|#880000|Sputnik V}}{{Legend|#FF008C|Sputnik Light}}{{Legend|#888800|Convidecia}}{{Legend|#008CFF|iNCOVACC}}
File:COVID-19 inactivated vaccines authorization map.svg| Inactivated virus vaccines{{Legend|#008888|Sinopharm BIBP}}{{Legend|#888800|CoronaVac}}{{Legend|#800080|Covaxin}}{{Legend|#FF008C|Valneva}}{{Legend|#FF8C00|Sinopharm WIBP}}{{Legend|#666666|Others}}
File:COVID-19 subunit and VLP vaccines authorization map.svg| Subunit vaccines{{Legend|#FF8C00|Novavax}}{{Legend|#880000|Sanofi–GSK}}{{Legend|#008CFF|Abdala}}{{Legend|#008888|EpiVacCorona}}{{Legend|#8C00FF|Zifivax}}{{Legend|#8CFF00|Soberana 02}}{{Legend|#666666|Others}}
|
Oxford–AstraZeneca
{{infobox
| image = {{Graph:Map|scale=65|defaultValue=gainsboro
|AD=dodgerblue|AE=dodgerblue|AF=dodgerblue|AG=dodgerblue|AI=dodgerblue|AL=dodgerblue|AM=dodgerblue|AO=dodgerblue|AR=dodgerblue|AT=dodgerblue|AU=blueviolet|AW=dodgerblue|AZ=dodgerblue
|BA=limegreen|BB=dodgerblue|BD=dodgerblue|BE=dodgerblue|BF=dodgerblue|BG=dodgerblue|BH=dodgerblue|BJ=dodgerblue|BM=dodgerblue|BN=limegreen|BO=dodgerblue|BQ=dodgerblue|BR=blueviolet|BS=dodgerblue|BT=dodgerblue|BW=dodgerblue|BZ=dodgerblue
|CA=blueviolet|CD=dodgerblue|CF=dodgerblue|CG=dodgerblue|CH=turquoise|CI=dodgerblue|CK=dodgerblue|CL=dodgerblue|CM=dodgerblue|CO=dodgerblue|CR=dodgerblue|CV=dodgerblue|CW=dodgerblue|CY=dodgerblue|CZ=dodgerblue
|DE=dodgerblue|DJ=dodgerblue|DK=dodgerblue|DM=dodgerblue|DO=dodgerblue|DZ=dodgerblue
|EC=dodgerblue|EE=dodgerblue|EG=dodgerblue|ES=dodgerblue|ET=dodgerblue
|FI=darkred|FJ=dodgerblue|FK=dodgerblue|FM=dodgerblue|FR=dodgerblue
|GB=dodgerblue|GD=dodgerblue|GE=dodgerblue|GG=dodgerblue|GH=dodgerblue|GL=dodgerblue|GM=dodgerblue|GN=dodgerblue|GP=dodgerblue|GR=dodgerblue|GT=dodgerblue|GW=dodgerblue|GY=dodgerblue
|HK=turquoise|HN=dodgerblue|HR=dodgerblue|HT=dodgerblue|HU=dodgerblue
|ID=dodgerblue|IE=dodgerblue|IM=dodgerblue|IN=blueviolet|IQ=dodgerblue|IR=dodgerblue|IS=dodgerblue|IT=dodgerblue
|JE=dodgerblue|JP=dodgerblue|JM=dodgerblue|JO=dodgerblue
|KE=dodgerblue|KG=dodgerblue|KH=dodgerblue|KI=dodgerblue|KM=dodgerblue|KN=dodgerblue|KP=limegreen|KR=dodgerblue|KW=dodgerblue|KY=dodgerblue
|LA=dodgerblue|LB=dodgerblue|LC=dodgerblue|LI=dodgerblue|LK=dodgerblue|LR=dodgerblue|LS=dodgerblue|LT=dodgerblue|LU=dodgerblue|LV=dodgerblue|LY=dodgerblue
|MA=dodgerblue|MC=limegreen|MD=dodgerblue|ME=dodgerblue|MG=dodgerblue|MH=limegreen|MK=dodgerblue|ML=dodgerblue|MM=dodgerblue|MN=dodgerblue|MR=dodgerblue|MS=dodgerblue|MT=dodgerblue|MU=dodgerblue|MV=dodgerblue|MW=dodgerblue|MX=dodgerblue|MY=dodgerblue|MZ=dodgerblue
|NA=dodgerblue|NE=dodgerblue|NG=dodgerblue|NI=dodgerblue|NL=dodgerblue|NO=darkred|NP=dodgerblue|NR=limegreen|NZ=dodgerblue
|OM=dodgerblue
|PA=dodgerblue|PE=dodgerblue|PF=dodgerblue|PG=dodgerblue|PH=dodgerblue|PK=dodgerblue|PL=dodgerblue|PN=dodgerblue|PS=dodgerblue|PT=dodgerblue|PY=dodgerblue
|QA=dodgerblue
|RO=dodgerblue|RS=dodgerblue|RW=dodgerblue
|SA=dodgerblue|SB=dodgerblue|SC=dodgerblue|SD=dodgerblue|SE=dodgerblue|SG=dodgerblue|SH=dodgerblue|SI=dodgerblue|SK=darkred|SL=dodgerblue|SN=dodgerblue|SO=dodgerblue|SR=dodgerblue|SS=dodgerblue|ST=dodgerblue|SV=dodgerblue|SX=dodgerblue|SY=dodgerblue|SZ=dodgerblue
|TD=limegreen|TG=dodgerblue|TH=dodgerblue|TJ=dodgerblue|TL=dodgerblue|TM=dodgerblue|TN=dodgerblue|TO=dodgerblue|TR=turquoise|TT=dodgerblue|TV=dodgerblue|TW=dodgerblue
|UA=dodgerblue|UG=dodgerblue|US=turquoise|UY=dodgerblue|UZ=dodgerblue
|VC=dodgerblue|VE=limegreen|VG=dodgerblue|VN=dodgerblue|VU=dodgerblue
|WF=dodgerblue|WS=limegreen
|XK=dodgerblue
|YE=dodgerblue
|ZA=darkred|ZM=dodgerblue|ZW=dodgerblue
}}
| caption = {{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
{{leftlegend|limegreen|Eligible COVAX recipient}}
{{leftlegend|darkred|Usage stopped}}
}}
The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevria{{cite web | title=Vaxzevria (previously COVID-19 Vaccine AstraZeneca) EPAR | date=25 January 2021 | publisher=European Medicines Agency (EMA) | url=https://www.ema.europa.eu/en/medicines/human/EPAR/vaxzevria-previously-covid-19-vaccine-astrazeneca }} and Covishield,{{cite news|date=4 March 2021|title=Covishield and Covaxin: What we know about India's Covid-19 vaccines|work=BBC News|url=https://www.bbc.com/news/world-asia-india-55748124|access-date=8 March 2021|archive-date=7 March 2021|archive-url=https://web.archive.org/web/20210307222320/https://www.bbc.com/news/world-asia-india-55748124|url-status=live}} is a viral vector vaccine{{#invoke:Cite web||date=26 May 2020|title=Investigating a Vaccine Against COVID-19|url=https://clinicaltrials.gov/ct2/show/NCT04400838|url-status=live|archive-url=https://web.archive.org/web/20201011084750/https://clinicaltrials.gov/ct2/show/NCT04400838/|archive-date=11 October 2020|access-date=14 July 2020|website=ClinicalTrials.gov|publisher=United States National Library of Medicine|id=NCT04400838}} produced by the British University of Oxford, British-Swedish company AstraZeneca, and the Coalition for Epidemic Preparedness Innovations.{{#invoke:Cite web||date=21 April 2020|title=A Phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19|url=https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001228-32/GB|url-status=live|archive-url=https://web.archive.org/web/20201005201654/https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001228-32/GB|archive-date=5 October 2020|access-date=3 August 2020|website=EU Clinical Trials Register|publisher=European Union|id=EudraCT 2020-001228-32}}{{cite journal|last1=O'Reilly|first1=Peter|date=26 May 2020|title=A Phase III study to investigate a vaccine against COVID-19|doi=10.1186/ISRCTN89951424|id=ISRCTN89951424|doi-access=free|website=ISRCTN}} Finland, Denmark, and Norway suspended the use of the Oxford–AstraZeneca vaccine due to a small number of reports of a rare blood clot disorder.{{cite web |title=THL temporarily suspends the use of the AstraZeneca COVID-19 vaccine - Press release - THL |url=https://thl.fi/en/web/thlfi-en/-/thl-temporarily-suspends-the-use-of-the-astrazeneca-covid-19-vaccine |website=Finnish Institute for Health and Welfare (THL), Finland |access-date=5 December 2021 }}{{cite web | title=Denmark continues its vaccine rollout without the COVID-19 vaccine from AstraZeneca | website=Danish Health Authority | date=14 April 2021 | url=https://www.sst.dk/en/english/news/2021/denmark-continues-its-vaccine-rollout-without-the-covid-19-vaccine-from-astrazeneca | access-date=31 July 2021 | quote=That is why it is important to emphasise that it is still an approved vaccine. }}{{cite news |last1=Peltier |first1=Elian |title=Denmark says it's permanently stopping use of the AstraZeneca vaccine. |url=https://www.nytimes.com/2021/04/14/world/europe/denmark-astrazeneca-vaccine.html |work=The New York Times |date=14 April 2021}}{{#invoke:Cite web||last=omsorgsdepartementet|first=Helse-og|date=12 May 2021|title=AstraZeneca-vaksinen tas ut av koronavaksinasjons-programmet|url=https://www.regjeringen.no/no/aktuelt/astrazeneca-vaksinen-tas-ut-av-koronavaksinasjonsprogrammet/id2849494/|access-date=12 May 2021|website=Regjeringen.no|language=no}} Slovakia suspended its use after the death of a predisposed recipient.{{cite news |title=Slovakia suspends use of AstraZeneca COVID-19 vaccine as a recipient dies |url=https://www.reuters.com/business/healthcare-pharmaceuticals/slovakia-halting-use-astrazeneca-covid-vaccine-first-doses-2021-05-11/ |access-date=23 June 2021 |date=11 May 2021 |publisher=Reuters }} South Africa suspended its use because a small trial found only minimal protection against mild to moderate disease from the locally predominant Beta variant.{{cite news |title=South Africa sells AstraZeneca COVID-19 vaccines to other African countries |url=https://www.reuters.com/article/us-health-coronavirus-safrica-vaccine-idUSKBN2BD0K4 |access-date=23 June 2021 |publisher=Reuters |date=21 March 2021 }} Japan approved the vaccine for emergency use in May 2021, but did not plan to use them immediately because of rare cases of a blood clotting disorder reported overseas.{{cite news | title = Japan to donate millions more AstraZeneca vaccine doses across Asia | date = 25 June 2021 | url = https://english.kyodonews.net/news/2021/06/082ff96b4bdb-japan-to-donate-millions-more-astrazeneca-vaccines-across-asia.html | work = Kyodo News }} Later, Japan started to use the vaccine for people aged 40 or over to mitigate the surge of the Delta variant in August.{{cite web|date=4 August 2021|title=Japan to give COVID-19 emergency areas AstraZeneca vaccine|url=https://www.japantimes.co.jp/news/2021/08/04/national/japan-give-covid-19-emergency-areas-astrazeneca-vaccine/|access-date=28 August 2021|website=The Japan Times|archive-date=28 August 2021|archive-url=https://web.archive.org/web/20210828022422/https://www.japantimes.co.jp/news/2021/08/04/national/japan-give-covid-19-emergency-areas-astrazeneca-vaccine/}} Finland ceased use of the vaccine as the last batch expired on 30 November 2021. Until then it was only offered for those aged 65 or more due to extremely rare coagulation disorders among younger recipients of the vaccine. After this Finland will not procure more of the vaccine.{{cite web |title=Suspension of AstraZeneca COVID-19 vaccines for those under the age of 65 extended – THL evaluating how it affects the vaccination programme - Press release - THL |url=https://thl.fi/en/web/thlfi-en/-/suspension-of-astrazeneca-covid-19-vaccines-for-those-under-the-age-of-65-extended-thl-evaluating-how-it-affects-the-vaccination-programme |website=Finnish Institute for Health and Welfare (THL), Finland |access-date=5 December 2021 }}{{cite web |title=Use of AstraZeneca coronavirus vaccine to end in Finland in November - News - THL |url=https://thl.fi/en/web/thlfi-en/-/use-of-astrazeneca-coronavirus-vaccine-to-end-in-finland-in-november |website=Finnish Institute for Health and Welfare (THL), Finland |access-date=5 December 2021 }}{{cite web |title=Adenovirus vaccines: FAQ - THL |url=https://thl.fi/en/web/infectious-diseases-and-vaccinations/what-s-new/coronavirus-covid-19-latest-updates/vaccines-and-coronavirus/adenovirus-vaccines-faq |website=Finnish Institute for Health and Welfare (THL), Finland |access-date=3 December 2021 }}{{cite web |title=Getting vaccinated against COVID-19: how, why and when? - THL |url=https://thl.fi/en/web/infectious-diseases-and-vaccinations/what-s-new/coronavirus-covid-19-latest-updates/vaccines-and-coronavirus/getting-vaccinated-against-covid-19-how-why-and-when- |website=Finnish Institute for Health and Welfare (THL), Finland |access-date=3 December 2021 }} The AstraZeneca vaccine is the most widely accepted internationally,{{cite news|date=23 July 2021|title=Which covid-19 vaccine is the most widely accepted for international travel?|url=https://www.economist.com/graphic-detail/2021/07/20/which-covid-19-vaccine-is-the-most-widely-accepted-for-international-travel|access-date=11 June 2022|newspaper=The Economist}} and the most popular in terms of total inoculated worldwide, over 1.3 billion.{{cite web|date=21 October 2021|title=India celebrates 1 billion COVID-19 vaccine doses with song and dance|url=https://www.reuters.com/world/india/india-celebrates-1-bln-covid-19-vaccine-doses-with-song-film-2021-10-21/|access-date=11 June 2022|publisher=Reuters}}{{cite web|date=29 July 2021|title=Oxford vaccine reaches one billion doses released|url=https://www.ox.ac.uk/news/2021-07-29-oxford-vaccine-reaches-one-billion-doses-released|access-date=11 June 2022|website=University of Oxford}}{{cite web|date=16 November 2021|title=Two billion doses of AstraZeneca's COVID-19 vaccine supplied to countries across the world less than 12 months after first approval|url=https://www.astrazeneca.com/media-centre/press-releases/2021/two-billion-doses-of-astrazenecas-covid-19-vaccine-supplied-to-countries-across-the-world-less-than-12-months-after-first-approval.html|access-date=11 June 2022|website=AstraZeneca}}{{cite web|date=8 June 2022|title=Vaxzevria COVID-19 Vaccine (AstraZeneca)|url=https://www.precisionvaccinations.com/vaccines/vaxzevria-covid-19-vaccine-astrazeneca|access-date=11 June 2022|website=precisionvaccinations.com}} The AstraZeneca vaccine is administered in more countries than any other vaccine.{{cite web|date=9 June 2022|title=Where are Vaccines (Company and Brand) Administered Globally?|url=https://covid.cdc.gov/covid-data-tracker/#global-vaccinations|access-date=13 June 2022|website=CDC Covid Data Tracker}}
;Full (5)
- Australia{{cite news|date=16 February 2021|title=AstraZeneca coronavirus vaccine approved for use in Australia by TGA|newspaper=ABC News (Australia)|url=https://www.abc.net.au/news/2021-02-16/coronavirus-astrazeneca-vaccine-approved-for-use-in-australia/13115784|access-date=16 February 2021}}{{#invoke:Cite web||date=16 February 2021|title=TGA provisionally approves AstraZeneca's COVID-19 vaccine|url=https://www.tga.gov.au/media-release/tga-provisionally-approves-astrazenecas-covid-19-vaccine|access-date=16 February 2021|publisher=Therapeutic Goods Administration (TGA)}}
- Brazil{{cite news|date=12 March 2021|title=Brazil grants full approval to Oxford vaccine, orders Sputnik|publisher=France 24|agency=Agence France-Presse|location=Brasilia|url=https://www.france24.com/en/live-news/20210312-brazil-grants-full-approval-to-oxford-vaccine-orders-sputnik|access-date=13 March 2021}}
- Canada{{cite web | title=AstraZeneca Vaxzevria COVID-19 vaccine | website=Health Canada | date=7 June 2022 | url=https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/astrazeneca.html | access-date=30 October 2022 }}{{cite web | title=Regulatory Decision Summary - Vaxzevria | website=Health Canada | url=https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detail.html?linkID=RDS00889 | access-date=26 November 2021}}
- India{{cite news|last1=Sharma|first1=Milan|last2=Mordani|first2=Sneha|date=27 January 2022|title=Covaxin, Covishield granted market approval in India but conditions apply|work=India Today|url=https://www.indiatoday.in/coronavirus-outbreak/vaccine-updates/story/covaxin-covishield-granted-regular-market-approval-india-1905218-2022-01-27|access-date=29 January 2022}}
- Israel{{cite web|date=18 October 2021|title=Israel to offer AstraZeneca vaccines starting Thursday|url=https://www.timesofisrael.com/israel-to-offer-astrazeneca-vaccines-starting-thursday/|access-date=13 June 2022|website=The Times of Israel}}{{cite web|date=31 May 2022|title=Vaccines "Three vaccines have been approved for use in Israel for protection from coronavirus, by Pfizer, Moderna and AstraZeneca."|url=https://corona.health.gov.il/en/vaccine-for-covid/fully-vaccinated/|access-date=13 June 2022|website=Vaccines - Corona Traffic Light Model (Ramzor) Website}}
{{nowrap|EMA countries}}{{cite web | title=Comirnaty | website=Union Register of medicinal products | date=21 December 2020 | url=https://ec.europa.eu/health/documents/community-register/html/h1528.htm | access-date=26 November 2021}}{{cite web | title=COVID-19 vaccines: authorised | publisher=European Medicines Agency (EMA) | date=11 January 2021 | url=https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/covid-19-vaccines-authorised | access-date=31 October 2022}}
- Austria
- Belgium
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Malta
- Netherlands
- Norway
- Poland
- Portugal
- Romania
- Slovakia
- Slovenia
- Spain
- Sweden
;Emergency (170)
- Afghanistan{{cite news|last=Sediqi|first=Abdul Qadir|date=7 February 2021|title=First doses of COVID-19 vaccine arrive in Afghanistan from India|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-afghanistan-vaccine-idUSKBN2A707M|access-date=24 February 2021}}{{#invoke:Cite web||title=India donates 500,000 COVID vaccines to Afghanistan|url=https://www.aljazeera.com/news/2021/2/8/afghanistan-gets-first-doses-of-covid-19-vaccine-from-india|access-date=24 February 2021|publisher=Al Jazeera}}
- Albania
- Algeria{{#invoke:Cite web||last=Kreo|title=البلاد الوطني / وزارة الصناعات الصيدلانية ترخص باستعمال لقاح "أسترا زينيكا -أوكسفورد " المضاد لكورونا|url=http://elbilad.net/article/detail?id=113247|access-date=1 April 2021|website=elbilad.net|language=AR}}
- Andorra
- Angola{{#invoke:Cite web||last=AfricaNews|date=3 March 2021|time=CET13:13:37+01:00|title=Angola begins Covid immunization fight with COVAX vaccines|url=https://www.africanews.com/2021/03/03/angola-begins-covid-immunization-fight-with-covax-vaccines/|access-date=14 April 2021|website=Africanews}}
- Argentina{{cite news|date=30 December 2020|title=Argentine regulator approves AstraZeneca/Oxford COVID-19 vaccine|url=https://www.reuters.com/article/us-health-coronavirus-argentina-astrazen/argentine-regulator-approves-astrazeneca-oxford-covid-19-vaccine-astrazeneca-idUSKBN29421P|access-date=30 December 2020|publisher=Reuters}}
- Armenia{{cite news |title=Armenia Scraps Restrictions For AstraZeneca Vaccine |url=https://www.azatutyun.am/a/31226006.html |website=«Ազատ Եվրոպա/Ազատություն» ռադիոկայան |date=27 April 2021 |language=hy|last1=Ghalechian |first1=Narine }}
- Azerbaijan
- Bahrain{{#invoke:Cite web||date=25 January 2021|title=Bahrain approves Oxford/AstraZeneca coronavirus vaccine produced in India|url=http://saudigazette.com.sa/article/602862|access-date=30 January 2021|website=Saudigazette}}
- Bangladesh{{#invoke:Cite web||title=Oxford University-Astrazeneca vaccine: Bangladesh okays it for emergency use|url=https://www.thedailystar.net/frontpage/news/oxford-university-astrazeneca-vaccine-bangladesh-okays-it-emergency-use-2022381|access-date=6 January 2021|website=The Daily Star|date=4 January 2021}}{{#invoke:Cite web||title=Bangladesh approves Oxford-AstraZeneca COVID-19 vaccine|url=https://www.aa.com.tr/en/asia-pacific/bangladesh-approves-oxford-astrazeneca-covid-19-vaccine/2099147|access-date=6 January 2021|website=aa.com.tr}}
- Benin
- Bhutan{{#invoke:Cite web||title=Bhutan receives 400,000 doses of COVID-19 vaccine from India |url=http://www.xinhuanet.com/english/asiapacific/2021-03/22/c_139827645.htm|access-date=1 April 2021|publisher=Xinhuanet}}{{#invoke:Cite web||title=Bhutan begins biggest vaccination drive against COVID-19|url=https://www.channelnewsasia.com/news/asia/bhutan-begins-biggest-covid-19-vaccination-drive-astrazeneca-14504644|access-date=1 April 2021|website=CNA}}
- Bolivia
- Bosnia and Herzegovina
- Botswana{{#invoke:Cite web||title=Botswana starts COVID-19 vaccine rollout |url=http://www.xinhuanet.com/english/2021-03/26/c_139838942.htm|access-date=1 April 2021|publisher=Xinhuanet}}
- Brunei
- Burkina Faso
- Cambodia
- Cameroon
- Cape Verde{{#invoke:Cite web||title=COVID-19 vaccines sent by COVAX arrive in Cabo Verde |url=https://reliefweb.int/report/cabo-verde/covid-19-vaccines-sent-covax-arrive-cabo-verde|access-date=17 April 2021|website=ReliefWeb|date=15 March 2021 }}
- Central African Republic
- Chile{{#invoke:Cite web||title=Instituto de Salud Pública de Chile|url=https://www.ispch.cl/noticia/isp-aprueba-la-tercera-vacuna-para-combatir-covid-19/|access-date=1 April 2021|language=es}}
- Colombia{{cite news|title=Colombia approves emergency use of AstraZeneca coronavirus vaccine |url=https://www.reuters.com/article/us-health-coronavirus-colombia-idUSKBN2AO01A|publisher=Reuters|access-date=22 March 2021|date=23 February 2021}}
- Comoros
- Congo-Brazzaville
- Congo-Kinshasa{{#invoke:Cite web||title=More than 1.7 million COVID-19 vaccines arrive in the Democratic Republic of Congo|url=https://www.unicef.org/press-releases/more-17-million-covid-19-vaccines-arrive-democratic-republic-congo|access-date=25 April 2021|website=www.unicef.org}}
- Costa Rica{{cite web |title=Costa Rica approves use of AstraZeneca's COVID-19 vaccine |url=https://qcostarica.com/costa-rica-approves-use-of-astrazenecas-covid-19-vaccine/ |website=Q COSTA RICA |date=9 April 2021}}
- Djibouti
- Dominican Republic{{cite news|date=31 December 2020|title=La República Dominicana aprueba la vacuna de AstraZeneca contra la covid-19|language=es|work=Agencia EFE|url=https://www.efe.com/efe/america/sociedad/la-republica-dominicana-aprueba-vacuna-de-astrazeneca-contra-covid-19/20000013-4431079}}
- East Timor{{#invoke:Cite web||date=1 April 2021|title=First vaccines for East Timor arrive in Dili on Monday – LUSA|url=https://covid19.gov.tl/en/first-vaccines-for-east-timor-arrive-in-dili-on-monday-lusa/|url-status=live|archive-url=https://web.archive.org/web/20210402144040/https://covid19.gov.tl/en/first-vaccines-for-east-timor-arrive-in-dili-on-monday-lusa/|archive-date=2 April 2021|website=COVID-19 Timor-Leste Dashboard}}
- Ecuador{{cite news|date=24 January 2021|title=Ecuador approves use of AstraZeneca vaccine for COVID-19|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-ecuador-astrazeneca-idUSL1N2JZ0HC|access-date=30 January 2021}}
- Egypt
- El Salvador{{cite news|date=30 December 2020|title=El Salvador greenlights AstraZeneca, Oxford University COVID-19 vaccine|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-el-salvador-vaccin/el-salvador-greenlights-astrazeneca-oxford-university-covid-19-vaccine-idINKBN2942HQ}}
- Eswatini{{#invoke:Cite web||title=Eswatini launches nationwide COVID-19 vaccination campaign|date=24 March 2021 |url=https://www.afro.who.int/news/eswatini-launches-nationwide-covid-19-vaccination-campaign|access-date=1 April 2021|publisher=World Health Organization (WHO) }}
- Ethiopia{{#invoke:Cite web||title=Ethiopia begins COVID-19 vaccine rollout|url=https://www.aa.com.tr/en/africa/ethiopia-begins-covid-19-vaccine-rollout/2174904|access-date=19 March 2021|website=aa.com.tr}}{{#invoke:Cite web||title=Ethiopia introduces COVID-19 vaccine in a national launching ceremony|url=https://www.afro.who.int/news/ethiopia-introduces-covid-19-vaccine-national-launching-ceremony|access-date=19 March 2021|website=World Health Organization (WHO)}}{{cite news|date=9 February 2021|title=Ethiopia says it has secured 9 million doses of COVID-19 vaccines till April|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-ethiopia-idUSKBN2A916S|access-date=19 March 2021}}
- Fiji
- Gambia{{#invoke:Cite web||title=The Arrival of COVAX vaccines Raises Hope in The Gambia|url=https://www.afro.who.int/news/arrival-covax-vaccines-raises-hope-gambia|access-date=19 March 2021|website=World Health Organization (WHO)}}
- Georgia{{#invoke:Cite web||title=Georgia to receive first doses of COVID-19 vaccine in early March instead of February|url=https://agenda.ge/en/news/2021/477|access-date=22 March 2021|website=Agenda.ge}}
- Ghana{{#invoke:Cite web||title=Welcome to Ghana Food And Drug Authority |url=http://fdaghana.gov.gh/news-media.php?page=78|access-date=1 April 2021|website=fdaghana.gov.gh}}
- Guatemala
- Guinea-Bissau{{cite web |title=Today, 28,800 doses of COVID-19 vaccine arrive in Bissau |url=https://www.unicef.org/guineabissau/press-releases/today-28800-doses-covid-19-vaccine-arrive-bissau |website=www.unicef.org}}
- Guinea
- Honduras
- Indonesia{{#invoke:Cite web||title=BPOM Terbitkan Izin Penggunaan Darurat Vaksin Covid-19 AstraZeneca|url=https://nasional.kompas.com/read/2021/03/09/12124611/bpom-terbitkan-izin-penggunaan-darurat-vaksin-covid-19-astrazeneca|access-date=10 February 2021|website=Kompas}}
- Iran{{cite web |date=17 February 2021|title=Iran issues permit for emergency use for three other COVID-19 vaccines: Official|url=https://en.irna.ir/news/84233593/Iran-issues-permit-for-emergency-use-for-three-other-COVID-19|access-date=1 April 2021|website=IRNA English}}
- Iraq{{#invoke:Cite web||title=Iraq approves Sinopharm, AstraZeneca vaccines|url=https://www.bignewsnetwork.com/news/267583081/iraq-approves-sinopharm-astrazeneca-vaccines|access-date=30 January 2021|website=Big News Network}}
- Ivory Coast{{cite news|date=1 March 2021|title=Covax: Ivory Coast and Ghana begin mass Covid vaccination rollouts|work=BBC News|url=https://www.bbc.com/news/world-africa-56239136|access-date=19 March 2021}}
- Japan{{cite news | title=Japan Approves Moderna, AstraZeneca Coronavirus Vaccines | website=Bloomberg | date=20 May 2021 | url=https://www.bloomberg.com/news/articles/2021-05-20/japan-approves-moderna-astra-covid-shots-report-says | access-date=2 July 2021}}
- Jordan{{#invoke:Cite web||title=COVAX roll-out - Jordan|url=https://www.gavi.org/covax-vaccine-roll-out/jordan|access-date=14 May 2021|website=www.gavi.org}}
- Kenya{{#invoke:Cite web||title=Kenya Receives 1M Vaccine Doses, Will Distribute to Health Workers First |date=3 March 2021 |url=https://www.voanews.com/covid-19-pandemic/kenya-receives-1m-vaccine-doses-will-distribute-health-workers-first|access-date=19 March 2021|publisher=Voice of America}}
- Kiribati
- Kosovo{{#invoke:Cite web||date=29 March 2021|title=Kosovo receives first COVID-19 vaccines through Covax scheme|url=https://www.euronews.com/2021/03/29/kosovo-receives-first-covid-19-vaccines-through-covax-programme|access-date=14 April 2021|website=euronews}}{{#invoke:Cite news||title=Kosovo PM Becomes Nation's First Person To Receive COVID-19 Vaccine|url=https://www.rferl.org/a/kosovo-covid-vaccines-immunization-last-europe-astrazeneca-covax/31174048.html|access-date=14 April 2021|newspaper=Radio Free Europe/Radio Liberty|date=29 March 2021 }}
- Kuwait{{#invoke:Cite web||last=Godinho|first=Varun|date=31 January 2021|title=Kuwait authorises emergency use of Oxford-AstraZeneca Covid-19 vaccine|url=https://gulfbusiness.com/kuwait-authorises-emergency-use-of-oxford-astrazeneca-covid-19-vaccine/|access-date=1 April 2021|website=Gulf Business}}
- Kyrgyzstan
- Laos
- Lebanon{{#invoke:Cite web||title=Lebanon Received 33600 Doses of The AstraZeneca Vaccine as First Batch|url=https://www.moph.gov.lb/en/Drugs/index/0/48177/page:3/sort:Drug.brand_name/direction:ASC|website=Ministry of Public Health of Lebanon}}
- Lesotho{{#invoke:Cite web||title=Lesotho receives 1st batch of COVID-19 vaccines|url=https://www.aa.com.tr/en/africa/lesotho-receives-1st-batch-of-covid-19-vaccines/2164388|access-date=19 March 2021|website=aa.com.tr}}
- Liberia{{#invoke:Cite web||title=96,000 Doses of COVID-19 Vaccine Arrives in Liberia|url=https://www.afro.who.int/news/96000-doses-covid-19-vaccine-arrives-liberia|access-date=11 April 2021|publisher=World Health Organization (WHO)}}
- Libya{{#invoke:Cite web||title=Libya kicks off delayed COVID-19 vaccination drive|url=https://www.aljazeera.com/news/2021/4/10/libya-launches-covid-19-vaccination-drive-after-delays|access-date=25 April 2021|website=Al Jazeera}}{{#invoke:Cite web||title=57,600 COVID-19 vaccine doses received today in Tripoli, Libya|url=https://reliefweb.int/report/libya/57600-covid-19-vaccine-doses-received-today-tripoli|access-date=25 April 2021|website=ReliefWeb|date=8 April 2021 }}
- Madagascar
- Malawi{{#invoke:Cite web||title=Malawi to receive COVID-19 vaccines in late February – Xinhua |url=http://www.xinhuanet.com/english/2021-02/02/c_139716241.htm|access-date=19 March 2021|publisher=Xinhuanet}}{{#invoke:Cite web||title=Malawi Sticks to AstraZeneca Despite Concerns Over Efficacy |date=8 February 2021 |url=https://www.voanews.com/covid-19-pandemic/malawi-sticks-astrazeneca-despite-concerns-over-efficacy|access-date=19 March 2021|publisher=Voice of America}}
- Malaysia{{cite news|last1=Sipalan|first1=Joseph|last2=Donovan|first2=Kirsten|date=3 March 2021|title=Malaysia approves Sinovac, AstraZeneca COVID-19 vaccines for use|agency=Reuters|url=https://www.msn.com/en-au/lifestyle/wellbeing/malaysia-approves-sinovac-astrazeneca-covid-19-vaccines-for-use/ar-BB1e9q01|access-date=7 March 2021}}
- Maldives{{#invoke:Cite web||title=Maldives starts training healthcare workers on COVID-19 vaccine distribution – Xinhua |url=http://www.xinhuanet.com/english/2021-01/23/c_139691718.htm|access-date=19 February 2021|publisher=Xinhuanet}}
- Mali{{#invoke:Cite web||last=AfricaNews|date=6 March 2021 |title=Mali receives first batch of COVID-19 vaccines|url=https://www.africanews.com/2021/03/06/mali-receives-first-batch-of-covid-19-vaccines/|access-date=1 April 2021|website=Africanews}}
- Mauritania
- Mauritius{{#invoke:Cite web||last=AfricaNews|date=26 January 2021|title=Mauritius begins vaccinating frontline health workers against covid-19|url=https://www.africanews.com/2021/01/26/mauritius-begins-vaccinating-frontline-health-workers-against-covid-19/|access-date=24 February 2021|website=Africanews}}
- Mexico{{cite news|date=5 January 2021|title=Mexico approves AstraZeneca COVID-19 vaccine, minister says|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-mexico-vaccine-idUSKBN29A04O|access-date=14 January 2021}}
- Micronesia
- Moldova
- Mongolia{{#invoke:Cite web||date=11 January 2021|title=Mongolia approved three Covid-19 vaccines |url=https://news.mn/en/795048/|access-date=1 April 2021|website=News.MN}}
- Montenegro
- Morocco{{cite news|date=7 January 2021|title=Morocco approves AstraZeneca/Oxford COVID-19 vaccine – Minister|publisher=Reuters|url=https://www.reuters.com/article/uk-health-coronavirus-morocco-idUSKBN29C0QA|access-date=22 March 2021}}
- Mozambique
- Myanmar{{cite news|date=27 January 2021|title=Myanmar launches nationwide COVID-19 vaccination program|website=Xinhua News|url=http://www.xinhuanet.com/english/2021-01/27/c_139700809.htm}}
- Namibia{{cite web|url=https://mhss.gov.na/documents/119527/775250/SKM_36721030413220.pdf/7a4534bb-022f-46e4-9113-571432290194|title=Importation of COVID-19 Vaccines into Namibia for Public Use and Guidance on Administration of Vaccines by Private Health Care Providers|date=31 March 2021|website=Republic of Namibia Ministry of Health and Social Services |access-date=14 April 2021|archive-date=22 April 2021|archive-url=https://web.archive.org/web/20210422075829/https://mhss.gov.na/documents/119527/775250/SKM_36721030413220.pdf/7a4534bb-022f-46e4-9113-571432290194}} Public Notice No.: 05/032021
- Nauru{{#invoke:Cite web||title=Samoa receives 24,000 doses of COVID-19 vaccines through the COVAX facility - Samoa|url=https://reliefweb.int/report/samoa/samoa-receives-24000-doses-covid-19-vaccines-through-covax-facility|access-date=7 June 2021|website=ReliefWeb|date=14 April 2021 }}
- Nepal{{cite news|date=15 January 2021|title=Nepal approves AstraZeneca COVID vaccine for emergency use – government statement|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-nepal/nepal-approves-astrazeneca-covid-vaccine-for-emergency-use-government-statement-idUSKBN29K140}}
- New Zealand
- Nicaragua
- Niger
- Nigeria{{cite news|title=Wetin we sabi about NAFDAC approval of Oxford AstraZeneca vaccine use for Nigeria|publisher=BBC News Pidgin|url=https://www.bbc.com/pidgin/media-56084858|access-date=24 February 2021}}
- North Macedonia{{cite web |title=Сѐ за вакцините |url=https://kovid19vakcinacija.mk/za-vakcinite/ |website=Официјална веб-страница за вакцинација против КОВИД19 |language=mk-MK}}
- Oman
- Pakistan{{cite news|date=16 January 2021|title=Pakistan approves AstraZeneca COVID-19 vaccine for emergency use|url=https://www.reuters.com/article/us-health-coronavirus-pakistan-astrazene/pakistan-approves-astrazeneca-covid-19-vaccine-for-emergency-use-idUKKBN29L0DO}}
- Palestine
- Panama
- Papua New Guinea{{#invoke:Cite web||date=30 March 2021|title=PNG prime minister first to be vaccinated with Australian-supplied doses 'to show it's safe'|url=http://www.theguardian.com/world/2021/mar/30/png-prime-minister-first-to-be-vaccinated-with-australian-supplied-doses-to-show-its-safe|access-date=1 April 2021|website=The Guardian}}{{#invoke:Cite web||date=17 March 2021|title=Australia gives Covid-19 vaccine doses to hard-hit Papua New Guinea|url=https://www.france24.com/en/asia-pacific/20210317-australia-gives-covid-19-vaccine-doses-to-hard-hit-papua-new-guinea|access-date=1 April 2021|publisher=France 24}}
- Paraguay
- Peru{{cite web |title=DIGEMID |url=http://www.digemid.minsa.gob.pe/main.asp?Seccion=1065 |website=www.digemid.minsa.gob.pe |language=es |access-date=2 May 2021 |archive-date=7 May 2021 |archive-url=https://web.archive.org/web/20210507204150/http://www.digemid.minsa.gob.pe/main.asp?Seccion=1065 }}
- Philippines{{cite news|date=28 January 2021|title=Philippine regulator approves emergency use of AstraZeneca vaccine|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-philippines-vaccin-idUSKBN29X0CY|access-date=28 January 2021}}
- Qatar
- Rwanda{{#invoke:Cite web||title=Rwanda receives COVID-19 Vaccines through COVAX|url=https://www.afro.who.int/news/rwanda-receives-covid-19-vaccines-through-covax|access-date=19 March 2021|website=World Health Organization (WHO)}}
- Samoa
- São Tomé and Príncipe
- Saudi Arabia
- Senegal
- Serbia{{cite news|date=21 February 2021|title=Serbia receives first shipment of AstraZeneca COVID-19 vaccine|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-serbia-vaccines-idUSL1N2KR03M|access-date=19 March 2021}}
- Seychelles{{cite news|last=Bhattacherjee|first=Kallol|date=22 January 2021|title=Coronavirus {{!}} Myanmar, Mauritius, Seychelles receive Covishield vaccine|work=The Hindu|url=https://www.thehindu.com/news/national/coronavirus-myanmar-mauritius-seychelles-receive-covishield-vaccine/article33638057.ece|access-date=1 April 2021}}
- Sierra Leone{{#invoke:Cite web||title=COVID-19 vaccines shipped by COVAX arrive in Sierra Leone|url=https://www.afro.who.int/news/covid-19-vaccines-shipped-covax-arrive-sierra-leone|access-date=19 March 2021|website=World Health Organization (WHO)}}
- Singapore{{#invoke:Cite web||title=Those who opt for Sinovac, other vaccines under WHO emergency list to be considered fully vaccinated |url=https://www.channelnewsasia.com/singapore/sinovac-vaccine-covid19-sinopharm-astrazeneca-fully-vaccinated-2096576 |access-date=6 August 2021 |work=CNA |date=6 August 2021}} (restricted)
- Solomon Islands
- Somalia{{#invoke:Cite web||title=Somalia Receives Its First Batch of COVID-19 Vaccines |date=15 March 2021 |url=https://www.voanews.com/covid-19-pandemic/somalia-receives-its-first-batch-covid-19-vaccines|access-date=1 April 2021|publisher=Voice of America}}
- South Korea{{cite news|last1=Kim|first1=Han-joo|date=10 February 2021|title=S. Korea approves AstraZeneca's COVID-19 vaccine for all adults|publisher=Yonhap News |url=https://en.yna.co.kr/view/AEN20210210006351320|access-date=10 February 2021}}{{cite news|last1=Maresca|first1=Thomas|date=10 February 2021|title=South Korea approves AstraZeneca COVID-19 vaccine|publisher=United Press International|url=https://www.upi.com/Top_News/World-News/2021/02/10/South-Korea-approves-AstraZeneca-COVID-19-vaccine/4231612945438/|access-date=10 February 2021}}
- South Sudan{{#invoke:Cite web||title=COVID-19 vaccination kicks-off in South Sudan|url=https://www.afro.who.int/news/covid-19-vaccination-kicks-south-sudan|access-date=14 April 2021|publisher=World Health Organization (WHO)}}
- Sri Lanka{{#invoke:Cite web||date=22 January 2021|title=Sri Lanka approves vaccine amid warnings of virus spread|url=https://apnews.com/article/sri-lanka-coronavirus-pandemic-340488c48ab372050825e70e057dd294|access-date=22 January 2021|publisher=Associated Press}}
- Sudan{{#invoke:Cite web||title=COVID-19 vaccination in Sudan|url=https://www.unicef.org/sudan/stories/covid-19-vaccination-sudan|access-date=19 March 2021|website=UNICEF}}{{#invoke:Cite web||title=Sudan receives first delivery of COVID-19 vaccines with over 800,000 doses|url=https://www.unicef.org/press-releases/sudan-receives-first-delivery-covid-19-vaccines-over-800000-doses|access-date=19 March 2021|website=UNICEF}}
- Syria
- Taiwan{{cite news|date=20 February 2021|title=Taiwan grants emergency authorisation for AstraZeneca COVID-19 vaccine|url=https://www.reuters.com/article/us-health-coronavirus-taiwan-idUSKBN2AK05R|access-date=13 March 2021|publisher=Reuters}}
- Tajikistan{{#invoke:Cite web||title=Tajikistan becomes first country in Central Asia to receive COVID-19 vaccine through COVAX Facility|url=https://www.unicef.org/tajikistan/press-releases/tajikistan-becomes-first-country-central-asia-receive-covid-19-vaccine-through-0|access-date=14 April 2021|website=unicef.org}}
- Thailand{{#invoke:Cite web||date=23 January 2021|title=Thai Food and Drug registers COVID-19 vaccine developed by AstraZeneca|url=https://www.pattayamail.com/thailandnews/thai-food-and-drug-registers-covid-19-vaccine-developed-by-astrazeneca-341186|website=Pattaya Mail}}
- Togo{{#invoke:Cite web||last=First|first=Togo|title=Covid-19: First vaccination campaign to soon begin|url=https://www.togofirst.com/en/health/1602-7300-covid-19-first-vaccination-campaign-to-soon-begin|access-date=19 March 2021|website=togofirst}}
- Tonga{{#invoke:Cite web||title=Over 500 people given first COVID-19 vaccine shot in Tonga – Xinhua |url=http://www.xinhuanet.com/english/asiapacific/2021-04/16/c_139885080.htm|access-date=25 April 2021|website=xinhuanet}}{{#invoke:Cite web||date=16 April 2021|title=Tonga's Princess takes the lead on Covid-19 vaccination|url=https://www.rnz.co.nz/international/pacific-news/440580/tonga-s-princess-takes-the-lead-on-covid-19-vaccination|access-date=25 April 2021|website=RNZ }}{{#invoke:Cite web||title=Kingdom of Tonga receives 24,000 doses of COVID-19 vaccines through the COVAX facility|url=https://www.who.int/westernpacific/about/how-we-work/pacific-support/news/detail/31-03-2021-kingdom-of-tonga-receives-24-000-doses-of-covid-19-vaccines-through-the-covax-facility|access-date=25 April 2021|publisher=World Health Organization (WHO)}}
- Tunisia
- Turkmenistan{{cite web |title=WHO Coronavirus (COVID-19) Dashboard |url=https://covid19.who.int/ |publisher=World Health Organization (WHO) }}
- Tuvalu
- Uganda{{#invoke:Cite web||last=AfricaNews|date=10 March 2021|title=Uganda starts COVID-19 vaccinations|url=https://www.africanews.com/2021/03/10/uganda-starts-covid-19-vaccinations/|access-date=19 March 2021|website=Africanews}}
- Ukraine{{#invoke:Cite web||title=COVID-19: AstraZeneca vaccine certified for use in Ukraine|url=https://covid.unian.info/covid-19-astrazeneca-vaccine-certified-for-use-in-ukraine-11330906.html|access-date=10 March 2021|website=covid.unian.info}}
- United Arab Emirates
- United Kingdom{{#invoke:Cite web||date=30 December 2020|title=Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca|url=https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca|access-date=4 January 2021|website=Medicines and Healthcare products Regulatory Agency (MHRA)}}{{cite press release|title=Oxford University/AstraZeneca vaccine authorised by UK medicines regulator|url=https://www.gov.uk/government/news/oxford-universityastrazeneca-vaccine-authorised-by-uk-medicines-regulator|publisher=Department of Health and Social Care|access-date=30 December 2020|date=30 December 2020}}{{#invoke:Cite web||date=30 December 2020|title=Conditions of Authorisation for COVID-19 Vaccine AstraZeneca|url=https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/conditions-of-authorisation-for-covid-19-vaccine-astrazeneca|access-date=4 January 2021|website=Medicines and Healthcare products Regulatory Agency (MHRA)}}
- Uruguay
- Uzbekistan
- Vanuatu
- Vietnam{{#invoke:Cite web||title=Vietnam approves AstraZeneca COVID-19 vaccine, cuts short Communist Party congress|url=https://www.channelnewsasia.com/news/asia/vietnam-approves-astrazeneca-vaccine-reports-34-new-covid-19-14074712|access-date=5 February 2021|website=CNA}}
- Yemen{{#invoke:Cite web||title=Yemen receives 360,000 COVID-19 vaccine doses through the COVAX Facility|url=https://www.unicef.org/press-releases/yemen-receives-360000-covid-19-vaccine-doses-through-covax-facility|access-date=7 June 2021|website=www.unicef.org}}
- Zambia{{cite news|date=25 March 2021|title=Zambia sets out plans to vaccinate all people over 18 against COVID-19|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-zambia-vaccine-idUSKBN2BH2NS|access-date=17 April 2021}}{{#invoke:Cite web||title=Zambia launches the COVID-19 vaccination|url=https://reliefweb.int/report/zambia/zambia-launches-covid-19-vaccination|access-date=17 April 2021|website=ReliefWeb|date=16 April 2021 }}{{#invoke:Cite web||title=Zambia gets 1st 228,000 vaccine doses from COVAX|url=https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/zambia-gets-1st-228-000-vaccine-doses-from-covax/2206521|access-date=17 April 2021|website=aa.com.tr}}
- Zimbabwe
{{nowrap|CARPHA countries and entities}}{{cite web |title=CARPHA Issues its First Emergency Use Recommendation for a COVID-19 Vaccine |url=https://www.carpha.org/More/Media/Articles/ArticleID/435/CARPHA-Issues-its-First-Emergency-Use-Recommendation-for-a-COVID-19-Vaccine |website=Caribbean Public Health Agency}}
- Antigua and Barbuda
- Bahamas
- Barbados
- Belize
- Dominica
- Grenada
- Guyana
- Haiti
- Jamaica
- Saint Kitts and Nevis
- Saint Lucia
- Saint Vincent and the Grenadines
- Suriname{{cite news|date=23 February 2021|title=Suriname begins coronavirus vaccination campaign with donated doses|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-suriname-vaccine-idUSKBN2AN2AT|access-date=28 February 2021}}
- Trinidad and Tobago
:* Anguilla
:* Aruba
:* British Virgin Islands
:* Bermuda
:* Caribbean Netherlands
:* Cayman Islands
:* Curaçao
:* Montserrat
:* Sint Maarten
:* Turks and Caicos Islands
- Cook Islands
- Falkland Islands
- French Polynesia
- Greenland
- Guadeloupe
- Guernsey
- Isle of Man
- Jersey
- Northern Cyprus{{#invoke:Cite web||last=Psyllides|first=George|title=Coronavirus: 10,000 vaccines handed over to north |url=https://cyprus-mail.com/2021/03/31/coronavirus-10000-vaccines-handed-over-to-north/|access-date=17 April 2021|website=cyprus-mail.com/|date=31 March 2021 }}
- Pitcairn
- Saint Helena, Ascension and Tristan da Cunha
- Wallis and Futuna
- World Health Organization{{cite web | title=COVID-19 Vaccines with WHO Emergency Use Listing | website=World Health Organization (WHO) | date=3 November 2021 | url=https://extranet.who.int/pqweb/vaccines/vaccinescovid-19-vaccine-eul-issued | access-date=30 October 2022 | archive-date=21 December 2021 | archive-url=https://web.archive.org/web/20211221213532/https://extranet.who.int/pqweb/vaccines/vaccinescovid-19-vaccine-eul-issued | url-status=dead }}{{#invoke:Cite web||title=Interim recommendations for use of the AZD1222 (ChAdOx1-S (recombinant)) vaccine against COVID-19 developed by Oxford University and AstraZeneca|url=https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGE_recommendation-AZD1222-2021.1|access-date=27 February 2021|publisher=World Health Organization (WHO)}}{{cite news|title=AstraZeneca/Oxford Covid-19 Vaccine Gets Emergency Approval From WHO|website=Forbes|url=https://www.forbes.com/sites/alisondurkee/2021/02/15/astrazeneca-oxford-covid-19-vaccine-gets-emergency-approval-from-who/|access-date=16 February 2021}}{{cite web | title=WHO Recommendation AstraZeneca/SKBio - COVID-19 Vaccine (ChAdOx1-S [recombinant]) | website=World Health Organization (WHO) | date=15 February 2021 | url=https://extranet.who.int/pqweb/vaccines/covid-19-vaccine-chadox1-s-recombinant | access-date=8 May 2021 | archive-date=4 July 2021 | archive-url=https://web.archive.org/web/20210704174442/https://extranet.who.int/pqweb/vaccines/covid-19-vaccine-chadox1-s-recombinant }}{{cite web | title=WHO recommendation Serum Institute of India Pvt Ltd - COVID-19 Vaccine (ChAdOx1-S [recombinant]) - Covishield | website=World Health Organization (WHO) | date=15 February 2021 | url=https://extranet.who.int/pqweb/vaccines/covid-19-vaccine-chadox1-s-recombinant-covishield | access-date=8 May 2021 | archive-date=6 July 2021 | archive-url=https://web.archive.org/web/20210706125046/https://extranet.who.int/pqweb/vaccines/covid-19-vaccine-chadox1-s-recombinant-covishield }}
;Travel-only
- Hong Kong{{cite web |title=List of COVID-19 Vaccines Recognised for Specified Purposes |url=https://www.coronavirus.gov.hk/pdf/list_of_recognised_covid19_vaccines.pdf |publisher=Hong Kong Department of Health |access-date=24 November 2021}}
- Switzerland{{cite web|last=FOPH|first=Federal Office of Public Health|title=Coronavirus: Entering Switzerland|url=https://www.bag.admin.ch/bag/en/home/krankheiten/ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-epidemien/novel-cov/empfehlungen-fuer-reisende/quarantaene-einreisende.html|access-date=19 November 2021|website=www.bag.admin.ch|archive-date=24 July 2020|archive-url=https://web.archive.org/web/20200724080307/https://www.bag.admin.ch/bag/en/home/krankheiten/ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-epidemien/novel-cov/empfehlungen-fuer-reisende/quarantaene-einreisende.html}}
- United States{{cite web|date=11 February 2020|title=COVID-19 and Your Health|url=https://www.cdc.gov/coronavirus/2019-ncov/travelers/proof-of-vaccination.html|access-date=17 November 2021|website=U.S. Centers for Disease Control and Prevention (CDC)}}
{{nowrap|EMA countries}}{{cite web | title=Vaxzevria | website=Union Register of medicinal products | url=https://ec.europa.eu/health/documents/community-register/html/h1529.htm | access-date=26 November 2021}}
- Austria
- Belgium
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Malta
- Netherlands
- Norway
- Poland
- Portugal
- Romania
- Slovakia
- Slovenia
- Spain
- Sweden
Pfizer–BioNTech
{{infobox
| image = {{Graph:Map|scale=65|defaultValue=gainsboro
|AD=dodgerblue|AE=dodgerblue|AF=dodgerblue|AG=dodgerblue|AI=dodgerblue|AL=dodgerblue|AM=dodgerblue|AO=limegreen|AR=dodgerblue|AS=dodgerblue|AT=blueviolet|AU=blueviolet|AW=dodgerblue|AZ=dodgerblue
|BA=dodgerblue|BB=dodgerblue|BD=dodgerblue|BE=blueviolet|BF=limegreen|BG=blueviolet|BH=dodgerblue|BJ=dodgerblue|BM=dodgerblue|BN=limegreen|BO=dodgerblue|BQ=dodgerblue|BR=blueviolet|BS=dodgerblue|BT=dodgerblue|BW=dodgerblue|BZ=dodgerblue
|CA=blueviolet|CD=dodgerblue|CF=limegreen|CG=limegreen|CH=blueviolet|CI=dodgerblue|CK=dodgerblue|CL=dodgerblue|CM=dodgerblue|CO=dodgerblue|CR=dodgerblue|CV=dodgerblue|CW=dodgerblue|CY=blueviolet|CZ=blueviolet
|DE=blueviolet|DJ=dodgerblue|DK=blueviolet|DM=dodgerblue|DO=dodgerblue|DZ=dodgerblue
|EC=dodgerblue|EE=blueviolet|EG=dodgerblue|ES=blueviolet|ET=limegreen
|FI=blueviolet|FJ=limegreen|FM=blueviolet|FO=dodgerblue|FR=blueviolet
|GA=dodgerblue|GB=dodgerblue|GD=dodgerblue|GE=dodgerblue|GH=dodgerblue|GI=dodgerblue|GL=dodgerblue|GM=limegreen|GN=dodgerblue|GP=dodgerblue|GR=blueviolet|GT=dodgerblue|GU=dodgerblue|GY=dodgerblue
|HK=dodgerblue|HN=dodgerblue|HR=blueviolet|HT=dodgerblue|HU=blueviolet
|ID=dodgerblue|IE=blueviolet
|IL=dodgerblue|IM=dodgerblue|IN=limegreen|IQ=dodgerblue|IR=limegreen|IS=blueviolet|IT=blueviolet
|JE=dodgerblue|JM=dodgerblue|JO=dodgerblue|JP=dodgerblue
|KE=dodgerblue|KG=dodgerblue|KH=dodgerblue|KI=limegreen|KM=limegreen|KN=dodgerblue|KP=limegreen|KR=dodgerblue|KW=dodgerblue|KY=dodgerblue|KZ=dodgerblue
|LA=dodgerblue|LB=limegreen|LC=dodgerblue|LI=blueviolet|LK=dodgerblue|LR=limegreen|LS=limegreen|LT=blueviolet|LU=blueviolet|LV=blueviolet|LY=dodgerblue
|MA=dodgerblue|MC=dodgerblue|MD=dodgerblue|ME=dodgerblue|MH=blueviolet|MK=dodgerblue|ML=limegreen|MM=limegreen|MN=dodgerblue|MO=dodgerblue|MP=dodgerblue|MQ=dodgerblue|MR=limegreen|MS=dodgerblue|MT=blueviolet|MU=limegreen|MV=dodgerblue|MW=dodgerblue|MX=dodgerblue|MY=dodgerblue|MZ=limegreen
|NA=dodgerblue|NC=dodgerblue|NE=limegreen|NG=dodgerblue|NI=dodgerblue|NL=blueviolet|NO=blueviolet|NP=dodgerblue|NR=limegreen|NU=dodgerblue|NZ=blueviolet
|OM=dodgerblue
|PA=dodgerblue|PE=dodgerblue|PF=dodgerblue|PG=dodgerblue|PH=dodgerblue|PK=dodgerblue|PL=blueviolet|PR=dodgerblue|PS=dodgerblue|PT=blueviolet|PW=blueviolet|PY=dodgerblue
|QA=dodgerblue
|RO=blueviolet|RS=dodgerblue|RW=dodgerblue
|SA=blueviolet|SB=limegreen|SD=dodgerblue|SE=blueviolet|SG=dodgerblue|SI=blueviolet|SK=blueviolet|SL=limegreen|SM=dodgerblue|SN=limegreen|SO=dodgerblue|SR=dodgerblue|SS=limegreen|ST=limegreen|SV=dodgerblue|SX=dodgerblue|SY=dodgerblue|SZ=dodgerblue
|TC=dodgerblue|TD=limegreen|TG=limegreen|TH=dodgerblue|TJ=dodgerblue|TK=dodgerblue|TL=dodgerblue|TN=dodgerblue|TO=dodgerblue|TR=dodgerblue|TT=dodgerblue|TV=limegreen|TW=dodgerblue|TZ=dodgerblue
|UA=dodgerblue|UG=dodgerblue|US=blueviolet|UY=dodgerblue|UZ=dodgerblue
|VA=dodgerblue|VC=dodgerblue|VE=limegreen|VG=dodgerblue|VN=dodgerblue|VU=limegreen
|WS=dodgerblue
|XK=dodgerblue
|YE=dodgerblue
|ZA=dodgerblue|ZM=dodgerblue|ZW=limegreen
}}
| caption = {{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|limegreen|Eligible COVAX recipient}}
}}
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty,{{#invoke:Cite web||title=Comirnaty EPAR|url=https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty|access-date=23 December 2020|publisher=European Medicines Agency (EMA)}} is an mRNA vaccine{{#invoke:Cite web||date=9 December 2020|title=Regulatory Decision Summary – Pfizer-BioNTech COVID-19 Vaccine|url=https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detailTwo.html?linkID=RDS00730|access-date=9 December 2020|publisher=Health Canada, Government of Canada}} produced by the German company BioNTech and the American company Pfizer.{{#invoke:Cite web||date=30 April 2020|title=Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults|url=https://clinicaltrials.gov/ct2/show/NCT04368728|url-status=live|archive-url=https://web.archive.org/web/20201011084828/https://clinicaltrials.gov/ct2/show/NCT04368728/|archive-date=11 October 2020|access-date=14 July 2020|website=ClinicalTrials.gov|publisher=United States National Library of Medicine|id=NCT04368728}}{{#invoke:Cite web||date=14 April 2020|title=A Multi-site Phase I/II, 2-Part, Dose-Escalation Trial Investigating the Safety and Immunogenicity of four Prophylactic SARS-CoV-2 RNA Vaccines Against COVID-19 Using Different Dosing Regimens in Healthy Adults|url=https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001038-36/DE|url-status=live|archive-url=https://web.archive.org/web/20200422111024/https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001038-36/DE|archive-date=22 April 2020|access-date=22 April 2020|website=EU Clinical Trials Register|publisher=European Union|id=EudraCT 2020-001038-36}} In Hong Kong, Macau, and Taiwan, Comirnaty is distributed by Fosun Pharma.{{#invoke:Cite web||title=BioNTech and China partner, not Pfizer, to produce HK shots|url=https://www.thestandard.com.hk/section-news/section/11/225661/BioNTech-and-China-partner,-not-Pfizer,-to-produce-HK-shots|website=The Standard}}{{#invoke:Cite web||title=Pfizer and BioNTech's overlooked third partner will distribute the vaccine in China – and it's facing some resistance |url=https://fortune.com/2021/01/09/covid-vaccine-china-fosun-pfizer-biontech/|access-date=18 April 2021}}{{cite news|last=Burger|first=Ludwig|date=16 March 2020|title=BioNTech in China alliance with Fosun over potential coronavirus vaccine|work=Reuters|url=https://www.reuters.com/article/us-biontech-fosunpharma-vaccine-collabor-idUKKBN2130O5|access-date=18 April 2021}}{{cite news|date=25 November 2020|title=BioNTech, Fosun start Phase II trial of COVID-19 vaccine in China|work=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-biontech-fosunphar-idUSKBN2850ZZ|access-date=18 April 2021}}
= Original =
;Full (39)
- Australia{{#invoke:Cite web||title=Comirnaty|url=https://www.tga.gov.au/apm-summary/comirnaty|date=25 January 2021|access-date=25 January 2021|publisher=Therapeutic Goods Administration (TGA)}}{{cite report | url=https://www.tga.gov.au/sites/default/files/auspar-bnt162b2-mrna-210125.pdf | title=Australian Public Assessment Report for BNT162b2 (mRNA) | publisher=Therapeutic Goods Administration (TGA) | access-date=25 January 2021}}
- Brazil{{#invoke:Cite web||url=https://g1.globo.com/bemestar/vacina/noticia/2021/02/23/anvisa-concede-registro-definitivo-a-vacina-da-pfizer.ghtml|title=Vacina da Pfizer é a 1ª a obter registro definitivo no Brasil|publisher=G1|date=23 February 2021|access-date=23 February 2021|language=pt-br}}
- Canada{{cite news|last=Osman|first=Laura|date=16 September 2021|title=Goodbye Pfizer, hello Comirnaty: Top COVID-19 vaccines given brand names in Canada|work=CBC News|url=https://www.cbc.ca/news/health/vaccine-name-change-canada-1.6178484|access-date=16 September 2021}}
- Marshall Islands{{efn|name=CFA}}{{efn|name=useua|Full approval only for those aged 12+. EUA still applies for recipients aged 6 months through 11 years.}}
- Micronesia{{efn|name=CFA}}{{efn|name=useua}}
- New Zealand{{#invoke:Cite web||date=3 February 2021|title=Robust assessment ahead of Medsafe approval of vaccine|url=https://www.health.govt.nz/news-media/media-releases/robust-assessment-ahead-medsafe-approval-vaccine|access-date=6 February 2021|work=Ministry of Health}}
- Palau{{efn|name=CFA|via United States authorization through Compact of Free Association{{cite press release | title=Interior Applauds Inclusion of Insular Areas through Operation Warp Speed to Receive COVID-19 Vaccines | publisher=United States Department of the Interior (DOI) | date=12 December 2020 | url=https://www.doi.gov/oia/press/interior-applauds-inclusion-insular-areas-through-operation-warp-speed-receive-covid-19 | access-date=13 January 2021}} {{PD-notice}}{{cite news|url=https://www.hawaiipublicradio.org/post/asia-minute-palau-administers-vaccines-keep-country-free-covid#stream/0|publisher=Hawaii Public Radio|title=Asia Minute: Palau Administers Vaccines to Keep Country Free of COVID|first=Bill|last=Dorman|date=6 January 2021|access-date=13 January 2021}}}}{{efn|name=useua}}
- Saudi Arabia{{#invoke:Cite web||date=10 December 2020|title=Coronavirus: Saudi Arabia approves Pfizer COVID-19 vaccine for use|url=https://english.alarabiya.net/en/coronavirus/2020/12/10/Coronavirus-Saudi-Arabia-approves-Pfizer-COVID-19-vaccine-for-use|access-date=10 December 2020|website=Al Arabiya English}}{{cite news|last1=Zimmer|first1=Carl|last2=Corum|first2=Jonathan|last3=Wee|first3=Sui-Lee|title=Coronavirus Vaccine Tracker|work=The New York Times|date=10 June 2020 |url=https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html}}
- Switzerland{{cite press release|title=Swissmedic grants authorisation for the first COVID-19 vaccine in Switzerland|url=https://www.bag.admin.ch/bag/en/home/das-bag/aktuell/medienmitteilungen.msg-id-81761.html|publisher=Swiss Agency for Therapeutic Products (Swissmedic)|date=19 December 2020|access-date=19 December 2020}}{{#invoke:Cite web||title=Comirnaty Product information|url=https://www.swissmedicinfo.ch/ShowText.aspx?textType=FI&lang=DE&authNr=68225|access-date=31 January 2021|language=DE|trans-quote=Due to incomplete clinical data at the time of the assessment of the authorization application, the Comirnaty medicinal product is authorized for a limited period (Art. 9a Medicinal Products Act).}}
{{nowrap|EMA countries}}
- Austria
- Belgium
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Malta
- Netherlands
- Norway
- Poland
- Portugal
- Romania
- Slovakia
- Slovenia
- Spain
- Sweden
- Hong Kong{{#invoke:Cite web||date=25 January 2021|title=Use of vaccine approved|url=https://www.news.gov.hk/eng/2021/01/20210125/20210125_175428_123.html|access-date=15 February 2021|publisher=Government of Hong Kong}}{{#invoke:Cite web||date=20 December 2022|title=COVID-19 vaccines supplied by two drug manufacturers registered as pharmaceutical products in Hong Kong|url=https://www.info.gov.hk/gia/general/202212/20/P2022122000523.htm|access-date=23 December 2022|publisher=Government of Hong Kong}}
;Emergency (145)
- Afghanistan
- Albania{{#invoke:Cite web||title=Albania to start COVID-19 immunisation with Pfizer vaccine in January – report|url=https://seenews.com/news/albania-to-start-covid-19-immunisation-with-pfizer-vaccine-in-jan-report-726470|website=Seenews}}
- Algeria{{cite web|date=5 May 2021|title=Canada allows Pfizer COVID-19 vaccine for children aged 12-15|url=https://www.reuters.com/world/americas/canada-authorizes-pfizer-covid-19-vaccine-children-aged-12-15-2021-05-05/|access-date=19 August 2021|website=Reuters}}
- Andorra{{#invoke:Cite web||title=Andorra COVID-19|url=https://www.govern.ad/covid19_newsletter/en/|access-date=19 February 2021|website=govern.ad}}
- Argentina{{cite news|title=Coronavirus en la Argentina: La ANMAT aprobo el uso de emergencia de la vacuna Pfizer|url=https://www.lanacion.com.ar/sociedad/coronavirus-argentina-anmat-aprobo-uso-emergencia-vacuna-nid2548852|access-date=23 December 2020|website=La Nación|language=es}}
- Armenia{{#invoke:Cite web||date=30 June 2021|title=Dashboard: Vaccinating Eurasia- June|url=https://eurasianet.org/dashboard-vaccinating-eurasia-june|access-date=4 August 2021|website=Eurasianet}}
- Azerbaijan
- Bahrain{{#invoke:Cite web||title=Bahrain becomes second country to approve Pfizer COVID-19 vaccine|url=https://www.aljazeera.com/news/2020/12/4/bahrain-becomes-second-country-to-approve-pfizer-covid-19-vaccine|access-date=5 December 2020|publisher=Al Jazeera}}{{cite web | title=The Pfizer-BioNTech COVID-19 Vaccine Was Granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) & Bahrain National Health Regulatory Authority (NHRA) | website=cvdvaccine | url=https://www.cvdvaccine-bh.com/ | access-date=18 April 2021}}
- Bangladesh{{#invoke:Cite web||title=Bangladesh approves Pfizer Covid-19 vaccine for emergency use|date=27 May 2021|url=https://www.dhakatribune.com/bangladesh/2021/05/27/bangladesh-approves-pfizer-covid-19-vaccine-for-emergency-use|access-date=27 May 2021|publisher=Dhaka Tribune}}
- Benin
- Bhutan
- Bolivia
- Bosnia and Herzegovina{{#invoke:Cite web||title=Pfizer/BioNTech COVID-19 vaccines shipped by COVAX arrive in Bosnia and Herzegovina|url=https://bosniaherzegovina.un.org/en/123137-pfizerbiontech-covid-19-vaccines-shipped-covax-arrive-bosnia-and-herzegovina|access-date=14 April 2021|publisher=United Nations}}
- Botswana{{cite news|title=Botswana expects to welcome multiple COVID-19 vaccines |url=http://www.xinhuanet.com/english/africa/2021-02/27/c_139771113.htm|access-date=1 April 2021|publisher=Xinhuanet}}
- Brunei{{#invoke:Cite web||title=COVID-19: Brunei to begin mass vaccination on April 3 |url=https://thescoop.co/2021/04/02/covid-19-brunei-to-begin-mass-vaccination-on-april-3/|access-date=6 April 2021|website=TheScoop|date=2 April 2021}}
- Cambodia
- Cameroon
- Cape Verde
- Chile{{#invoke:Cite web||date=17 December 2020|title=Chile approves Pfizer-BioNTech Covid-19 vaccine for emergency use|url=https://www.straitstimes.com/world/chile-approves-pfizer-biontech-covid-19-vaccine-for-emergency-use|access-date=17 December 2020|website=The Straits Times}}
- China (For German citizens){{#invoke:Cite web||date=22 December 2022|title=BioNTech ships COVID shots to China for use by Germans|url=https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-says-shipped-11500-doses-covid-vaccine-china-2022-12-22/|access-date=23 December 2022|website=Reuters}}
- Colombia{{cite news|date=6 January 2021|title=Colombia regulator approves Pfizer-BioNTech vaccine for emergency use|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-colombia-vaccine/colombia-regulator-approves-pfizer-biontech-vaccine-for-emergency-use-idINL1N2JH00P/|access-date=6 January 2021}}
- Congo-Kinshasa{{cite web|date=7 December 2021|title=Covid-19 en RDC: des officiers et agents de la Police se font vacciner après échanges avec le ministre de la Santé|url=https://actualite.cd/2021/12/07/covid-19-en-rdc-des-officiers-et-agents-de-la-police-se-font-vacciner-apres-echanges|access-date=12 January 2022|website=Actualite.cd|language=fr}}
- Costa Rica{{#invoke:Cite web||date=16 December 2020|title=Costa Rica authorizes Pfizer-BioNTech coronavirus vaccine|url=https://ticotimes.net/2020/12/16/costa-rica-authorizes-pfizer-biontech-coronavirus-vaccine|access-date=16 December 2020|website=The Tico Times}}
- Djibouti
- Dominican Republic[https://covid-19pharmacovigilance.paho.org/pfizer-biontech Pfizer-BioNTech COVID-19 vaccine]. Pan American Health Organization.
- East Timor
- Ecuador{{#invoke:Cite web||title=Arcsa autoriza ingreso al país de vacuna Pfizer-BioNTech para el Covid-19 – Agencia Nacional de Regulación, Control y Vigilancia Sanitaria|url=https://www.controlsanitario.gob.ec/arcsa-autoriza-ingreso-al-pais-de-vacuna-pfizer-biontech-para-el-covid-19/|access-date=17 December 2020|language=es}}
- Egypt
- El Salvador{{#invoke:Cite web||last=McGwin|first=Kevin|date=30 December 2020|title=Greenland to begin new year with COVID vaccinations|url=https://www.arctictoday.com/greenland-to-begin-new-year-with-covid-vaccinations/|access-date=21 March 2021|website=ArcticToday}}
- Eswatini
- Fiji{{cite web|title=Vaccine FAQs – MINISTRY OF HEALTH & MEDICAL SERVICES| date=24 March 2021 |url=https://www.health.gov.fj/covid-vaccine/vaccine-faqs/|access-date=6 January 2022}}
- Gabon
- Georgia
- Ghana{{cite web|title=Ghana approves two more COVID-19 vaccines - Xinhua | English.news.cn|url=http://www.xinhuanet.com/english/africa/2021-07/29/c_1310092883.htm|access-date=30 November 2021|website=xinhuanet}}
- Guatemala{{cite web |title=COVID-19 Information |url=https://gt.usembassy.gov/alert-covid-19-2/ |website=U.S. Embassy in Guatemala |date=25 February 2020 |access-date=14 April 2021 |archive-date=7 May 2021 |archive-url=https://web.archive.org/web/20210507124017/https://gt.usembassy.gov/alert-covid-19-2/ }}
- Guinea
- Honduras
- Indonesia{{cite news|url=https://www.cnnindonesia.com/nasional/20210715145336-20-668159/bpom-terbitkan-izin-penggunaan-darurat-vaksin-covid-19-pfizer|title=BPOM Terbitkan Izin Penggunaan Darurat Vaksin COVID-19 Pfizer|work=CNN Indonesia|date=15 July 2021|access-date=15 July 2021|language=id}}
- Iraq{{#invoke:Cite web||title=Iraq grants emergency approval for Pfizer COVID-19 vaccine|url=https://www.msn.com/en-ae/news/other/iraq-grants-emergency-approval-for-pfizer-covid-19-vaccine/ar-BB1cgvD6|access-date=27 December 2020|publisher=MSN}}
- Israel{{#invoke:Cite web||title=Israeli Health Minister 'pleased' as FDA approves Pfizer COVID-19 vaccine|url=https://www.jpost.com/breaking-news/fda-approves-pfizer-biontech-covid-19-vaccine-for-emergency-use-nyt-651871|access-date=28 December 2020|website=The Jerusalem Post|date=12 December 2020 }}
- Ivory Coast
- Japan{{cite news|date=14 February 2021|title=Japan approves Pfizer's COVID-19 vaccine, 1st for domestic use|work=Nikkei Asia|url=https://asia.nikkei.com/Spotlight/Coronavirus/Japan-approves-Pfizer-s-COVID-19-vaccine-1st-for-domestic-use|access-date=14 February 2021|archive-date=18 March 2021|archive-url=https://web.archive.org/web/20210318232113/https://asia.nikkei.com/Spotlight/Coronavirus/Japan-approves-Pfizer-s-COVID-19-vaccine-1st-for-domestic-use}}{{#invoke:Cite web||last=Tsukimori|first=Osamu|date=15 February 2021|title=Japan gives OK to Pfizer coronavirus vaccine, with rollout to begin this week|url=https://www.japantimes.co.jp/news/2021/02/15/national/science-health/pfizer-vaccine-approval-japan/|access-date=1 April 2021|website=The Japan Times}}
- Jordan{{#invoke:Cite web||date=15 December 2020|title=Jordan approves Pfizer-BioNTech Covid vaccine|url=https://www.france24.com/en/live-news/20201215-jordan-approves-pfizer-biontech-covid-vaccine|access-date=15 December 2020|publisher=France 24}}
- Kazakhstan
- Kenya{{#invoke:Cite news||date=2 August 2021|title=Kenya Approves J&J, Pfizer Covid-19 Vaccines as Cases Surge|work=Bloomberg.com|url=https://www.bloomberg.com/news/articles/2021-08-02/kenya-approves-j-j-pfizer-covid-19-vaccines-as-cases-surge|access-date=24 September 2021}}
- Kosovo
- Kuwait{{#invoke:Cite web||date=13 December 2020|title=Kuwait authorizes emergency use of Pfizer-BioNTech COVID-19 vaccine|url=https://arab.news/427j9|access-date=15 December 2020|website=Arab News}}
- Kyrgyzstan
- Laos
- Lebanon{{#invoke:Cite web||date=14 February 2021|title=Lebanon starts Covid-19 vaccination campaign|url=https://www.france24.com/en/middle-east/20210214-lebanon-starts-covid-19-vaccination-campaign|access-date=16 March 2021|publisher=France 24}}
- Libya
- Malawi{{cite web|title=Malawi Ministry of Health on Facebook|url=https://www.facebook.com/login/?next=https%253A%252F%252Fwww.facebook.com%252Fmalawimoh%252Fposts%252F4098884300167054|access-date=14 September 2021|website=Facebook}}
- Malaysia{{cite news|last=Lim|first=Ida|date=8 January 2021|title=Khairy: Malaysia can use Pfizer's Covid-19 vaccine now as conditional registration granted|work=The Malay Mail|url=https://www.msn.com/en-my/news/national/khairy-malaysia-can-use-pfizer-e2-80-99s-covid-19-vaccine-now-as-conditional-registration-granted/ar-BB1czVUU|access-date=8 January 2021}}
- Maldives{{#invoke:Cite web||date=15 March 2021|title=Sinopharm & Pfizer approved for use in Maldives|url=https://timesofaddu.com/2021/03/15/breaking-sinopharm-pfizer-approved-for-use-in-maldives/|access-date=1 April 2021|website=The Times of Addu}}
- Mexico{{cite news|date=12 December 2020|title=Mexico Approves Pfizer Vaccine for Emergency Use as Covid Surges|publisher=Bloomberg|url=https://www.bloomberg.com/news/articles/2020-12-12/mexico-approves-pfizer-vaccine-for-emergency-use-as-covid-surges|access-date=12 December 2020}}{{cite news|date=12 December 2020|title=Mexico authorizes emergency use of Pfizer-BioNTech coronavirus vaccine|website=The Economic Times|url=https://economictimes.indiatimes.com/news/international/world-news/mexico-authorizes-emergency-use-of-pfizer-biontech-coronavirus-vaccine/articleshow/79696221.cms|access-date=14 January 2021}}
- Moldova{{cite news|title=Moldova approves Russia's Sputnik V vaccine as political row simmers|url=https://news.trust.org/item/20210227162136-o0jx5/|access-date=1 April 2021|website=Thomson Reuters Foundation|archive-date=3 April 2021|archive-url=https://web.archive.org/web/20210403221351/https://news.trust.org/item/20210227162136-o0jx5/|url-status=dead}}
- Monaco{{#invoke:Cite web||title=First Vaccines Arrive in Monaco – COVID-19 vaccination campaign begins tomorrow / Actualités / Coronavirus (Covid-19) / Policy & Practice / Portail du Gouvernement – Monaco|url=https://en.gouv.mc/Policy-Practice/Coronavirus-Covid-19/Actualites/FIRST-VACCINES-ARRIVE-IN-MONACO-COVID-19-vaccination-campaign-begins-tomorrow|access-date=19 February 2021|website=en.gouv.mc}}
- Mongolia{{#invoke:Cite web||title=Mongolia will receive 300,000 doses of COVID-19 vaccine developed by China|url=https://akipress.com/news:654794:Mongolia_will_receive_300,000_doses_of_COVID-19_vaccine_developed_by_China/|access-date=19 March 2021|website=AKIpress News Agency}}
- Montenegro
- Morocco
- Namibia
- Nepal{{cite web|date=14 November 2021|title=People to get Pfizer vaccine from today|url=https://thehimalayantimes.com/nepal/people-to-get-pfizer-vaccine-from-today|access-date=28 December 2021|website=himalayantimes}}
- Nicaragua
- Nigeria{{#invoke:Cite web||date=30 April 2021|title=NAFDAC approves Pfizer Biotech Vaccine for emergency use authorisation|url=https://editor.guardian.ng/news/nafdac-approves-pfizer-biotech-vaccine-for-emergency-use-authorisation/|access-date=21 July 2021|website=The Guardian Nigeria News - Nigeria and World News}}
- North Macedonia{{#invoke:Cite news||title=North Macedonia Kicks Off COVID-19 Vaccinations As Serbia Looks To Highlight Regional Efforts|url=https://www.rferl.org/a/north-macedonia-kicks-off-covid-19-vaccinations/31108206.html|access-date=19 February 2021|newspaper=Radio Free Europe/Radio Liberty|date=18 February 2021 }}
- Oman{{cite news|date=15 December 2020|title=Oman issues licence to import Pfizer BioNTech Covid vaccine – TV|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-oman-vaccine-int-idUSKBN28P1RA|access-date=16 December 2020}}
- Pakistan{{cite web |title=DRAP gives emergency approval for Pfizer's coronavirus vaccine |url=https://www.geo.tv/latest/352816-drap-gives-emergency-approval-for-pfizers-coronavirus-vaccine |website=www.geo.tv }}
- Palestine
- Panama{{#invoke:Cite web||title=Panama approves Pfizer's COVID-19 vaccine – health ministry|date=16 December 2020 |url=https://finance.yahoo.com/news/panama-approves-pfizers-covid-19-010942802.html|access-date=16 December 2020|publisher=Yahoo! Finance}}
- Papua New Guinea{{#invoke:Cite web||date=12 August 2021|title=Vaccination is not compulsory, Prime Minister tells Parliament|url=https://covid19.info.gov.pg/vaccination-is-not-compulsory-prime-minister-tells-parliament/|access-date=24 September 2021|website=PNG | COVID 19}}
- Paraguay{{#invoke:Cite web||title=DNVS otorga registro sanitario de emergencia a Pfizer - MSPBS Py|url=https://www.mspbs.gov.py/portal/23306/dnvs-otorga-registro-sanitario-de-emergencia-a-pfizer.html}}{{#invoke:Cite web||title=Pfizer: la nueva vacuna que compró Paraguay. MSPBS Paraguay|url=https://www.mspbs.gov.py/portal/23192/pfizer-la-nueva-vacuna-que-compro-paraguay.html}}
- Peru{{#invoke:Cite web||title=Peru regulators approve Pfizer vaccine against COVID-19: filing|date=2 February 2021 |url=https://news.yahoo.com/peru-regulators-approve-pfizer-vaccine-173719455.html|access-date=31 March 2021|publisher=Yahoo! News}}
- Philippines{{#invoke:cite news||date=14 January 2021|title=PH authorizes Pfizer's COVID-19 vaccine for emergency use|publisher=CNN Philippines|url=https://cnnphilippines.com/news/2021/1/14/Pfizer-COVID-19-vaccine-Philippines-FDA-emergency-use-EUA.html|archive-url=https://web.archive.org/web/20210114035215/https://cnnphilippines.com/news/2021/1/14/Pfizer-COVID-19-vaccine-Philippines-FDA-emergency-use-EUA.html|url-status=dead|archive-date=14 January 2021|access-date=14 January 2021}}
- Qatar{{#invoke:cite news||title=Qatar, Oman to receive Pfizer-BioNTech COVID-19 vaccine this week|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-vaccine-qatar/qatar-oman-to-receive-pfizer-biontech-covid-19-vaccine-this-week-idUSKBN28U0VE|access-date=24 December 2020}}
- Rwanda
- Samoa
- San Marino
- Serbia{{#invoke:cite news||date=21 December 2020|title=Serbia leads region in expecting COVID-19 vaccines within days|work=BalkanInsight|url=https://balkaninsight.com/2020/12/21/serbia-leads-region-in-expecting-covid-19-vaccines-within-days/|access-date=26 December 2020}}{{cite news|date=22 December 2020|title=First shipment of Pfizer-BioNTech vaccine arrives in Serbia|work=Serbian government website|url=https://www.srbija.gov.rs/vest/en/165409/first-shipment-of-pfizer-biontech-vaccine-arrives-in-serbia.php|access-date=26 December 2020}}
- Singapore{{#invoke:Cite web||date=14 December 2020|title=Singapore approves use of Pfizer's COVID-19 vaccine|url=https://apnews.com/article/science-singapore-coronavirus-pandemic-lee-hsien-loong-coronavirus-vaccine-5bf8461b9d2d32ec08d56fcf5958317a|access-date=15 December 2020|publisher=Associated Press}}
- Somalia
- South Africa{{#invoke:Cite web||title=South Africa approves Pfizer Covid-19 vaccine for emergency use|url=https://businesstech.co.za/news/trending/476360/south-africa-approves-pfizer-covid-19-vaccine-for-emergency-use/|access-date=18 March 2021}}{{#invoke:Cite web||title=Pfizer-BioNTec approved for emergency use in SA: here is what you need to know about the vaccine|url=https://www.timeslive.co.za/news/south-africa/2021-03-18-pfizer-biontec-approved-for-emergency-use-in-sa-here-is-what-you-need-to-know-about-the-vaccine/|access-date=19 March 2021|website=TimesLIVE}}
- South Korea{{cite news|last1=Lee|first1=Kyung-eun|date=27 February 2021|title=S. Korea begins rolling out Pfizer vaccines on second day of national vaccination program|work=Arirang News|url=https://www.arirang.com/news/News_View.asp?nseq=273056|access-date=28 February 2021|archive-date=10 March 2021|archive-url=https://web.archive.org/web/20210310013846/https://www.arirang.com/news/News_View.asp?nseq=273056}}{{cite news|last1=Kim|first1=Han-joo|date=5 March 2021|title=S. Korea approves Pfizer's COVID-19 vaccine amid immunization push|publisher=Yonhap News |url=https://en.yna.co.kr/view/AEN20210305001500320|access-date=5 March 2021}}
- Sri Lanka{{cite web |title=Sri Lanka approves Pfizer COVID vaccine for emergency use |url=https://www.reuters.com/business/healthcare-pharmaceuticals/sri-lanka-approves-pfizer-covid-vaccine-emergency-use-2021-05-08/ |website=Reuters |date=8 May 2021}}
- Sudan
- Syria
- Taiwan{{cite web | last=Kemp | first=Robert | title=Fosun says it has struck deal to send Taiwan vaccines | website=RTHK | date=11 July 2021 | url=https://news.rthk.hk/rthk/en/component/k2/1600277-20210711.htm? | access-date=11 July 2021}}{{cite press release | title=10 Million Doses of mRNA-based COVID-19 Vaccine to be supplied to Taiwan Region | website=BioNTech | date=12 July 2021 | url=https://investors.biontech.de/news-releases/news-release-details/10-million-doses-mrna-based-covid-19-vaccine-be-supplied-taiwan | access-date=18 July 2021}}
- Tajikistan
- Tanzania
- Thailand{{cite news | title = Thailand approves Pfizer-Biontech vaccine for emergency use | date = 24 June 2021 | url = https://www.reuters.com/world/asia-pacific/thailand-approves-pfizer-biontech-vaccine-emergency-use-2021-06-24/ | work = Reuters }}
- Tonga
- Tunisia
- Turkey{{cite web |author=Gözde Bayar |date=18 March 2021 |url=https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/turkey-to-receive-45m-doses-of-pfizer-vaccine-this-month/2179702 |title=Turkey to receive 4.5M doses of Pfizer vaccine this month |publisher=Anadolu Agency}}
- Uganda
- Ukraine{{#invoke:Cite web||title=Наказ МОЗ України від 22.02.2021 № 308 "Про державну реєстрацію лікарського засобу (медичного імунобіологічного препарату) для екстреного медичного застосування"|url=https://moz.gov.ua/article/ministry-mandates/nakaz-moz-ukraini-vid-22022021--308-pro-derzhavnu-reestraciju-likarskogo-zasobu-medichnogo-imunobiologichnogo-preparatu-dlja-ekstrenogo-medichnogo-zastosuvannja|access-date=19 March 2021|website=moz.gov.ua}}
- United Arab Emirates{{#invoke:Cite web||date=23 December 2020|title=Dubai approves the Pfizer-BioNTech vaccine which will be free of charge|url=https://emirateswoman.com/dubai-approves-the-pfizer-biontech-vaccine-for-free/|access-date=28 December 2020|website=Emirates Woman}}
- United Kingdom{{#invoke:Cite web||date=2 December 2020|title=UK medicines regulator gives approval for first UK COVID-19 vaccine|url=https://www.gov.uk/government/news/uk-medicines-regulator-gives-approval-for-first-uk-covid-19-vaccine|access-date=2 December 2020|publisher=Medicines and Healthcare Products Regulatory Agency, Government of the UK}}{{#invoke:Cite web||date=8 December 2020|title=Information for Healthcare Professionals on Pfizer/BioNTech COVID-19 vaccine|url=https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/information-for-healthcare-professionals-on-pfizerbiontech-covid-19-vaccine|access-date=13 December 2020|website=Medicines & Healthcare products Regulatory Agency (MHRA)}}{{#invoke:Cite web||date=3 December 2020|title=Conditions of Authorisation for Pfizer/BioNTech COVID-19 vaccine|url=https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/conditions-of-authorisation-for-pfizerbiontech-covid-19-vaccine|access-date=13 December 2020|website=Medicines & Healthcare products Regulatory Agency (MHRA)}}
- Uruguay{{cite web |title=Uruguay acquired Pfizer and Sinovac vaccines; details will be announced Saturday |url=https://en.mercopress.com/2021/01/23/uruguay-acquired-pfizer-and-sinovac-vaccines-details-will-be-announced-saturday |website=MercoPress }}
- Uzbekistan{{cite web|date=12 September 2021|title=U.S. Donates Over 1.2 million COVID-19 Pfizer Vaccines to Uzbekistan|url=https://uz.usembassy.gov/u-s-donates-over-1-2-million-covid-19-pfizer-vaccines-to-uzbekistan/|access-date=4 October 2021|website=
[[U.S. Embassy in Uzbekistan }} - Vatican City{{cite news|last=McElwee|first=Joshua J.|date=11 December 2020|title=Vatican to offer coronavirus vaccine to residents and staff in early 2021|publisher=National Catholic Reporter|url=https://www.ncronline.org/news/coronavirus/vatican-offer-coronavirus-vaccine-residents-and-staff-early-2021|access-date=9 February 2021}}{{cite press release|url=https://www.vaticannews.va/it/vaticano/news/2020-12/in-vaticano-parte-il-piano-vaccinale-anticovid.html|title=In Vaticano parte il piano vaccinale anticovid|date=11 December 2020|access-date=9 February 2021|first=Massimiliano|last=Menichetti|website=vatican.va}}
- Vietnam{{cite news|last=Le|first=Nga|date=12 June 2021|title=Vietnam approves Pfizer Covid vaccine for emergency use|work=VnExpress|url=https://e.vnexpress.net/news/news/vietnam-approves-pfizer-covid-vaccine-for-emergency-use-4293267.html}}
- Yemen
- Zambia{{cite web|title=COVID19 Vaccine Tracker|url=https://covid19.trackvaccines.org/|access-date=12 January 2022|website=covid19.trackvaccines.org}}
{{nowrap|CARPHA countries and entities}}{{cite web | title=Caribbean Public Health Agency > Who We Are > Member States | website=The Caribbean Public Health Agency (CARPHA) | url=https://www.carpha.org/Who-We-Are/Member-States | access-date=7 April 2021}}{{#invoke:Cite web||date=6 January 2021|title=Pfizer vaccine approved for region but Health Ministry wants more info|url=https://newsday.co.tt/2021/01/06/pfizer-vaccine-approved-for-region-but-health-ministry-wants-more-info/|access-date=24 February 2021|website=Trinidad and Tobago Newsday}}
- Antigua and Barbuda
- Bahamas
- Barbados
- Belize
- Dominica
- Grenada
- Guyana
- Haiti
- Jamaica
- Saint Kitts and Nevis
- Saint Lucia
- Saint Vincent and the Grenadines
- Suriname
- Trinidad and Tobago
:* Anguilla
:* Aruba
:* British Virgin Islands
:* Bermuda
:* Caribbean Netherlands
:* Cayman Islands
:* Curaçao
:* Montserrat
:* Sint Maarten
:* Turks and Caicos Islands
- American Samoa
- Cook Islands
- Faroe Islands{{#invoke:Cite web||last=Nielsdóttir|first=Alda|date=30 December 2020|title=First Covid-19 vaccines administered in the Faroe Islands|url=https://local.fo/first-covid-19-vaccines-administered-in-the-faroe-islands/|access-date=29 March 2021|website=Local.fo}}
- French Polynesia
- Gibraltar
- Greenland{{#invoke:Cite web||last1=Sevunts|first1=Levon|last2=International|first2=Radio Canada|date=4 January 2021|title=Greenland launches COVID-19 vaccination campaign|url=https://www.rcinet.ca/eye-on-the-arctic/2021/01/04/greenland-launches-covid-19-vaccination-campaign-1/|access-date=21 March 2021|website=Eye on the Arctic}}
- Guadeloupe
- Guam
- Guernsey
- Isle of Man
- Jersey
- Macau{{#invoke:cite web||title=Local BioNTech vaccination to resume on April 5 |url=https://www.macaubusiness.com/local-biontech-vaccination-to-resume-on-april-5/ |website=macaubusiness.com |date=2 April 2021 |access-date=15 April 2021}}
- Martinique
- New Caledonia
- Niue
- Northern Cyprus
- Northern Mariana Islands
- Puerto Rico
- Tokelau
- World Health Organization{{cite press release|title=WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access|website=World Health Organization (WHO)|url=https://www.who.int/news/item/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access|date=31 December 2020|access-date=6 January 2021}}{{cite web | title=WHO recommendation Tozinameran – COVID-19 mRNA vaccine (nucleoside modified) – Comirnaty | website=World Health Organization (WHO) | date=31 December 2020 | url=https://extranet.who.int/pqweb/vaccines/who-recommendation-covid-19-mrna-vaccine-nucleoside-modified-comirnaty | access-date=8 May 2021 | archive-date=9 May 2021 | archive-url=https://web.archive.org/web/20210509155424/https://extranet.who.int/pqweb/vaccines/who-recommendation-covid-19-mrna-vaccine-nucleoside-modified-comirnaty }}
= Bivalent original–BA.1 =
- Japan{{citation needed|date=December 2022}}
{{nowrap|EMA countries}}{{cite web|date=13 September 2022|title=Comirnaty|url=https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty|publisher=European Medicines Agency (EMA)}}
- Austria
- Belgium
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Malta
- Netherlands
- Norway
- Poland
- Portugal
- Romania
- Slovakia
- Slovenia
- Spain
- Sweden
= Bivalent original–BA.4/5 =
- Canada{{cite web | title=Pfizer-BioNTech Comirnaty COVID-19 vaccine | date=21 October 2022 | publisher=Health Canada | url=https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/pfizer-biontech.html | access-date=30 October 2022 }}{{cite web | url=https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detail.html?linkID=RDS01006 | title=Drug Details }}
- China (For German citizens)
{{nowrap|EMA countries}}
- Austria
- Belgium
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Malta
- Netherlands
- Norway
- Poland
- Portugal
- Romania
- Slovakia
- Slovenia
- Spain
- Sweden
- Hong Kong{{cite web |title=Comirnaty bivalent jab use authorised |url=https://www.news.gov.hk/eng/2022/11/20221118/20221118_115437_114.html |website=news.gov.hk |access-date=18 November 2022 |date=18 November 2022}}
- Macau{{cite web |title=Comirnaty Bivalent Vaccine Arrives in Hong Kong SAR and Macau SAR and Will Soon Be Available to the Local Residents |url=https://www.fosunpharma.com/en/content/details37_12001.html |publisher=Fosun Pharma |access-date=6 January 2023 |date=28 November 2022}}
- World Health Organization
= XBB.1.5 =
= JN.1 =
= KP.2 =
Janssen
{{infobox|image={{Graph:Map|scale=65|defaultValue=gainsboro
|AD=dodgerblue|AE=dodgerblue|AF=dodgerblue|AG=dodgerblue|AI=dodgerblue|AL=limegreen|AM=limegreen|AO=limegreen|AR=dodgerblue|AS=dodgerblue|AT=dodgerblue|AU=lightpink|AW=dodgerblue|AZ=limegreen
|BA=limegreen|BB=dodgerblue|BD=dodgerblue|BE=dodgerblue|BF=dodgerblue|BG=dodgerblue|BH=dodgerblue|BJ=dodgerblue|BM=dodgerblue|BN=dodgerblue|BO=dodgerblue|BR=blueviolet|BS=dodgerblue|BT=limegreen|BW=dodgerblue|BZ=dodgerblue
|CA=blueviolet|CD=dodgerblue|CF=dodgerblue|CG=limegreen|CH=blueviolet|CI=dodgerblue|CL=dodgerblue|CM=dodgerblue|CO=dodgerblue|CR=limegreen|CV=limegreen|CW=dodgerblue|CY=dodgerblue|CZ=dodgerblue
|DE=dodgerblue|DJ=dodgerblue|DK=darkred|DM=dodgerblue|DO=limegreen|DZ=limegreen
|EC=limegreen|EE=dodgerblue|EG=dodgerblue|ES=dodgerblue|ET=dodgerblue
|FI=dodgerblue|FJ=limegreen|FM=dodgerblue|FO=dodgerblue|FR=dodgerblue
|GA=dodgerblue|GB=dodgerblue|GD=dodgerblue|GE=limegreen|GH=dodgerblue|GL=dodgerblue|GM=limegreen|GN=dodgerblue|GR=dodgerblue|GT=limegreen|GU=dodgerblue|GY=dodgerblue
|HK=turquoise|HN=dodgerblue|HR=dodgerblue|HT=dodgerblue|HU=dodgerblue
|ID=dodgerblue|IE=dodgerblue|IN=dodgerblue|IQ=dodgerblue|IR=dodgerblue|IS=dodgerblue|IT=dodgerblue
|JP=turquoise|JM=dodgerblue|JO=dodgerblue
|KE=dodgerblue|KG=limegreen|KH=dodgerblue|KI=limegreen|KM=limegreen|KN=dodgerblue|KP=limegreen|KR=dodgerblue|KW=dodgerblue|KY=dodgerblue
|LA=dodgerblue|LB=dodgerblue|LC=dodgerblue|LI=dodgerblue|LK=limegreen|LR=dodgerblue|LS=dodgerblue|LT=dodgerblue|LU=dodgerblue|LV=dodgerblue|LY=dodgerblue
|MA=dodgerblue|MC=dodgerblue|MD=dodgerblue|ME=limegreen|MG=dodgerblue|MH=dodgerblue|MK=limegreen|ML=dodgerblue|MM=limegreen|MN=limegreen|MP=dodgerblue|MR=dodgerblue|MS=dodgerblue|MT=dodgerblue|MU=limegreen|MV=dodgerblue|MW=dodgerblue|MX=dodgerblue|MY=dodgerblue|MZ=dodgerblue
|NA=dodgerblue|NC=dodgerblue|NE=limegreen|NG=dodgerblue|NI=dodgerblue|NL=dodgerblue|NO=darkred|NP=dodgerblue|NR=limegreen|NZ=dodgerblue
|OM=dodgerblue
|PA=limegreen|PE=dodgerblue|PF=dodgerblue|PG=dodgerblue|PH=dodgerblue|PK=dodgerblue|PL=dodgerblue|PR=dodgerblue|PS=dodgerblue|PT=dodgerblue|PW=dodgerblue|PY=limegreen
|QA=dodgerblue
|RO=dodgerblue|RS=limegreen|RW=dodgerblue
|SA=dodgerblue|SB=limegreen|SD=dodgerblue|SE=dodgerblue|SG=limegreen|SI=darkred|SK=dodgerblue|SL=limegreen|SN=dodgerblue|SO=dodgerblue|SR=dodgerblue|SS=dodgerblue|ST=limegreen|SV=limegreen|SX=dodgerblue|SY=dodgerblue|SZ=dodgerblue
|TC=dodgerblue|TD=limegreen|TH=dodgerblue|TG=limegreen|TJ=limegreen|TL=limegreen|TN=dodgerblue|TO=limegreen|TR=turquoise|TT=dodgerblue|TV=limegreen|TW=dodgerblue|TZ=dodgerblue
|UA=dodgerblue|UG=dodgerblue|US=dodgerblue|UY=limegreen|UZ=limegreen
|VC=dodgerblue|VE=limegreen|VG=dodgerblue|VN=dodgerblue|VU=dodgerblue
|WS=limegreen
|XK=limegreen
|YE=dodgerblue
|ZA=dodgerblue|ZM=dodgerblue|ZW=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|lightpink|Full authorization, not used}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
{{leftlegend|limegreen|Eligible COVAX recipient}}
{{leftlegend|darkred|Usage stopped}}
}}
The Janssen COVID-19 vaccine{{cite web | title=Janssen COVID-19 Emergency Use Authorization (EUA) Official Website | website=Janssen | date=28 February 2021 | url=https://www.janssencovid19vaccine.com/hcp.html | access-date=28 February 2021}} is a viral vector vaccine{{cite tech report|type=Briefing|date=26 February 2021|title=Janssen Ad26.COV2.S Vaccine for the Prevention of COVID-19|publisher=U.S. Food and Drug Administration (FDA)|url=https://www.fda.gov/media/146217/download|page=6|access-date=6 March 2021|quote=The vaccine, known as Ad26.COV2.S, is a replication-incompetent adenovirus type 26 (Ad26) vectored vaccine encoding a stabilized variant of the SARS-CoV-2 S protein.}} produced by Janssen Pharmaceutica (a subsidiary of Johnson & Johnson) and Beth Israel Deaconess Medical Center.{{#invoke:Cite web||date=4 August 2020|title=A Study of Ad26.COV2.S in Adults|url=https://clinicaltrials.gov/ct2/show/NCT04436276|url-status=live|archive-url=https://web.archive.org/web/20200916063346/https://clinicaltrials.gov/ct2/show/NCT04436276|archive-date=16 September 2020|access-date=23 August 2020|website=ClinicalTrials.gov}}{{#invoke:Cite web||title=A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants|url=https://clinicaltrials.gov/ct2/show/NCT04505722|url-status=live|archive-url=https://web.archive.org/web/20200926145744/https://clinicaltrials.gov/ct2/show/NCT04505722|archive-date=26 September 2020|website=ClinicalTrials.gov|publisher=US National Library of Medicine}} It is also known as Johnson & Johnson COVID-19 Vaccine and as COVID-19 Vaccine Janssen.{{#invoke:Cite web||date=5 March 2021|title=COVID-19 Vaccine Janssen EPAR|url=https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-janssen|access-date=16 March 2021|publisher=European Medicines Agency (EMA)}} Three countries, Denmark, Finland, and Norway, discontinued the use of the Janssen vaccine in favor of other available vaccines due to a possible link between the vaccine and a rare blood clot disorder.{{cite web |title=The Danish COVID-19 vaccine rollout continues without the COVID-19 vaccine from Johnson & Johnson |url=https://www.sst.dk/en/english/news/2021/the-danish-covid-19-vaccine-rollout-continues-without-the-covid-19-vaccine-from-johnson-johnson |website=www.sst.dk }}{{cite web |title=Decision on using the Johnson & Johnson coronavirus vaccine in Finland to come after European Medicines Agency issues recommendations - News - THL |url=https://thl.fi/en/web/thlfi-en/-/decision-on-using-the-johnson-johnson-coronavirus-vaccine-in-finland-to-come-after-european-medicines-agency-issues-recommendations |website=Finnish Institute for Health and Welfare (THL), Finland |access-date=5 December 2021 }} The use of the Janssen adenovirus vector vaccine began in Finland in October 2021. It is only offered for those aged 65 and over because of a very rare risk of thrombosis in younger age groups. The United States began use of the Janssen vaccine in March 2021,{{cite press release | title=FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine | publisher=U.S. Food and Drug Administration (FDA) | date=27 February 2021 | url=https://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization-third-covid-19-vaccine | access-date=27 February 2021}} but discouraged use in favor of other available vaccines in December 2021 due to the risk of a rare clotting disorder.{{cite web|url=https://www.cdc.gov/mmwr/volumes/71/wr/mm7103a4.htm|title=(CDC) Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021|date=21 January 2022|website=U.S. Food & Drug Administration}} The Janssen vaccine became unavailable in the United States in May 2023 after all existing doses expired.{{cite web|url=https://www.cdc.gov/vaccines/covid-19/info-by-product/janssen/index.html|title=(CDC) Janssen (Johnson & Johnson) COVID-19 Vaccine|date=10 May 2023|website=U.S. Food & Drug Administration}}
;Full (4)
- Australia (not used){{cite web | title= COVID-19 Vaccine Janssen | website=Therapeutic Goods Administration | date=25 June 2021 | url=https://www.tga.gov.au/apm-summary/covid-19-vaccine-janssen | access-date=26 June 2021 }}{{#invoke:Cite web||date=25 June 2021|title=TGA grants third provisional approval to COVID-19 vaccine: Janssen|url=https://www.tga.gov.au/media-release/tga-grants-third-provisional-approval-covid-19-vaccine-janssen|access-date=28 June 2021|website=Therapeutic Goods Administration (TGA)}}
- Brazil{{cite web|url=https://g1.globo.com/saude/coronavirus/vacinas/noticia/2022/04/05/anvisa-aprova-registro-definitivo-da-vacina-da-janssen.ghtml|title=Anvisa aprova registro definitivo de vacina da Janssen|website=G1|language=pt-br|date=5 April 2022|accessdate=21 June 2024|trans-title=Anvisa approves definitive registration of Janssen vaccine}}
- Canada{{cite web | title=Janssen Jcovden (Johnson & Johnson) COVID-19 vaccine | website=Health Canada | date=21 September 2022 | url=https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/janssen.html | access-date=30 October 2022}}{{cite web | title=Regulatory Decision Summary - Janssen COVID-19 Vaccine | website=Health Canada | url=https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detail.html?linkID=RDS00890 | access-date=24 November 2021}}
- Switzerland{{cite news|agency=Keystone-SDA/Reuters/sb|title=Johnson & Johnson Covid vaccine approved for use in Switzerland|url=https://www.swissinfo.ch/eng/johnson---johnson-covid-vaccine-approved-for-use-in-switzerland/46469458|access-date=1 April 2021|website=SWI swissinfo.ch}}{{cite news | title=Swissmedic regulator approves Johnson & Johnson COVID-19 vaccine | publisher=Reuters | date=22 March 2021 | url=https://www.reuters.com/article/health-coronavirus-swiss-johnsonjohnson-idUSZ8N2K8003 | access-date=3 April 2021}}
{{Clear}}
;Emergency (132)
- Afghanistan
- Andorra{{cite news|title=Informació en relació amb la vacunació contra la COVID-19|publisher=Govern d'Andorra|url=https://www.govern.ad/vacunacio/faqs/FAQS_Vacunacio_COVID19.pdf|access-date=14 March 2021 | language=ca }}
- Argentina{{cite web |title=COVID-19: la ANMAT aprobó el uso de emergencia de la vacuna de Johnson & Johnson|url=https://www.infobae.com/salud/2021/10/06/covid-19-la-anmat-aprobo-el-uso-de-emergencia-de-la-vacuna-de-janssen/|access-date=6 October 2021|website=infobae|date=6 October 2021 |language=es-ES}}
- Bahamas{{cite web|title=Farmacovigilancia de vacunas para COVID-19 - Janssen|url=https://covid-19pharmacovigilance.paho.org/|access-date=9 October 2021|website=Farmacovigilancia de vacunas para COVID-19}}
- Bahrain{{cite news | title=Bahrain first to approve Johnson & Johnson COVID-19 vaccine for emergency use | publisher=Reuters | date=25 February 2021 | url=https://www.reuters.com/article/health-coronavirus-bahrain-idUSS8N2I4021 | access-date=25 February 2021}}{{cite news | title=Bahrain becomes 1st nation to grant J&J shot emergency use | website=ABC News (United States) | date=25 February 2021 | url=https://abcnews.go.com/International/wireStory/bahrain-1st-nation-grant-jj-shot-emergency-76112143 | access-date=25 February 2021}}
- Bangladesh{{cite news | title=Bangladesh approves Johnson & Johnson's Covid-19 vaccine for emergency use| publisher=Dhaka Tribune | date=15 June 2021| url=https://www.dhakatribune.com/bangladesh/2021/06/15/johnson-johnson-s-covid-19-vaccine-approved-for-emergency-use | access-date=15 June 2021}}{{cite news |url=https://www.thedailystar.net/coronavirus-deadly-new-threat/news/single-dose-covid-19-vaccine-janssen-gets-emergency-use-authorization-bangladesh-2111557| title=Single-dose Covid-19 vaccine Janssen gets emergency use authorization in Bangladesh| website=The Daily Star| date=15 June 2021|access-date=15 June 2021}}
- Benin
- Bolivia
- Botswana{{cite web |title=COVID-19 Vaccines Approved by BoMRA |url=https://www.bomra.co.bw/index.php/news-updates/177-covid-19-vaccines-approved-by-bomra |website=www.bomra.co.bw |access-date=11 June 2021 |archive-date=13 June 2021 |archive-url=https://web.archive.org/web/20210613171202/https://www.bomra.co.bw/index.php/news-updates/177-covid-19-vaccines-approved-by-bomra }}
- Brunei
- Burkina Faso
- Cambodia
- Cameroon
- Central African Republic
- Chile{{cite web |title=Chile authorizes emergency use of Johnson & Johnson's Janssen vaccine through COVAX|url=https://www.ispch.cl/noticia/isp-valida-uso-de-emergencia-de-la-vacuna-janssen-de-johnson-johnson-a-traves-de-mecanismo-covax/|publisher=Public Health Institute, Ministry of Health of Chile|date=10 June 2021}}
- Colombia{{cite news|last=Acosta|first=Luis Jaime|location=Bogotá|title=Colombia grants emergency use for J&J coronavirus vaccine |url=https://www.reuters.com/article/health-coronavirus-colombia/colombia-grants-emergency-use-for-jj-coronavirus-vaccine-idUSL1N2LO01O |access-date=25 March 2021 |publisher=Reuters |date=25 March 2021}}
- Congo-Kinshasa
- Djibouti
- Egypt
- Eswatini
- Ethiopia
- Gabon
- Ghana{{#invoke:cite web ||title=Johnson & Johnson COVID-19 vaccine to be available in Ghana by August |url=https://www.graphic.com.gh/news/general-news/johnson-johnson-covid-19-vaccine-to-be-available-in-ghana-by-august.html |website=Graphic Online}}
- Guinea
- Honduras
- India{{#invoke:Cite web||date=7 August 2021|title=India approves J&J COVID-19 vaccine for emergency use|url=https://www.reuters.com/world/india/india-approves-jj-covid-19-vaccine-emergency-use-2021-08-07/|access-date=7 August 2021|website=Reuters}}
- Indonesia{{cite web|date=7 September 2021|title=BPOM Terbitkan Izin Penggunaan Darurat Vaksin Covid-19 Produksi Johnson & Johnson dan Cansino|url=https://nasional.kompas.com/read/2021/09/07/18330171/bpom-terbitkan-izin-penggunaan-darurat-vaksin-covid-19-produksi-johnson|access-date=7 September 2021|website=KOMPAS.com|language=id}}
- Iran
- Iraq
- Ivory Coast
- Jordan
- Kenya
- Kuwait{{cite web |title=Kuwait authorises emergency use of Johnson & Johnson vaccine |url=https://www.kuna.net.kw/ArticleDetails.aspx?id=2980741&language=en |publisher=Kuwait News Agency (KUNA) |date=8 June 2021}}
- Laos
- Lebanon
- Lesotho
- Liberia
- Libya
- Madagascar
- Malawi
- Malaysia{{cite news|date=15 June 2021|title=Malaysia grants conditional approval for CanSino, J&J COVID-19 vaccines|url= https://www.reuters.com/business/healthcare-pharmaceuticals/malaysia-grants-conditional-approval-cansino-jj-covid-19-vaccines-2021-06-15/|work=Reuters|access-date= 15 June 2021}}
- Maldives{{cite web |title=Approval to use of Covid-19 vaccine Janssen |url=http://health.gov.mv/Uploads/Downloads//Informations/Informations(381).pdf |publisher=Maldives Food and Drug Authority |date=6 June 2021 |access-date=11 June 2021 |archive-date=11 June 2021 |archive-url=https://web.archive.org/web/20210611230415/http://health.gov.mv/Uploads/Downloads//Informations/Informations(381).pdf }}
- Mali
- Marshall Islands{{efn|name=CFA}}
- Mauritania
- Mexico{{cite web |title= El Comité de Moléculas Nuevas de COFEPRIS informa sobre los resultados de votación para la vacuna COVID-19 (Ad26.COV2-S [Recombinante]) |url=https://www.gob.mx/cofepris/articulos/el-comite-de-moleculas-nuevas-de-cofepris-informa-sobre-los-resultados-de-votacion-para-la-vacuna-covid-19-ad26-cov2-s-recombinante |website=www.gob.mx/cofepris |language=es}}{{cite web |title= COFEPRIS emite autorización para uso de emergencia a vacuna contra COVID-19 Ad26.COV2.S de Janssen (Johnson & Johnson) |url=https://www.gob.mx/cofepris/articulos/cofepris-emite-autorizacion-para-uso-de-emergencia-a-vacuna-contra-covid-19-ad26-cov2-s-de-janssen-johnson-johnson |website=www.gob.mx/cofepris |language=es}}
- Micronesia{{efn|name=CFA}}
- Moldova
- Monaco
- Morocco
- Mozambique
- Namibia
- Nepal{{#invoke:Cite web||title=1.5 million doses of J&J vaccine arrive in Nepal|url=https://kathmandupost.com/health/2021/07/12/1-5-million-doses-of-j-j-vaccine-arrive-in-nepal|access-date=12 July 2021|website=kathmandupost}}
- New Zealand
- Nicaragua
- Nigeria{{#invoke:Cite web||date=20 April 2021|title=905m COVID-19 shots administered worldwide – Report|url=https://www.premiumtimesng.com/health/456360-905m-covid-19-shots-administered-worldwide-report.html|access-date=7 June 2021}}
- Oman
- Pakistan
- Palau{{efn|name=CFA}}
- Palestine
- Papua New Guinea
- Peru{{#invoke:Cite web||date=9 July 2021|title=Peru authorizes use of Johnson & Johnson COVID-19 vaccine|url=https://andina.pe/ingles/noticia-peru-authorizes-use-of-johnson-johnson-covid19-vaccine-852510.aspx|access-date=3 August 2021|website=Andina}}
- Philippines{{#invoke:Cite web||url=https://cnnphilippines.com/news/2021/4/19/covaxin-janssen-emergency-use-authorization.html|archive-url=https://web.archive.org/web/20210419141507/https://cnnphilippines.com/news/2021/4/19/covaxin-janssen-emergency-use-authorization.html|url-status=dead|archive-date=19 April 2021|title=Covaxin, Janssen approved for emergency use in PH |work=CNN Philippines|date=19 April 2021}}
- Qatar
- Rwanda
- Saudi Arabia
- Senegal
- Singapore (restricted)
- Somalia
- South Africa{{cite news|url=https://www.bbc.com/news/world-africa-55675806|title=Coronavirus: South Africa rolls out vaccination programme|date=17 February 2021|access-date=19 February 2021|work=BBC News}}
- South Korea{{cite news |last1=Lardieri |first1=Alexa |title=South Korea Approves Johnson & Johnson Vaccine |url=https://www.usnews.com/news/health-news/articles/2021-04-07/south-korea-grants-conditional-approval-to-johnson-johnson-coronavirus-vaccine |access-date=8 April 2021 |work=U.S. News & World Report |date=7 April 2021}}
- South Sudan
- Sudan
- Syria
- Taiwan (not used){{cite news|date=10 June 2021|title=嬌生疫苗通過我緊急使用授權 BNT僅「有條件通過」|publisher=The Liberty Times|url=https://news.ltn.com.tw/news/life/breakingnews/3565594}}
- Tanzania
- Thailand{{cite news|date=25 March 2021|title=Thailand approves Johnson & Johnson's COVID-19 vaccine|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-thailand-idUSKBN2BH1L7|access-date=1 April 2021}}
- Tunisia{{cite news |title=Tunisia approve Johnson & Johnson COVID-19 vaccine |url=https://www.reuters.com/article/uk-health-coronavirus-tunisia/tunisia-approve-johnson-johnson-covid-19-vaccine-idUSKBN2BV1SQ |website=Reuters |date=8 April 2021}}
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom{{cite news |title=Janssen single-dose Covid vaccine approved by UK |url=https://www.bbc.com/news/health-57283837 |publisher=BBC News |date=28 May 2021}}
- United States{{cite web|url=https://www.fda.gov/media/146303/download|title=Janssen COVID-19 Vaccine EUA Letter of Authorization 06102021|date=10 June 2021|website=U.S. Food & Drug Administration}} (no longer available as of May 7, 2023 )
- Vanuatu
- Vietnam{{cite news|date=15 July 2021|title=Việt Nam phê duyệt khẩn cấp vaccine COVID-19 của Johnson & Johnson|work=Lao Động|url=https://laodong.vn/y-te/viet-nam-phe-duyet-khan-cap-vaccine-covid-19-cua-johnson--johnson-930853.ldo}}{{cite news|date=15 July 2021|title=Bộ Y tế phê duyệt vaccine phòng COVID-19 Janssen của Johnson & Johnson|work=Vietnam+|url=https://www.vietnamplus.vn/bo-y-te-phe-duyet-vaccine-phong-covid19-janssen-cua-johnson-johnson/726931.vnp}}
- Yemen
- Zambia
- Zimbabwe{{#invoke:Cite web||date=28 July 2021|title=Zimbabwe approves J&J COVID-19 vaccine for emergency use|url=https://www.reuters.com/business/healthcare-pharmaceuticals/zimbabwe-approves-jj-covid-19-vaccine-emergency-use-2021-07-28/|access-date=23 August 2021|website=Reuters}}
{{nowrap|EMA countries}}{{#invoke:Cite web||title=Marketing authorisation|url=https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation|access-date=23 March 2021|publisher=European Medicines Agency (EMA)}}{{cite web | title=COVID-19 Vaccine Janssen | website=Union Register of medicinal products | url=https://ec.europa.eu/health/documents/community-register/html/h1525.htm | access-date=26 November 2021}}
- Austria
- Belgium
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Malta
- Netherlands
- Norway
- Poland
- Portugal
- Romania
- Slovakia
- Slovenia
- Spain
- Sweden
{{nowrap|CARPHA countries and entities}}{{cite web |title=COVID-19 Vaccine Information |url=https://www.carpha.org/What-We-Do/Public-Health/Novel-Coronavirus/COVID-19-Vaccine-Information |website=www.carpha.org}}
- Antigua and Barbuda
- Bahamas
- Barbados
- Belize
- Dominica
- Grenada
- Guyana
- Haiti
- Jamaica
- Saint Kitts and Nevis
- Saint Lucia
- Saint Vincent and the Grenadines
- Suriname
- Trinidad and Tobago
:* Anguilla
:* Aruba
:* British Virgin Islands
:* Bermuda
:* Caribbean Netherlands
:* Cayman Islands
:* Curaçao
:* Montserrat
:* Sint Maarten
:* Turks and Caicos Islands
Non-country entities
- American Samoa
- French Polynesia
- Greenland
- Guam
- New Caledonia
- Northern Cyprus{{cite web|title=Aşı Türleri - K.K.T.C. Sağlık Bakanlığı - Aşı Bilgi Sistemi|url=https://asi.saglik.gov.ct.tr/content/vaccine-types|access-date=19 November 2021|website=asi.saglik.gov.ct.tr}}
- Northern Mariana Islands
- Puerto Rico
- Africa Regulatory Taskforce{{#invoke:Cite web||title=UPDATE: Statement to Member States regarding thromboembolic events after vaccination with Janssen COVID-19 vaccine (Johnson & Johnson)|url=https://africacdc.org/news-item/update-statement-to-member-states-regarding-thromboembolic-events-after-vaccination-with-janssen-covid-19-vaccine-johnson-johnson/|access-date=7 June 2021|website=Africa CDC}}
- World Health Organization{{cite news |title=WHO approves J&J's COVID-19 vaccine for emergency listing |url=https://www.channelnewsasia.com/news/world/covid-19-who-approves-johnson-jj-vaccine-emergency-listing-14394654 |access-date=13 March 2021 |publisher=Channel NewsAsia |date=13 March 2021 |archive-date=18 March 2021 |archive-url=https://web.archive.org/web/20210318014950/https://www.channelnewsasia.com/news/world/covid-19-who-approves-johnson-jj-vaccine-emergency-listing-14394654 }}{{cite web | title=WHO recommendation Janssen–Cilag International NV (Belgium) COVID-19 Vaccine (Ad26.COV2-S [recombinant]) | website=World Health Organization (WHO) | date=12 March 2021 | url=https://extranet.who.int/pqweb/vaccines/who-recommendation-janssen-cilag-international-nv-belgium-covid-19-vaccine-ad26cov2-s | access-date=8 May 2021 | archive-date=8 May 2021 | archive-url=https://web.archive.org/web/20210508195419/https://extranet.who.int/pqweb/vaccines/who-recommendation-janssen-cilag-international-nv-belgium-covid-19-vaccine-ad26cov2-s }}
;Travel-only
- Hong Kong
- Japan{{cite web |title=Requirements for a valid vaccination certificate (3 doses) |url=https://www.mhlw.go.jp/content/000997373.pdf |website=Quarantine Station, Ministry of Health, Labour and Welfare, the Government of Japan |access-date=5 October 2022 |archive-date=5 October 2022 |archive-url=https://web.archive.org/web/20221005053329/https://www.mhlw.go.jp/content/000997373.pdf }}
- Turkey{{cite web|date=10 April 2019|title=Vaccinations for Turkey: Do I need an Approved COVID Vaccine?|url=https://www.easyturkeyvisa.com/news/vaccinations-for-turkey|access-date=24 November 2021|website=Turkey Visa}}{{Dead link|date=February 2024 |bot=InternetArchiveBot |fix-attempted=yes }}{{Unreliable source?|date=June 2023}}
Moderna
{{infobox
| image = {{Graph:Map|scale=65|defaultValue=gainsboro
|AD=dodgerblue|AE=dodgerblue|AF=limegreen|AG=dodgerblue|AI=dodgerblue|AL=limegreen|AM=dodgerblue|AO=limegreen|AR=dodgerblue|AS=dodgerblue|AU=blueviolet|AT=blueviolet|AW=dodgerblue|AZ=limegreen
|BA=limegreen|BB=dodgerblue|BD=dodgerblue|BE=blueviolet|BF=limegreen|BG=blueviolet|BH=dodgerblue|BJ=limegreen|BM=dodgerblue|BN=dodgerblue|BO=limegreen|BQ=dodgerblue|BR=dodgerblue|BS=dodgerblue|BT=dodgerblue|BW=dodgerblue|BZ=dodgerblue
|CA=blueviolet|CD=dodgerblue|CF=limegreen|CG=dodgerblue|CH=blueviolet|CI=limegreen|CL=dodgerblue|CM=limegreen|CO=dodgerblue|CR=limegreen|CV=dodgerblue|CW=dodgerblue|CY=blueviolet|CZ=blueviolet
|DE=blueviolet|DJ=dodgerblue|DK=blueviolet|DM=dodgerblue|DO=limegreen|DZ=limegreen
|EC=limegreen|EE=blueviolet|EG=dodgerblue|ES=blueviolet|ET=limegreen
|FI=blueviolet|FJ=dodgerblue|FM=dodgerblue|FO=dodgerblue|FR=blueviolet
|GB=blueviolet|GD=dodgerblue|GE=limegreen|GF=dodgerblue|GH=dodgerblue|GL=dodgerblue|GM=limegreen|GN=limegreen|GP=dodgerblue|GR=blueviolet|GT=dodgerblue|GU=dodgerblue|GY=dodgerblue
|HK=turquoise|HN=dodgerblue|HR=blueviolet|HT=dodgerblue|HU=blueviolet
|ID=dodgerblue|IE=blueviolet|IL=dodgerblue|IM=dodgerblue|IN=dodgerblue|IQ=dodgerblue|IR=dodgerblue|IS=blueviolet|IT=blueviolet
|JE=dodgerblue|JP=dodgerblue|JM=dodgerblue|JO=dodgerblue
|KE=dodgerblue|KG=dodgerblue|KH=limegreen|KI=limegreen|KM=limegreen|KN=dodgerblue|KP=limegreen|KR=dodgerblue|KW=dodgerblue|KY=dodgerblue
|LA=limegreen|LB=dodgerblue|LC=dodgerblue|LK=dodgerblue|LR=limegreen|LS=limegreen|LT=blueviolet|LU=blueviolet|LV=blueviolet|LY=dodgerblue
|MA=dodgerblue|MC=dodgerblue|MD=dodgerblue|ME=limegreen|MH=dodgerblue|MK=limegreen|ML=limegreen|MM=limegreen|MN=dodgerblue|MP=dodgerblue|MR=limegreen|MS=dodgerblue|MT=blueviolet|MU=limegreen|MV=dodgerblue|MW=dodgerblue|MX=dodgerblue|MY=dodgerblue|MZ=limegreen
|NA=limegreen|NE=limegreen|NG=dodgerblue|NI=limegreen|NL=blueviolet|NO=blueviolet|NP=dodgerblue|NR=limegreen|NZ=turquoise
|OM=dodgerblue
|PA=limegreen|PE=dodgerblue|PG=limegreen|PH=dodgerblue|PK=dodgerblue|PL=blueviolet|PR=dodgerblue|PS=dodgerblue|PT=blueviolet|PW=dodgerblue|PY=dodgerblue
|QA=dodgerblue
|RO=blueviolet|RS=dodgerblue|RW=dodgerblue
|SA=dodgerblue|SB=limegreen|SD=dodgerblue|SE=blueviolet|SG=dodgerblue|SI=blueviolet|SK=blueviolet|SL=limegreen|SN=limegreen|SO=limegreen|SR=dodgerblue|SS=limegreen|ST=limegreen|SV=dodgerblue|SX=dodgerblue|SY=dodgerblue|SZ=limegreen
|TC=dodgerblue|TD=limegreen|TG=limegreen|TH=dodgerblue|TJ=dodgerblue|TL=limegreen|TN=|TR=turquoise |TO=limegreen|TT=dodgerblue|TV=limegreen|TW=dodgerblue
|UA=dodgerblue|UG=dodgerblue|US=blueviolet|UY=limegreen|UZ=dodgerblue
|VC=dodgerblue|VE=limegreen|VG=dodgerblue|VU=limegreen|VN=dodgerblue
|WF=dodgerblue|WS=limegreen
|XK=limegreen
|YE=dodgerblue
|ZA=limegreen|ZM=limegreen|ZW=limegreen
}}
| caption = {{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
{{leftlegend|limegreen|Eligible COVAX recipient}}
}}
The Moderna COVID-19 vaccine, also known as Spikevax, is an mRNA vaccine{{#invoke:Cite web||date=16 March 2020|title=Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)|url=https://clinicaltrials.gov/ct2/show/NCT04283461|access-date=5 March 2021|website=ClinicalTrials.gov|publisher=United States National Library of Medicine|id=NCT04283461}} produced by the American company Moderna, the U.S. National Institute of Allergy and Infectious Diseases, the U.S. Biomedical Advanced Research and Development Authority, and the Coalition for Epidemic Preparedness Innovations.{{#invoke:Cite web||date=14 July 2020|title=A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19|url=https://clinicaltrials.gov/ct2/show/NCT04470427|url-status=live|archive-url=https://web.archive.org/web/20201011084833/https://clinicaltrials.gov/ct2/show/NCT04470427/|archive-date=11 October 2020|access-date=27 July 2020|website=ClinicalTrials.gov|publisher=United States National Library of Medicine|id=NCT04470427}}{{cite news|last1=Palca|first1=Joe|date=27 July 2020|title=COVID-19 vaccine candidate heads to widespread testing in U.S.|publisher=NPR|url=https://www.npr.org/sections/coronavirus-live-updates/2020/07/27/895672859/us-vaccine-candidate-heads-to-widespread-testing-in-people|url-status=live|access-date=27 July 2020|archive-url=https://web.archive.org/web/20201011084836/https://www.npr.org/sections/coronavirus-live-updates/2020/07/27/895672859/us-vaccine-candidate-heads-to-widespread-testing-in-people/|archive-date=11 October 2020}} The Moderna vaccine is not offered for men under 30 years of age in Finland as a precaution to reduce a very rare risk of myocarditis.{{cite web |title=THL issues instructions that men under 30 years of age should only be offered the Comirnaty coronavirus vaccine - Press release - THL |url=https://thl.fi/en/web/thlfi-en/-/thl-issues-instructions-that-men-under-30-years-of-age-should-only-be-offered-the-comirnaty-coronavirus-vaccine |website=Finnish Institute for Health and Welfare (THL), Finland |access-date=5 December 2021 }}
= Original =
;Full (34)
- Australia{{#invoke:Cite web||date=9 August 2021|title=TGA provisionally approves Moderna's COVID-19 vaccine|url=https://www.tga.gov.au/media-release/tga-provisionally-approves-modernas-covid-19-vaccine-0|website=Therapeutic Goods Administration}}
- Canada{{cite web | title=Moderna Spikevax COVID-19 vaccines | website=Health Canada | date=1 September 2022 | url=https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/moderna.html | access-date=30 October 2022}}{{cite web|date=23 December 2020|title=Regulatory Decision Summary – Moderna COVID-19 Vaccine|url=https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detailTwo.html?linkID=RDS00736|access-date=23 December 2020|publisher=Health Canada, Government of Canada}}{{#invoke:Cite web||date=9 December 2020|title=Drug and vaccine authorizations for COVID-19: List of applications received|url=https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization/applications.html|access-date=9 December 2020|publisher=Health Canada, Government of Canada}}
- Switzerland{{cite press release|title=Swissmedic grants authorisation for the COVID-19 vaccine from Moderna |url=https://www.swissmedic.ch/swissmedic/en/home/news/coronavirus-covid-19/zulassung-covid-19-impfstoff-moderna.html |publisher=Swiss Agency for Therapeutic Products (Swissmedic) |date=12 January 2020 |access-date=12 January 2020}}
- United Kingdom{{#invoke:Cite web||date=1 April 2021|title=Information for Healthcare Professionals on COVID-19 Vaccine Moderna|url=https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-moderna/information-for-healthcare-professionals-on-covid-19-vaccine-moderna|access-date=6 April 2021|website=Medicines and Healthcare products Regulatory Agency (MHRA)}}{{#invoke:Cite web||date=19 February 2021|title=Summary of the Public Assessment Report for COVID-19 Vaccine Moderna|url=https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-moderna/summary-of-the-public-assessment-report-for-covid-19-vaccine-moderna|access-date=6 April 2021|website=Medicines and Healthcare products Regulatory Agency (MHRA)}}
{{nowrap|EMA countries}}{{cite web|title=Spikevax (previously COVID-19 Vaccine Moderna) EPAR|url=https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-moderna|website=European Medicines Agency (EMA)|date=4 January 2021 }}{{cite web | title=Spikevax | website=Union Register of medicinal products | url=https://ec.europa.eu/health/documents/community-register/html/h1507.htm | access-date=26 November 2021}}
- Austria
- Belgium
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Malta
- Netherlands
- Norway
- Poland
- Portugal
- Romania
- Slovakia
- Slovenia
- Spain
- Sweden
;Emergency (116)
- Andorra
- Argentina{{cite web|title=BOLETIN OFICIAL REPUBLICA ARGENTINA - MINISTERIO DE SALUD - Resolución 2711/2021|url=https://www.boletinoficial.gob.ar/detalleAviso/primera/250495|access-date=6 October 2021|website=www.boletinoficial.gob.ar}}
- Armenia
- Bahrain
- Bangladesh{{cite web |title=Moderna gets emergency use authorisation in Bangladesh|url=https://www.thedailystar.net/coronavirus-deadly-new-threat/news/moderna-gets-emergency-use-authorisation-bangladesh-2120677 |website=The Daily Star |date=29 June 2021|access-date=30 June 2021}}
- Bhutan
- Botswana{{cite press release |title=Moderna Announces Agreement to Supply the Republic of Botswana with its COVID-19 Vaccine |url=https://www.businesswire.com/news/home/20210603005629/en/Moderna-Announces-Agreement-to-Supply-the-Republic-of-Botswana-with-its-COVID-19-Vaccine |publisher=Moderna|via=Business Wire |date=3 June 2021}}
- Bolivia{{cite web |url=https://www.swissinfo.ch/spa/coronavirus-bolivia_bolivia-recibe-1-9-millones-de-vacunas-moderna-donadas-por-espa%C3%B1a-y-alemania/47231766|title=Bolivia recibe 1,9 millones de vacunas Moderna donadas por España y Alemania|date=January 2022 }}
- Brazil
- Brunei
- Cape Verde
- Chile{{cite web |title=Instituto de Salud Pública de Chile |url=https://www.ispch.cl/noticia/el-isp-valida-el-uso-de-emergencia-de-la-vacuna-contra-covid-19-del-laboratorio-moderna/#:~:text=La%20s%C3%A9ptima%20vacuna%20aprobada%20en,s%C3%A9ptima%20vacuna%20contra%20COVID-19. |access-date=21 May 2022 |website=www.ispch.cl}}
- Colombia{{cite web |url=https://www.elespectador.com/salud/colombia-autoriza-el-uso-de-la-vacuna-de-moderna-para-el-coronavirus/ |title=Colombia autoriza el uso de la vacuna de Moderna para el coronavirus|first=El|last=Espectador|date=25 June 2021|website=El Espectador}}
- Congo-Brazzaville
- Congo-Kinshasa
- Djibouti
- Egypt{{cite web |title=StackPath|url=https://dailynewsegypt.com/2021/10/31/egypt-receives-784280-doses-of-modernas-covid-19-vaccine/ |access-date=5 November 2021|website=dailynewsegypt|date=31 October 2021 }}
- El Salvador
- Fiji
- Ghana{{cite web|title=Farmacovigilancia de vacunas para COVID-19 - Moderna|url=https://covid-19pharmacovigilance.paho.org/|access-date=24 September 2021|website=Farmacovigilancia de vacunas para COVID-19}}
- Guatemala
- Honduras{{cite web |title=Honduras a la zaga de la vacunación en Centroamérica |url=https://proceso.hn/honduras-a-la-zaga-en-vacunacion-en-ca/ |website=Proceso Digital |language=es |date=10 April 2021}}
- India{{cite news |last1=Kaul |first1=Rhythma |title=Moderna's Covid vaccine approved for use in India |url=https://www.hindustantimes.com/india-news/modernas-covid-vaccine-approved-for-use-in-india-101624990937539.html |work=Hindustan Times |date=29 June 2021 }}
- Indonesia{{cite news |author= Friski Riana |editor= Laila Afifa|title=BPOM Issues Emergency Use Authorization for Moderna Vaccine |url=https://en.tempo.co/read/1478877/bpom-issues-emergency-use-authorization-for-moderna-vaccine |work=Tempo.co |date=2 July 2021 }}
- Iran
- Iraq
- Israel{{cite web|title=Israeli Ministry of Health Authorizes COVID-19 Vaccine Moderna for Use in Israel|url=https://investors.modernatx.com/news-releases/news-release-details/israeli-ministry-health-authorizes-covid-19-vaccine-moderna-use|publisher=modernatx.com|access-date=4 January 2021|date=4 January 2021|archive-date=17 February 2021|archive-url=https://web.archive.org/web/20210217215148/https://investors.modernatx.com/news-releases/news-release-details/israeli-ministry-health-authorizes-covid-19-vaccine-moderna-use}}
- Japan{{cite press release | title=Takeda Announces Approval of Moderna's COVID-19 Vaccine in Japan | publisher=Takeda | via=Business Wire | date=21 May 2021 | url=https://www.businesswire.com/news/home/20210520006154/en/Takeda-Announces-Approval-of-Moderna%E2%80%99s-COVID-19-Vaccine-in-Japan | access-date=2 July 2021}}
- Jordan
- Kenya{{cite news|title=Kenya approves Moderna Sinopharm vaccines amid fourth wave|url=https://www.bloomberg.com/news/articles/2021-08-19/kenya-approves-moderna-sinopharm-vaccines-amid-fourth-wave|access-date=28 August 2021|newspaper=Bloomberg.com|date = 19 August 2021}}
- Kuwait{{cite web |title=COVID-19: Kuwait unlikely to import Sputnik V |url=https://gulfnews.com/world/gulf/kuwait/covid-19-kuwait-unlikely-to-import-sputnik-v-1.78388637 |website=gulfnews.com |date=7 April 2021 |access-date=21 April 2021 }}
- Kyrgyzstan
- Lebanon
- Libya
- Malawi
- Malaysia{{cite web |author1=New Straits Times |title=DCA grants conditional approval for Moderna vaccine |url=https://www.nst.com.my/news/nation/2021/08/715318/dca-grants-conditional-approval-moderna-vaccine |date=8 August 2021}}
- Maldives{{cite web |author1=Maldives Food and Drug Agency |title=Approval to use of COVID-19 vaccine Moderna dispersion for injection |url=http://health.gov.mv/Uploads/Downloads//Informations/Informations(382).pdf |date=6 June 2021 |access-date=11 June 2021 |archive-date=6 September 2021 |archive-url=https://web.archive.org/web/20210906115734/http://health.gov.mv/Uploads/Downloads//Informations/Informations(382).pdf }}
- Marshall Islands{{efn|name=CFA}}
- Mexico{{cite web |title=Comité de Moléculas Nuevas y Subcomité emiten opinión favorable para vacuna Moderna|url=https://www.gob.mx/cofepris/articulos/comite-de-moleculas-nuevas-y-subcomite-emiten-opinion-favorable-para-vacuna-moderna |website=www.gob.mx/cofepris |language=es}}{{cite web |title=COFEPRIS emite autorización para uso de emergencia a vacuna Moderna|url=https://www.gob.mx/cofepris/articulos/cofepris-emite-autorizacion-para-uso-de-emergencia-a-vacuna-moderna |website=www.gob.mx/cofepris |language=es}}
- Micronesia{{efn|name=CFA}}
- Moldova{{cite web |title=Membrii NITAG au venit cu recomandări privind utilizarea vaccinurilor împotriva COVID-19 în Republica Moldova |url=https://msmps.gov.md/comunicare/comunicate/membrii-nitag-au-venit-cu-recomandari-privind-utilizarea-vaccinurilor-impotriva-covid-19-in-republica-moldova/ |website=Ministerul Sănătății, Muncii și Protecţiei Sociale |language=ro |date=3 March 2021}}
- Monaco
- Mongolia
- Morocco
- Nepal{{cite web|title=Nepal receives 1,965,600 doses of Moderna vaccine from COVAX|url=https://kathmandupost.com/health/2021/12/12/nepal-receives-1-965-600-doses-of-moderna-vaccine-from-covax|access-date=28 December 2021|website=kathmandupost.com}}
- Nigeria{{#invoke:Cite web||date=15 July 2021|title=NAFDAC approves emergency use of three additional Covid-19 vaccines for Nigeria|url=https://editor.guardian.ng/news/nafdac-approves-emergency-use-of-three-additional-covid-19-vaccines-for-nigeria/|access-date=21 July 2021|website=The Guardian Nigeria News - Nigeria and World News}}
- Oman
- Pakistan
- Palau{{efn|name=CFA}}
- Palestine{{cite web |title=COVID Data Tracker |url=https://covid.cdc.gov/covid-data-tracker/#global-vaccinations |website=U.S. Centers for Disease Control and Prevention (CDC) |date=28 March 2020}}
- Paraguay
- Peru{{cite web|date=17 September 2021|title=Gobierno suscribió acuerdo con Moderna por 20 millones de dosis contra la COVID-19|url=https://rpp.pe/peru/actualidad/gobierno-suscribio-acuerdo-con-moderna-por-20-millones-de-vacunas-contra-la-covid-19-noticia-1358438?ref=rpp|access-date=4 October 2021|website=RPP Noticias}}
- Philippines{{cite news |author1=Galvez, Daphne |title=Moderna COVID-19 vaccine gets emergency use authorization |url=https://newsinfo.inquirer.net/1427462/moderna-covid-19-vaccine-gets-emergency-use-authorization |publisher=Philippine Daily Inquirer |date=5 May 2021}}
- Qatar{{#invoke:Cite web||title=Qatar approves emergency use of Moderna's COVID-19 vaccine|url=https://www.aljazeera.com/news/2021/2/10/qatar-approves-emergency-use-for-modernas-covid-19-vaccine|website=Al Jazeera|access-date=31 March 2021}}
- Rwanda
- Saudi Arabia{{#invoke:Cite web||title=AstraZeneca and Moderna vaccines to be administered in Saudi Arabia|url=https://gulfnews.com/world/gulf/saudi/astrazeneca-and-moderna-vaccines-to-be-administered-in-saudi-arabia-1.76573439|access-date=19 January 2021|website=Gulf News|date=18 January 2021 }}
- Serbia{{cite web|title=Moderna arrived to Serbia| date=4 November 2021 |url=https://europa.rs/moderna-arrived-to-serbia/?lang=en}}
- Singapore{{cite news|date=3 February 2021|title=Singapore becomes first in Asia to approve Moderna's COVID-19 vaccine|url=https://www.reuters.com/article/us-health-coronavirus-singapore/singapore-becomes-first-in-asia-to-approve-modernas-covid-19-vaccine-idUSKBN2A30ZM|access-date=3 February 2021|publisher=Reuters}}
- South Korea{{cite news |last1=Kim |first1=Han-joo |date=21 May 2021|title=Moderna COVID-19 vaccine gets final nod in S. Korea |url=https://en.yna.co.kr/view/AEN20210521005500320|access-date=21 May 2021|work=Yonhap News Agency}}
- Sri Lanka
- Sudan
- Syria
- Taiwan{{#invoke:Cite web||date=5 May 2021|title=莫德納疫苗獲緊急授權 自費AZ疫苗供應不間斷|url=https://www.cna.com.tw/news/firstnews/202105050200.aspx|website=Central News Agency}}
- Tajikistan{{#invoke:Cite web||date=26 July 2021|title=1.5 million doses of Moderna Vaccines arrive in Tajikistan|url=https://www.unicef.org/tajikistan/press-releases/15-million-doses-moderna-vaccines-arrive-tajikistan|access-date=4 August 2021|website=UNICEF}}
- Thailand{{cite news | title = Thai FDA approves Moderna vaccine | date = 13 May 2021 | url = https://www.bangkokpost.com/thailand/general/2115195/thai-fda-approves-moderna-vaccine | work = Bangkok Post }}
- Tunisia
- Uganda
- Ukraine{{#invoke:Cite web||date=19 July 2021|title=U.S. Donates 2 Million Coronavirus Vaccine Doses To Ukraine|url=https://www.rferl.org/a/us-vaccine-ukraine-covid/31365604.html|access-date=4 August 2021|website=RadioFreeEurope}}
- United Arab Emirates{{cite news | title = Coronavirus latest: Moderna vaccine approved for emergency use by UAE | date = 4 July 2021 | url = https://www.thenationalnews.com/coronavirus/2021/07/03/coronavirus-latest-updates-uae-cases-vaccine-covid-test/ | work = The National }}
- Uzbekistan{{#invoke:Cite web||date=30 July 2021|title=U.S. Government Provides 3 Million of the Moderna COVID-19 Vaccine to Uzbekistan|url=https://uz.usembassy.gov/u-s-government-provides-3-million-doses-of-the-moderna-covid-19-vaccine-to-uzbekistan/|access-date=4 August 2021|website=}}
- Vietnam{{cite news|date=29 June 2021|title=Bộ Y tế phê duyệt có điều kiện vaccine COVID-19 Moderna|work=Vietnam Television|url=https://vtv.vn/suc-khoe/bo-y-te-phe-duyet-co-dieu-kien-vaccine-covid-19-moderna-20210629110122178.htm}}{{cite news|date=29 June 2021|title=Bộ Y tế phê duyệt có điều kiện vaccine COVID-19 Moderna|work=Vietnam Government Portal|url=http://baochinhphu.vn/Hoat-dong-Bo-nganh/Bo-Y-te-phe-duyet-co-dieu-kien-vaccine-COVID19-Moderna/436244.vgp}}
- Yemen
{{nowrap|CARPHA countries and entities}}
- Antigua and Barbuda
- Bahamas
- Barbados
- Belize
- Dominica
- Grenada
- Guyana
- Haiti
- Jamaica
- Saint Kitts and Nevis
- Saint Lucia
- Saint Vincent and the Grenadines
- Suriname
- Trinidad and Tobago
:* Anguilla
:* Aruba
:* British Virgin Islands
:* Bermuda
:* Caribbean Netherlands
:* Cayman Islands
:* Curaçao
:* Montserrat
:* Sint Maarten
:* Turks and Caicos Islands
Non-country entities
- American Samoa
- Faroe Islands
- Greenland
- Guadeloupe
- Guam
- Guernsey
- Isle of Man
- Jersey
- Northern Mariana Islands
- Puerto Rico
- Wallis and Futuna
- World Health Organization{{cite news |title=WHO lists anti-COVID Moderna vaccine for emergency use |url=https://newsinfo.inquirer.net/1425841/who-lists-anti-covid-moderna-vaccine-for-emergency-use |work=Agence France-Presse |publisher=Philippine Daily Inquirer |date=1 May 2021}}{{cite web | title=WHO Recommendation COVID-19 mRNA Vaccine (nucleoside modified) | website=World Health Organization (WHO) | date=30 April 2021 | url=https://extranet.who.int/pqweb/vaccines/covid-19-mrna-vaccine-nucleoside-modified | access-date=8 May 2021}}
;Travel-only
= Bivalent original–BA.1 =
- Australia{{cite web |title=TGA provisionally approves Moderna's Omicron booster for Australia |url=https://www.9news.com.au/national/therapeutic-goods-administration-tga-provisionally-approves-modernas-omicron-booster-for-australia/2f15a5ba-24fd-47ae-8ece-c2c4aa1209d7 |access-date=5 September 2022 |website=www.9news.com.au|date=30 August 2022 }}
- Canada{{cite web |last=Boisvert |first=Nick |date=1 September 2022 |title=Health Canada approves updated Moderna vaccine for Omicron variant |url=https://www.cbc.ca/news/politics/health-canada-moderna-bivalent-approval-1.6569398 |access-date=3 September 2022 |website=CBC}}
- Japan{{citation needed|date=December 2022}}
- Singapore{{cite news |date=15 September 2022 |title=New bivalent COVID-19 booster vaccine doses expected to be available in Singapore by end-Sep: Moderna |work=Channel News Asia |url=https://www.channelnewsasia.com/singapore/moderna-bivalent-covid-19-vaccine-booster-expected-available-end-september-2940001
|access-date=24 September 2022}}
- Switzerland{{cite news |date=29 August 2022 |title=Swissmedic approves first bivalent COVID-19 booster vaccine in Switzerland |work=Swissmedic |url=https://www.swissmedic.ch/swissmedic/en/home/news/coronavirus-covid-19/bivalenten_covid-19_booster-impfstoff-genehmigt.html |access-date=5 September 2022}}
- Taiwan{{cite news |date=16 September 2022 |title=First batch of 804,000 doses of Moderna's next-generation bivalent COVID-19 vaccine to arrive in Taiwan on evening of September 16 |work=Taiwan Centers for Disease Control |url=https://www.cdc.gov.tw/En/Bulletin/Detail/z3FhcAk4nR8yrigB4jk9qQ?typeid=158 |access-date=21 September 2022}}{{cite web |last1=Shen |first1=Pei-yiao |last2=Shih |first2=Hsiu-chuan |title=Taiwan grants EUA for 2nd-generation Moderna COVID-19 vaccine |url=https://focustaiwan.tw/society/202209020025 |website=Focus Taiwan |date=2 September 2022 |access-date=25 September 2022}}
- United Kingdom{{cite news |date=16 August 2022 |title=Covid: UK first country to approve dual-strain vaccine |work=BBC News |url=https://www.bbc.com/news/health-62548336 |access-date=4 September 2022}}
{{nowrap|EMA countries}}{{cite web|date=2 September 2022|title=Spikevax (previously COVID-19 Vaccine Moderna)|url=https://www.ema.europa.eu/en/medicines/human/EPAR/spikevax|publisher=European Medicines Agency (EMA)}}
- Austria
- Belgium
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Malta
- Netherlands
- Norway
- Poland
- Portugal
- Romania
- Slovakia
- Slovenia
- Spain
- Sweden
= Bivalent original–BA.4/5 =
- Brazil{{cite news|url=https://oglobo.globo.com/saude/noticia/2023/06/anvisa-aprova-vacina-bivalente-da-moderna-para-covid-19.ghtml|title=Anvisa aprova vacina bivalente da Moderna para Covid-19|website=O Globo|language=pt-br|first=Mariana|last=Rosário|date=26 June 2023|accessdate=21 June 2024}}
- Taiwan{{cite news |date=9 November 2022 |title=First batch of 703,000 doses of Moderna BA.4/5 bivalent COVID-19 vaccine to arrive in Taiwan on morning of November 10 |work=Taiwan Centers for Disease Control |url=https://www.cdc.gov.tw/En/Bulletin/Detail/uaaTo2mJe922M5rWBCSNkQ?typeid=158 |access-date=15 December 2022}}
= XBB.1.5 =
- Brazil{{cite web|url=https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-aprova-registro-da-vacina-spikevax-monovalente|title=Anvisa aprova registro da vacina Spikevax monovalente|website=Brazilian Health Regulatory Agency|language=pt-br|date=6 March 2024|accessdate=21 June 2024}}
- United States{{cite web |date=2023-11-01 |title=Moderna COVID-19 Vaccine |url=https://www.fda.gov/vaccines-blood-biologics/coronavirus-covid-19-cber-regulated-biologics/moderna-covid-19-vaccine |access-date=2024-01-26 |website=U.S. Food and Drug Administration (FDA) }}
= JN.1 =
- European Union{{cite web | title=Spikevax (previously COVID-19 Vaccine Moderna) | website=European Medicines Agency (EMA) | date=6 January 2021 | url=https://www.ema.europa.eu/en/medicines/human/EPAR/spikevax | access-date=16 September 2024}}
- Switzerland{{cite web | title=Covid-19, Swissmedic autorizza il vaccino aggiornato di Moderna | website=Corriere del Ticino | date=10 September 2024 | url=https://www.cdt.ch/news/svizzera/covid-19-swissmedic-autorizza-il-vaccino-aggiornato-di-moderna-362841 | language=it | access-date=13 September 2024 | archive-date=13 September 2024 | archive-url=https://web.archive.org/web/20240913051409/https://www.cdt.ch/news/svizzera/covid-19-swissmedic-autorizza-il-vaccino-aggiornato-di-moderna-362841 | url-status=live }}
- Taiwan{{cite press release | title=Taiwan Food & Drug Administration Approves Moderna's COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1 | website=Moderna | date=2 September 2024 | url=https://news.modernatx.com/news/news-details/2024/Taiwan-Food--Drug-Administration-Approves-Modernas-COVID-19-mRNA-Vaccine-Targeting-the-SARS-COV-2-Variant-JN.1/default.aspx | access-date=13 September 2024}}
- United Kingdom{{cite press release |title=MHRA approves Spikevax JN.1 COVID-19 vaccines for adults and children from infancy |url=https://www.gov.uk/government/news/mhra-approves-spikevax-jn1-covid-19-vaccines-for-adults-and-children-from-infancy |access-date=2024-09-04 |website=Medicines and Healthcare products Regulatory Agency (MHRA) |archive-date=3 September 2024 |archive-url=https://web.archive.org/web/20240903133943/https://www.gov.uk/government/news/mhra-approves-spikevax-jn1-covid-19-vaccines-for-adults-and-children-from-infancy |url-status=live }}
= KP.2 =
Sinopharm BIBP
{{infobox|image={{Graph:Map|scale=65|defaultValue=gainsboro
|AD=limegreen|AE=blueviolet|AF=dodgerblue|AG=dodgerblue|AL=limegreen|AM=dodgerblue|AO=dodgerblue|AR=dodgerblue|AT=turquoise|AU=turquoise|AZ=limegreen
|BA=dodgerblue|BB=dodgerblue|BD=dodgerblue|BF=dodgerblue|BG=turquoise|BH=blueviolet|BI=dodgerblue|BJ=limegreen|BN=dodgerblue|BO=dodgerblue|BR=dodgerblue|BS=limegreen|BT=dodgerblue|BW=limegreen|BY=dodgerblue|BZ=dodgerblue
|CA=turquoise|CD=limegreen|CF=limegreen|CG=dodgerblue|CH=turquoise|CI=dodgerblue|CL=limegreen|CM=dodgerblue|CN=blueviolet|CO=limegreen|CR=limegreen|CU=dodgerblue|CV=dodgerblue|CY=turquoise
|DJ=dodgerblue|DM=dodgerblue|DO=dodgerblue|DZ=dodgerblue
|EC=limegreen|EE=turquoise|EG=dodgerblue|ES=turquoise|ET=dodgerblue
|FI=turquoise|FJ=limegreen|FM=limegreen
|GA=dodgerblue|GB=turquoise|GD=limegreen|GE=dodgerblue|GH=limegreen|GM=dodgerblue|GN=dodgerblue|GQ=dodgerblue|GR=turquoise|GT=limegreen|GW=dodgerblue|GY=dodgerblue
|HN=limegreen|HR=turquoise|HT=limegreen|HU=dodgerblue
|ID=dodgerblue|IE=turquoise|IN=limegreen|IQ=dodgerblue|IR=dodgerblue|IS=turquoise
|JP=turquoise|JM=dodgerblue|JO=dodgerblue
|KE=dodgerblue|KG=dodgerblue|KH=dodgerblue|KI=dodgerblue|KM=dodgerblue|KN=limegreen|KP=dodgerblue|KR=limegreen|KZ=dodgerblue
|LA=dodgerblue|LB=dodgerblue|LC=limegreen|LI=turquoise|LK=dodgerblue|LR=limegreen|LS=dodgerblue|LV=turquoise|LY=dodgerblue
|MA=dodgerblue|MC=limegreen|MD=dodgerblue|ME=dodgerblue|MG=dodgerblue|MH=limegreen|MK=dodgerblue|ML=limegreen|MM=dodgerblue|MN=dodgerblue|MO=blueviolet|MR=dodgerblue|MU=dodgerblue|MV=dodgerblue|MW=dodgerblue|MX=dodgerblue|MY=dodgerblue|MZ=dodgerblue
|NA=dodgerblue|NE=dodgerblue|NG=dodgerblue|NI=dodgerblue|NL=turquoise|NP=dodgerblue|NR=limegreen|NZ=limegreen
|OM=limegreen
|PA=limegreen|PE=dodgerblue|PG=dodgerblue|PH=dodgerblue|PK=dodgerblue|PS=dodgerblue|PY=dodgerblue
|QA=turquoise
|RS=dodgerblue|RW=dodgerblue
|SA=turquoise|SB=dodgerblue|SC=blueviolet|SD=dodgerblue|SE=turquoise|SG=dodgerblue|SI=turquoise|SK=turquoise|SL=dodgerblue|SN=dodgerblue|SO=dodgerblue|SR=dodgerblue|SS=dodgerblue|ST=limegreen|SV=dodgerblue|SY=dodgerblue|SZ=limegreen
|TD=dodgerblue|TG=limegreen|TH=dodgerblue|TJ=limegreen|TL=limegreen|TM=dodgerblue|TN=dodgerblue|TO=limegreen|TR=turquoise|TT=dodgerblue|TV=limegreen|TZ=dodgerblue
|UA=limegreen|UG=limegreen|US=turquoise|UY=limegreen|UZ=limegreen
|VC=limegreen|VE=dodgerblue|VN=dodgerblue|VU=dodgerblue
|WS=limegreen
|XK=limegreen
|YE=limegreen
|ZA=limegreen|ZM=dodgerblue|ZW=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
{{leftlegend|limegreen|Eligible COVAX recipient}}
}}
The Sinopharm BIBP COVID-19 vaccine is an inactivated virus vaccine produced by the China National Pharmaceutical Group (Sinopharm) and its Beijing Institute of Biological Products.{{cite journal|last1=Chen|first1=Wei|last2=Al Kaabi|first2=Nawal|date=18 July 2020|title=A Phase III clinical trial for inactivated novel coronavirus pneumonia (COVID-19) vaccine (Vero cells)|url=http://www.chictr.org.cn/showprojen.aspx?proj=56651|journal=Chinese Clinical Trial Registry|access-date=15 August 2020|archive-date=11 October 2020|archive-url=https://web.archive.org/web/20201011084800/http://www.chictr.org.cn/showprojen.aspx?proj=56651%2F}}{{cite journal|vauthors=Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, Tan W, Wu G, Xu M, Lou Z, Huang W, Xu W, Huang B, Wang H, Wang W, Zhang W, Li N, Xie Z, Ding L, You W, Zhao Y, Yang X, Liu Y, Wang Q, Huang L, Yang Y, Xu G, Luo B, Wang W, Liu P, Guo W, Yang X|date=October 2020|title=Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial|journal=The Lancet. Infectious Diseases|volume=21|issue=1|pages=39–51|doi=10.1016/s1473-3099(20)30831-8|pmc=7561304|pmid=33069281}}
;Full (4)
- Bahrain{{#invoke:cite news||title=Bahrain approves China's Sinopharm coronavirus vaccine |url=https://www.arabianbusiness.com/healthcare/455832-bahrain-approves-chinas-sinopharm-coronavirus-vaccine |newspaper=Arabian Business |date=13 December 2020}}
- China{{#invoke:cite news||last1=Kuo |first1=Lily |title=China approves Sinopharm coronavirus vaccine, the country's first for general use |url=https://www.washingtonpost.com/world/asia_pacific/coronavirus-vaccine-china-sinopharm/2020/12/30/1cc4be9e-4a62-11eb-97b6-4eb9f72ff46b_story.html |newspaper=The Washington Post}}
- Seychelles{{#invoke:Cite web||title=President Ramkalawan and First Lady receives second dose SinoPharm Vaccine|url=http://www.statehouse.gov.sc/news/5090/president-ramkalawan-and-first-lady-receives-second-dose-sinopharm-vaccine|access-date=5 February 2021|website=statehouse.gov.sc}}
- United Arab Emirates{{#invoke:cite news||last1=Wee |first1=Sui-Lee |title=Chinese Covid-19 Vaccine Gets Key Push, but Doubts Swirl |url=https://www.nytimes.com/2020/12/09/business/china-coronavirus-vaccine-united-arab-emirates.html |access-date=12 December 2020 |work=The New York Times |date=9 December 2020}}{{#invoke:Cite web||title=Coronavirus: UAE authorises emergency use of vaccine for frontline workers|url=https://www.thenationalnews.com/uae/health/coronavirus-uae-authorises-emergency-use-of-vaccine-for-frontline-workers-1.1077680|access-date=24 November 2020|website=The National|date=14 September 2020}}
{{Clear}}
;Emergency (111)
- Afghanistan{{#invoke:Cite web||title=China 'to provide 400,000 COVID vaccine doses' to Afghanistan|url=https://www.aljazeera.com/news/2021/3/1/china-to-provide-400000-covid-vaccine-doses-to-afghanistan|access-date=22 March 2021|publisher=Al Jazeera}}
- Algeria{{#invoke:Cite web||last=Presse|first=AFP-Agence France|title=Algeria Receives 200,000 Coronavirus Jabs From China|url=https://www.barrons.com/news/algeria-receives-200-000-coronavirus-jabs-from-china-01614270916|access-date=22 March 2021|website=Barrons}}
- Angola{{#invoke:Cite web||date=25 March 2021|title=Angola recebeu doação chinesa de 200 mil doses de vacinas Sinopharm|url=https://www.noticiasaominuto.com/mundo/1718180/angola-recebeu-doacao-chinesa-de-200-mil-doses-de-vacinas-sinopharm|access-date=14 April 2021|website=Notícias ao Minuto|language=pt}}
- Argentina{{#invoke:cite news||last1=Biannchi|first1=Walter|date=21 February 2021|title=Argentina approves Sinopharm COVID-19 vaccine for emergency use|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-argentina-vaccine-idUSKBN2AL0P9|access-date=23 February 2021}}
- Armenia
- Bangladesh{{#invoke:cite news||date=29 April 2021|title=Bangladesh approves emergency use of China's Sinopharm vaccine amid supply squeeze|publisher=bdnews24.com|url=https://bdnews24.com/bangladesh/2021/04/29/bangladesh-approves-emergency-use-of-chinas-sinopharm-vaccine-amid-supply-squeeze|access-date=29 April 2021}}
- Belarus{{#invoke:Cite web||date=15 March 2021|title=Belarus begins COVID-19 vaccinations with Chinese shots|url=https://eng.belta.by/society/view/belarus-begins-covid-19-vaccinations-with-chinese-shots-138222-2021/|access-date=16 March 2021|publisher=Belta}}
- Bhutan{{#invoke:Cite web||title=Bhutan receives 500,000 doses of COVID-19 vaccines through COVAX|url=https://www.unicef.org/rosa/press-releases/bhutan-receives-500000-doses-covid-19-vaccines-through-covax|access-date=15 July 2021|website=www.unicef.org}}
- Bolivia{{#invoke:Cite web||title=Bolivia begins inoculation with Sinopharm jabs |url=https://www.thestar.com.my/aseanplus/aseanplus-news/2021/02/26/bolivia-begins-inoculation-with-sinopharm-jabs|access-date=28 February 2021|website=The Star|location=Malaysia}}
- Bosnia and Herzegovina{{cite web|url=https://www.sarajevotimes.com/finalized-contract-for-the-procurement-of-half-a-million-doses-of-sinopharm-vaccine/|title=Finalized Contract for the Procurement of half a Million Doses of Sinopharm Vaccine|date=2 July 2021}}
- Brazil{{#invoke:cite news||title=Covid-19: aumenta para sete o número de vacinas autorizadas no Brasil |url=https://agenciabrasil.ebc.com.br/radioagencia-nacional/saude/audio/2021-05/aumenta-para-sete-o-numero-de-vacinas-autorizadas-no-brasil |work=Agência Brasil |date=7 May 2021 |language=pt-br}}
- Brunei{{#invoke:Cite web||title=Vaccine donation from China arrives |url=https://www.thestar.com.my/aseanplus/aseanplus-news/2021/02/12/vaccine-donation-from-china-arrives|access-date=22 March 2021|website=The Star|location=Malaysia}}
- Burkina Faso
- Burundi
- Cambodia{{#invoke:Cite web||last1=Rinith|first1=Taing|date=4 February 2021|title=Health Ministry grants Emergency Use Authorization to China's Sinopharm vaccine|url=https://www.khmertimeskh.com/50810677/health-ministry-grants-emergency-use-authorization-to-chinas-sinopharm-vaccine/|access-date=4 February 2021|work=Khmer Times}}
- Cameroon
- Cape Verde
- Chad{{#invoke:Cite web||last=AfricaNews|date=6 June 2021|title=Chadians line up for Sinopharm as COVID-19 vaccination campaign begins|url=https://www.africanews.com/2021/06/06/chadians-line-up-for-sinopharm-as-covid-19-vaccination-campaign-begins/|access-date=6 June 2021|website=Africanews}}
- Comoros
- Congo-Brazzaville
- Cuba{{cite web|date=28 August 2021|title=Cuba aplicará vacuna china Sinopharm junto a inoculaciones de desarrollo local|url=https://es.euronews.com/2021/08/28/salud-coronavirus-cuba-china|access-date=29 August 2021|website=euronews|language=es}}
- Djibouti
- Dominican Republic{{#invoke:cite web||title=Ministro de Salud recibe su primera dosis de la vacuna Sinovac; asegura que el biológico es confiable |url=https://www.msp.gob.do/web/?p=11563 |website=Ministerio de Salud Pública |language=es |date=3 May 2021}}
- Egypt{{#invoke:Cite web||title=Egypt licenses China's Sinopharm COVID-19 vaccine for emergency use: health minister – Xinhua |url=http://xinhuanet.com/english/2021-01/03/c_139637781.htm|publisher=Xinhuanet}}
- El Salvador
- Equatorial Guinea{{#invoke:Cite web||title=StackPath|url=https://dailynewsegypt.com/2021/02/17/equatorial-guinea-president-receives-1st-dose-of-chinese-covid-19-vaccine/|access-date=22 March 2021|website=dailynewsegypt|date=17 February 2021 }}
- Ethiopia{{#invoke:Cite news||date=29 March 2021|title=Ethiopia to get 300,000 doses of Sinopharm COVID-19 shot, health minister says|publisher=Reuters|url=https://www.reuters.com/article/uk-healthcare-coronavirus-ethiopia-idUSKBN2BL1TE|access-date=14 April 2021}}
- Gabon{{#invoke:Cite web||date=12 March 2021|title=Gabon receives 100,000 doses of Sinopharm's vaccine from China|url=https://gabon24.ga/en/news/gabon-receives-100000-doses-of-sinopharms-vaccine-from-china/5155/|access-date=15 March 2021|publisher=Gabon 24}}
- Gambia
- Georgia{{#invoke:Cite web||date=4 May 2021|title=Georgia Starts COVID-19 Vaccination with Sinopharm|url=https://civil.ge/archives/417469|access-date=9 May 2021|website=Civil.ge}}
- Guinea-Bissau
- Guinea
- Hungary{{#invoke:Cite web||title=Hungary signs deal for Chinese Sinopharm's COVID-19 vaccine, first in EU|url=https://nationalpost.com/pmn/health-pmn/hungary-signs-deal-for-chinese-sinopharms-covid-19-vaccine-first-in-eu|website=National Post}}
- Indonesia{{#invoke:Cite web||title=Indonesia approves Sinopharm COVID-19 vaccine for emergency use|url=https://english.kontan.co.id/news/indonesia-approves-sinopharm-covid-19-vaccine-for-emergency-use|website=Kontan|date=30 April 2021|access-date=30 April 2021}}
- Iran{{#invoke:Cite web||date=22 February 2021|title=Iran Launches Phase Two of Mass Inoculation Campaign|url=https://financialtribune.com/articles/national/107614/iran-launches-phase-two-of-mass-inoculation-campaign|access-date=23 February 2021|website=Financial Tribune}}
- Iraq
- Ivory Coast
- Jordan{{#invoke:Cite web||title=First batch of Chinese Sinopharm vaccine arrives in Jordan|url=https://en.royanews.tv/news/24716/2021-01-10|access-date=9 January 2021|publisher=Roya News}}
- Kazakhstan{{#invoke:Cite web||last=Satubaldina|first=Assel|date=30 April 2021|title=Three Vaccines to Become Available to Kazakh Citizens|url=https://astanatimes.com/2021/04/three-vaccines-to-become-available-to-kazakh-citizens/|access-date=1 May 2021|website=The Astana Times}}
- Kenya
- Kiribati
- Kuwait
- Kyrgyzstan{{#invoke:Cite web||last=Kharizov|first=Ruslan|date=19 March 2021|title=150,000 doses of Sinopharm coronavirus vaccine delivered to Kyrgyzstan|url=https://24.kg/english/187138_150000_doses_of_Sinopharm_coronavirus_vaccine_delivered_to_Kyrgyzstan/|access-date=22 March 2021|website=24.kg}}
- Laos
- Lebanon{{#invoke:Cite web||last1=Crean|first1=Rosabel|title=China donates 50,000 doses of Sinopharm vaccine to Lebanon|url=http://www.dailystar.com.lb/News/Lebanon-News/2021/Mar-01/517953-china-donates-50000-doses-of-sinopharm-vaccine-to-lebanon.ashx|access-date=2 March 2021|work=The Daily Star}}
- Lesotho
- Libya{{#invoke:Cite web||date=2 August 2021|title=Libya gets 2 million Sinopharm doses with more expected|url=https://www.africanews.com/2021/08/02/libya-gets-2-million-sinopharm-doses-with-more-expected/|access-date=5 August 2021|website=Africanews}}
- Madagascar
- Malawi{{cite news|last1=Zimmer|first1=Carl|last2=Corum|first2=Jonathan|last3=Wee|first3=Sui-Lee|date=10 June 2020|title=Coronavirus Vaccine Tracker|work=The New York Times|url=https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html|access-date=29 August 2021|issn=0362-4331}}
- Malaysia{{#invoke:Cite news||last=Latiff|first=Rozanna|date=16 July 2021|title=Malaysia approves China's Sinopharm vaccine for emergency use|work=Reuters|url=https://www.reuters.com/article/health-coronavirus-malaysia-vaccine-idUSL4N2OS18D|access-date=16 July 2021}}
- Maldives{{#invoke:Cite web||last1=Rasheed|first1=Aishath Hanaan Hussain|title=MFDA approves Pfizer, Sinopharm Covid-19 vaccines for emergency use|url=https://raajje.mv/96801|access-date=16 March 2021|publisher=raajje.mv}}
- Mauritania{{#invoke:Cite web||title=Mauritania begins COVID-19 vaccination campaign|url=https://www.aa.com.tr/en/africa/mauritania-begins-covid-19-vaccination-campaign/2189322|access-date=29 March 2021|website=aa.com.tr}}
- Mauritius
- Mexico{{cite web |title= Comité de Moléculas Nuevas emite opiniones favorables por unanimidad sobre remdesivir y vacuna Sinopharm \|url=https://www.gob.mx/cofepris/es/articulos/comite-de-moleculas-nuevas-emite-opiniones-favorables-por-unanimidad-sobre-remdesivir-y-vacuna-sinopharm |website=www.gob.mx/cofepris |language=es}}{{cite web |title= Cofepris emite autorización para uso de emergencia a vacuna Sinopharm |url=https://www.gob.mx/cofepris/es/articulos/cofepris-emite-autorizacion-para-uso-de-emergencia-a-vacuna-sinopharm |website=www.gob.mx/cofepris |language=es}}
- Moldova{{#invoke:Cite web||last=Cristina|date=19 March 2021|title=O mie de studenți și medici-rezidenți din cadrul USMF vor fi imunizați anti-COVID cu vaccinul BBIBP-CorV, produs de către Sinopharm Beijing Institute of Biological Products|url=https://www.zdg.md/stiri/stiri-sociale/o-mie-de-studenti-si-medici-rezidenti-din-cadrul-usmf-vor-fi-imunizati-anti-covid-cu-vaccinul-bbibp-corv-produs-de-catre-sinopharm-beijing-institute-of-biological-products/|access-date=19 March 2021|website=Ziarul de Gardă|language=ro-RO}}
- Mongolia{{#invoke:Cite web||title=Deputy PM and City Governor get the first dose of Sinopharm vaccine|url=https://www.montsame.mn/en/read/256205|access-date=15 March 2021|publisher=Montsame}}
- Montenegro{{#invoke:Cite web||title=Montenegro receives 30,000 doses of China's COVID-19 vaccine|url=http://seenews.com/news/montenegro-receives-30000-doses-of-chinas-covid-19-vaccine-733151|access-date=22 March 2021|website=seenews|date=3 March 2021 }}
- Morocco{{#invoke:Cite web||title=Covid-19: Morocco authorizes use of the Sinopharm vaccine|url=https://en.yabiladi.com/articles/details/104807/covid-19-morocco-authorizes-sinopharm-vaccine.html|website=yabiladi}}
- Mozambique{{#invoke:cite news||date=6 March 2021|title=Mozambique expects to vaccinate 16 million against coronavirus by 2022|url=https://www.reuters.com/article/health-coronavirus-mozambique/mozambique-expects-to-vaccinate-16-million-against-coronavirus-by-2022-idUSL5N2L35GH|access-date=7 March 2021|publisher=Reuters}}
- Myanmar{{#invoke:Cite web||title=Myanmar to use China-donated Sinopharm Covid vaccine|url=https://elevenmyanmar.com/news/myanmar-to-use-china-donated-sinopharm-covid-vaccine|access-date=20 June 2021|website=Eleven Media Group Co., Ltd}}
- Namibia{{#invoke:Cite web||last=Namibian|first=The|title=Khomas, Erongo first to get vaccinated|url=https://www.namibian.com.na/index.php?page=read&id=99946|archive-url=https://web.archive.org/web/20210426025223/https://www.namibian.com.na/index.php?page=read&id=99946|url-status=dead|archive-date=26 April 2021|access-date=17 March 2021|website=The Namibian}}
- Nepal{{#invoke:Cite web||last1=Poudel|first1=Arjun|title=China's Shinopharm vaccine gets emergency use authorisation in Nepal|url=https://kathmandupost.com/health/2021/02/17/china-s-shinopharm-vaccine-gets-emergency-use-authorisation-in-nepal|access-date=19 February 2021|work=Kathmandu Post}}
- Nicaragua{{cite news|url=https://www.bbc.com/news/world-asia-59633388 |title=Nicaragua receives China vaccines after cutting ties with Taiwan |date= 13 December 2021|publisher=BBC News |access-date=4 March 2022}}
- Niger{{#invoke:Cite web||title=China donates 400,000 doses of Sinopharm COVID-19 vaccine to Niger|url=https://www.channelnewsasia.com/news/world/china-donates-400-000-doses-of-sinopharm-covid-19-vaccine-to-14461352|access-date=1 April 2021|website=CNA}}
- Nigeria{{cite web|date=24 August 2021|title=Nigeria approves Sinopharm COVID vaccine, expects 7.7 mln doses|url=https://www.reuters.com/world/africa/nigeria-approves-sinopharm-covid-vaccine-expects-77-mln-doses-2021-08-24/|access-date=28 August 2021|website=Reuters}}
- North Korea{{#invoke:Cite news||last1=Son|first1=Hyemin|last2=Ji|first2=Jeongeun |last3=Lee|first3=Myungchul|title=North Korea Has Been Importing Chinese COVID-19 Vaccines Since Early May |url=https://www.rfa.org/english/news/korea/vax-06152021112903.html |work=Radio Free Asia |date=15 June 2021}}
- North Macedonia{{#invoke:Cite web||title=North Macedonia looks to Chinese vaccine to revive program|url=https://abcnews.go.com/Health/wireStory/north-macedonia-chinese-vaccine-revive-program-77418628|access-date=1 May 2021|website=ABC News}}
- Oman
- Pakistan{{#invoke:Cite news||last1=Shahzad|first1=Asif|date=19 January 2021|title=Pakistan approves Chinese Sinopharm COVID-19 vaccine for emergency use|url=https://www.reuters.com/article/health-coronavirus-pakistan-sinopharm/pakistan-approves-chinese-sinopharm-covid-19-vaccine-for-emergency-use-idUSKBN29O049|publisher=Reuters}}
- Palestine{{#invoke:Cite web||title=What we know about China's Sinopharm COVID vaccine|url=https://www.thefinancialexpress.com.bd/national/what-we-know-about-chinas-sinopharm-covid-vaccine-1619625832|access-date=1 May 2021|website=The Financial Express}}
- Papua New Guinea{{#invoke:Cite web||date=7 May 2021|title=Chinese vaccine to be gazetted|url=https://postcourier.com.pg/chinese-vaccine-to-be-gazetted/|access-date=21 May 2021|website=Post Courier}}
- Paraguay
- Peru{{#invoke:Cite news||date=27 January 2021|title=Peru grants 'exceptional' approval for Sinopharm COVID-19 vaccine – government sources|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-peru/peru-grants-exceptional-approval-for-sinopharm-covid-19-vaccine-government-sources-idUSKBN29W2TL}}
- Philippines{{#invoke:Cite news||author1=Aguilar, Krissy|title=PH approves Sinopharm COVID-19 vaccine for emergency use|url=https://newsinfo.inquirer.net/1442960/ph-approves-sinopharm-covid-19-vaccine-for-emergency-use|publisher=Philippine Daily Inquirer|date=7 June 2021}}
- Qatar
- Rwanda{{cite web|date=12 August 2021|title=Rwanda to acquire Sinopharm vaccines next week|url=https://www.newtimes.co.rw/news/rwanda-acquire-sinopharm-vaccines-next-week|access-date=28 August 2021|website=The New Times |location=Rwanda}}
- Senegal{{#invoke:Cite web||last1=Asala|first1=Kizzi|title=Senegal Kicks Off COVID-19 Vaccination Campaign with China's Sinopharm|date=18 February 2021 |url=https://www.africanews.com/2021/02/18/senegal-kicks-off-covid-19-vaccination-campaign-with-china-s-sinopharm/|access-date=23 February 2021|publisher=Africanews}}
- Serbia{{#invoke:Cite news||title=Serbia Becomes First European Nation To Use China's Sinopharm Vaccine|url=https://www.rferl.org/a/serbia-covid-vaccine-china-sinopharm/31053091.html|newspaper=Radio Free Europe/Radio Liberty|date=20 January 2021 }}
- Sierra Leone{{#invoke:Cite web||last1=Thomas|first1=Abdul Rashid|date=15 March 2021|title=Sierra Leone's President Bio leads the way in taking COVID-19 Vaccine|url=https://www.thesierraleonetelegraph.com/sierra-leones-president-bio-leads-the-way-in-taking-covid-19-vaccine/|access-date=16 March 2021|work=Sierra Leone Telegraph}}
- Singapore{{#invoke:Cite web||title=11 Singapore private healthcare providers allowed to bring in Sinopharm COVID-19 vaccine|url=https://www.channelnewsasia.com/news/singapore/sinopharm-covid-19-hsa-special-access-route-vaccine-sinovac-15337454|access-date=30 July 2021|website=CNA}}
- Solomon Islands{{#invoke:Cite web||title=Health Ministry Prepares for Sinopharm Roll Out - Solomon Times Online|url=https://www.solomontimes.com/news/health-ministry-prepares-for-sinopharm-roll-out/10856|access-date=21 May 2021|website=SolomonTimes}}
- Somalia{{#invoke:Cite web||date=15 April 2021|title=Somalia rolls out Sinopharm vaccines to boost fight against COVID-19|url=https://newsghana.com.gh/somalia-rolls-out-sinopharm-vaccines-to-boost-fight-against-covid-19/|access-date=18 April 2021|website=News Ghana}}
- South Sudan{{cite web|date=27 August 2021|title=South Sudan to receive 100,000 doses of Sinopharm vaccines from China|url=https://jubaecho.com/2021/08/27/south-sudan-to-receive-100000-doses-of-sinopharm-vaccines-from-china/|access-date=29 August 2021|website=Juba echo|archive-date=29 August 2021|archive-url=https://web.archive.org/web/20210829043217/https://jubaecho.com/2021/08/27/south-sudan-to-receive-100000-doses-of-sinopharm-vaccines-from-china/}}
- Sri Lanka{{#invoke:Cite web||date=19 March 2021|title=NMRA approves sinopharm vaccine for emergency use|url=https://colombogazette.com/2021/03/19/nmra-approves-sinopharm-vaccine-for-emergency-use/|access-date=29 March 2021|website=Colombo Gazette}}
- Sudan{{#invoke:Cite web||title=China To Provide Sudan With 250,000 Doses Of Sinopharm Vaccine On Friday – Ambassador|url=https://www.urdupoint.com/en/world/china-to-provide-sudan-with-250000-doses-of-1203394.html|access-date=14 April 2021|website=UrduPoint}}{{#invoke:Cite web||title=StackPath|url=https://dailynewsegypt.com/2021/03/28/china-donated-sinopharm-covid-19-vaccines-arrive-in-sudan/|access-date=14 April 2021|website=dailynewsegypt|date=28 March 2021 }}
- Syria
- Tanzania
- Thailand{{#invoke:cite news|| title = FDA approves use of Sinopharm vaccine | date = 28 May 2021 | url = https://www.bangkokpost.com/thailand/general/2123307/fda-approves-use-of-sinopharm-vaccine | work = Bangkok Post}}
- Tunisia{{#invoke:Cite web||title=China's Sinopharm COVID-19 vaccine approved for marketing in Tunisia - Xinhua | English.news.cn|url=http://www.xinhuanet.com/english/africa/2021-07/13/c_1310057298.htm|access-date=21 July 2021|website=xinhuanet}}
- Turkmenistan{{#invoke:Cite web||title=В Туркменистане от COVID бесплатно прививают китайской вакциной, российский "Спутник" можно купить|url=https://rus.azathabar.com/a/31190974.html|access-date=9 May 2021|website=Радио Азатлык|date=7 April 2021 |language=ru}}
- Vanuatu{{#invoke:Cite web||title=PM to receive Sinopharm jab today|url=https://dailypost.vu/news/pm-to-receive-sinopharm-jab-today/article_353ada2c-cd65-11eb-96db-9308a7cd2ac1.html|access-date=15 June 2021|website=Vanuatu Daily Post|date=15 June 2021 }}
- Venezuela{{#invoke:cite news||last1=Sequera|first1=Vivian|date=1 March 2021|title=Venezuela approves use of China's Sinopharm coronavirus vaccine|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-venezuela-vaccine-idUSKCN2AT3T2|access-date=2 March 2021}}
- Vietnam{{#invoke:Cite web||date=4 June 2021|title=Vietnam approves China's Sinopharm vaccine for use against COVID-19|url=https://www.reuters.com/business/healthcare-pharmaceuticals/vietnam-approves-chinas-sinopharm-vaccine-use-against-covid-19-media-2021-06-04/|access-date=4 June 2021|website=Reuters}}
- Yemen
- Zambia{{#invoke:Cite web||last=Sachiti|first=Roselyne|title=Zambia to get Sinopharm COVID-19 vaccines|url=https://www.herald.co.zw/zambia-to-get-sinopharm-covid-19-vaccines/|access-date=21 May 2021|website=The Herald}}
- Zimbabwe{{#invoke:Cite web||last1=Mutsaka|first1=Farai|date=18 February 2021|title=Zimbabwe starts administering China's Sinopharm vaccines|url=https://www.thestar.com/news/world/africa/2021/02/18/zimbabwe-starts-administering-chinas-sinopharm-vaccines.html|access-date=20 February 2021|work=Toronto Star}}
{{nowrap|CARPHA countries and entities}}{{Cite web |title=COVID-19 Vaccine Update Supplement |url=https://www.carpha.org/Portals/0/Documents/COVID-19%20Vaccine%20Updates/CARPHA%20COVID-19%20Vaccine%20Update%20045%20November%2022%202021.pdf |website=CARPHA}}
- Antigua and Barbuda
- Bahamas
- Barbados
- Belize
- Dominica
- Grenada
- Guyana
- Haiti
- Jamaica
- Saint Kitts and Nevis
- Saint Lucia
- Saint Vincent and the Grenadines
- Suriname
- Trinidad and Tobago
:* Anguilla
:* Aruba
:* British Virgin Islands
:* Bermuda
:* Caribbean Netherlands
:* Cayman Islands
:* Curaçao
:* Montserrat
:* Sint Maarten
:* Turks and Caicos Islands
- Macau{{#invoke:Cite web||date=7 February 2021|title=Macau receives first batch of COVID-19 vaccines|url=https://www.asgam.com/index.php/2021/02/08/macau-receives-first-batch-of-covid-19-vaccines/|access-date=24 February 2021|website=IAG}}
- World Health Organization{{cite press release | title=WHO lists additional COVID-19 vaccine for emergency use and issues interim policy recommendations | publisher=World Health Organization (WHO) | date=7 May 2021 | url=https://www.who.int/news/item/07-05-2021-who-lists-additional-covid-19-vaccine-for-emergency-use-and-issues-interim-policy-recommendations | access-date=7 May 2021}}{{cite news | last=Taylor | first=Adam | title=WHO grants emergency use authorization for Chinese-made Sinopharm coronavirus vaccine | newspaper=The Washington Post | date=7 May 2021 | url=https://www.washingtonpost.com/world/2021/05/07/who-sinopharm-emergency-use/ | access-date=7 May 2021}}
;Travel-only
{{div col|colwidth=18em}}
- Andorra{{cite web|url=https://visitandorra.com/en/covid-19-in-andorra/faq-if-you-re-spending-a-few-days-in-andorra/|title=FAQ|website=Andorra Tourism}}
- Australia{{cite web | title=International COVID-19 vaccines recognised by Australia | website=Therapeutic Goods Administration (TGA) | url=https://www.tga.gov.au/international-covid-19-vaccines-recognised-australia | access-date=26 November 2021}}{{cite press release |date=1 November 2021 |title=TGA recognises two more COVID-19 vaccines not registered in Australia but used widely internationally |url=https://www.tga.gov.au/media-release/tga-recognises-two-more-covid-19-vaccines-not-registered-australia-used-widely-internationally |publisher=Therapeutic Goods Administration |access-date=11 November 2021}}
- Austria{{cite web|url=https://www.austria.info/en/service-and-facts/coronavirus-information/entry-regulations|title=Coronavirus: Entry Regulations to Austria|website=www.austria.info}} (only for entry)
- Bulgaria{{Cite web | url = https://www.mh.government.bg/media/filer_public/2021/08/30/order_01-733_en_final.pdf | title = Order | website = Bulgaria Ministry of Health}}
- Canada{{cite web|url=https://travel.gc.ca/travel-covid/travel-restrictions/covid-vaccinated-travellers-entering-canada|title=COVID-19 vaccinated travellers entering Canada - Travel restrictions in Canada|first=Global Affairs|last=Canada|date=8 April 2021|website=travel.gc.ca}}
- Chile{{cite web|url=https://www.chile.travel/en/traveltochileplan/|title=Travel to Chile Plan|first=Mi|last=Bajón}}
- Costa Rica{{cite web|url=https://www.visitcostarica.com/es/costa-rica/planning-your-trip/entry-requirements|title=Requisitos de entrada|date=8 June 2016|website=Visit Costa Rica}}
- Croatia{{cite web|url=https://mup.gov.hr/uzg-covid/english/286212|title=English|website=mup.gov.hr}}
- Cyprus{{cite web |url=https://cyprusflightpass.gov.cy/en/vaccinated-passengers |title=Vaccinated Passengers |publisher=Cyprus Flight Pass |date= |access-date=4 March 2022 |archive-date=6 March 2022 |archive-url=https://web.archive.org/web/20220306213314/https://cyprusflightpass.gov.cy/en/vaccinated-passengers }}
- Czech Republic{{cite web|author=Čeština |url=https://koronavirus.mzcr.cz/en/recognition-of-vaccination-certificates-from-other-countries/ |title=Recognition of vaccination certificates from other countries – Aktuální informace o COVID-19 |publisher=Koronavirus.mzcr.cz |date=21 April 2021 |access-date=4 March 2022}} (only for Hungarian citizens and EU nationals vaccinated in Hungary)
- Estonia{{cite web|url=https://kkk.kriis.ee/en/faq/covid-19-vaccination/vaccines#q10069311|title=Questions and answers on coronavirus, related decisions and changes: Vaccines|website=kkk.kriis.ee}} (only if approved in a person's country of origin)
- Finland{{cite web|title=Vaccine series accepted in Finland - Infectious diseases and vaccinations - THL|url=https://thl.fi/en/web/infectious-diseases-and-vaccinations/what-s-new/coronavirus-covid-19-latest-updates/travel-and-the-coronavirus-pandemic/which-vaccines-are-accepted-at-the-points-of-entry-into-the-country-|access-date=16 November 2021|website=Finnish Institute for Health and Welfare (THL), Finland|archive-date=16 November 2021|archive-url=https://web.archive.org/web/20211116182910/https://thl.fi/en/web/infectious-diseases-and-vaccinations/what-s-new/coronavirus-covid-19-latest-updates/travel-and-the-coronavirus-pandemic/which-vaccines-are-accepted-at-the-points-of-entry-into-the-country-}}
- Greece{{cite web|url=https://news.gtp.gr/2021/08/11/greece-accepting-most-covid-19-vaccines-for-travel/|title=Greece Accepting Most Covid-19 Vaccines for Travel|date=11 August 2021|website=GTP Headlines}}
- Grenada{{cite web |url=https://covid19.gov.gd/vaccinated-travellers/ |title=Vaccinated Travellers – Ministry Of Health – Government of Grenada |publisher=Covid19.gov.gd |date=6 November 2020 |access-date=4 March 2022 |archive-date=18 March 2022 |archive-url=https://web.archive.org/web/20220318190925/https://covid19.gov.gd/vaccinated-travellers/ }}
- Hong Kong
- Iceland{{cite web|url=https://www.landlaeknir.is/um-embaettid/greinar/grein/item44162/certificate-of-vaccination-against-covid-19-accepted-at-the-border|title=Certificates of vaccination accepted at the border in Iceland for exemption of border measures due to COVID-19|website=www.landlaeknir.is|access-date=5 November 2021|archive-date=5 November 2021|archive-url=https://web.archive.org/web/20211105184914/https://www.landlaeknir.is/um-embaettid/greinar/grein/item44162/certificate-of-vaccination-against-covid-19-accepted-at-the-border}}
- Ireland{{cite web|url=https://www.gov.ie/en/publication/77952-government-advice-on-international-travel/|title=Government advice on international travel|website=www.gov.ie|date=14 July 2021|access-date=16 November 2021|archive-date=16 November 2021|archive-url=https://web.archive.org/web/20211116193913/https://www.gov.ie/en/publication/77952-government-advice-on-international-travel/|url-status=dead}}
- Japan
- Latvia{{cite web |url=https://www.spkc.gov.lv/lv/valstu-saslimstibas-raditaji-ar-covid-19-0 |title=Valstu saraksti |language=lv |publisher=SPKC |date= |access-date=4 March 2022}}
- Liechtenstein{{cite web|url=https://tourismus.li/en/our-country/about-liechtenstein/current-information-on-covid-19-in-the-principality-of-liechtenstein/|title=Current information on COVID-19 in the Principality of Liechtenstein|website=tourismus.li}}
- New Zealand{{cite web|url=https://covid19.govt.nz/international-travel/travel-to-new-zealand/vaccination-requirements-for-travel-to-new-zealand/|title=Vaccination requirements for travel to New Zealand|website=Unite against COVID-19|date=4 January 2023 }}
- Oman{{Cite web | url=https://presspage-production-content.s3.amazonaws.com/uploads/2571/travelguideen-ar3.pdf | archive-url = https://web.archive.org/web/20211017192028/https://presspage-production-content.s3.amazonaws.com/uploads/2571/travelguideen-ar3.pdf |archive-date=17 October 2021 | title = Travel Policies & Procedures Manual | date = 1 September 2021}}
- Panama{{cite web|url=https://es.tourismpanama.com/planea-tus-vacaciones/avisos/|title=Protocolos COVID-19|website=tourismpanama}}
- Portugal{{cite web|url=https://www.visitmadeira.pt/en-gb/useful-info/corona-virus-(covid-19)/information-to-visitors-(covid-19)|title = Information COVID 19}} (only in Madeira)
- Qatar{{#invoke:Cite news||author1=Arslan|title=Qatar gives conditional approval for Sinopharm Vaccine|url=https://covid19.moph.gov.qa/EN/travel-and-return-policy/Pages/default.asp|publisher=qaziarslantariq|date=1 August 2021}}
- Saudi Arabia (for short visits, Hajj and Umrah only){{cite web|url=https://covid19.cdc.gov.sa/update-vaccinated-individuals-for-the-purpose-of-coming-to-the-kingdom-december-2021/# |title=Update vaccinated individuals (for the purpose of coming to the kingdom) December 2021 - Public Health Authority |publisher=Covid19.cdc.gov.sa |date= |access-date=4 March 2022}}
- Slovakia{{cite web|url=https://www.mic.iom.sk/en/news/637-covid-19-measures.html|title=COVID-19: official measures and important information (updated continually) - IOM Migration information center|website=www.mic.iom.sk}}
- Slovenia{{cite web|url=https://www.gov.si/en/topics/coronavirus-disease-covid-19/border-crossing/|title=Border Crossing | GOV.SI|website=Portal GOV.SI|date=18 February 2022 }}
- South Korea{{Cite web |date=22 July 2021 |title=South Korea Immigration Regulations |url=https://www.koreanair.com/kr/en/travel-update/covid19/travel-restriction/korea |archive-url=https://web.archive.org/web/20210730154938/https://www.koreanair.com/kr/en/travel-update/covid19/travel-restriction/korea |archive-date=30 July 2021 |website=Korean Air}}
- Spain{{cite web|title=Certificado Covid Digital De La Ue Y Otros Certificados|url=https://www.mscbs.gob.es/profesionales/saludPublica/sanidadExterior/CHS/Pdf/FAQs_CERTIFICADO_DIGITAL_COVID-19-UE_y_OTROS_CERTIFICADOS_ES_071021_v6.pdf|access-date=16 November 2021|archive-date=30 November 2021|archive-url=https://web.archive.org/web/20211130032702/https://www.mscbs.gob.es/profesionales/saludPublica/sanidadExterior/CHS/Pdf/FAQs_CERTIFICADO_DIGITAL_COVID-19-UE_y_OTROS_CERTIFICADOS_ES_071021_v6.pdf}}
- St. Kitts and Nevis{{Cite web|url=https://covid19.gov.kn/travel-protocols/|title=Site Under Maintenance|website=covid19.gov.kn}}
- St. Lucia{{cite web|url=https://www.stlucia.org/en/covid-19/faqs/|title=NEW-FAQs|website=Saint Lucia Tourism Authority|access-date=18 November 2021|archive-date=8 December 2022|archive-url=https://web.archive.org/web/20221208103421/https://www.stlucia.org/en/covid-19/faqs/}}
- St. Vincent and the Grenadines{{Cite web | url = http://health.gov.vc/health/images/PDF/SVG_Health_Services_Subcommittee_Protocol_for_Fully_Vaccinated_Travelers_to_SVG_10112021.pdf | title = ROTOCOL FOR THE ENTRY OF FULLY VACCINATED TRAVELLERS TO ST. VINCENT AND THE GRENADINES – revised 10/11/2021 | website = health.gov.vc}}
- Sweden{{cite web|title=Certificate requirements for foreign nationals travelling to Sweden - The Public Health Agency of Sweden|url=https://www.folkhalsomyndigheten.se/the-public-health-agency-of-sweden/communicable-disease-control/covid-19/if-you-are-planning-to-travel/negative-covid-19-test-required-for-entry-into-sweden/|access-date=16 November 2021|website=www.folkhalsomyndigheten.se|archive-date=16 November 2021|archive-url=https://web.archive.org/web/20211116182910/https://www.folkhalsomyndigheten.se/the-public-health-agency-of-sweden/communicable-disease-control/covid-19/if-you-are-planning-to-travel/negative-covid-19-test-required-for-entry-into-sweden/}}
- Switzerland{{cite web|url=https://www.bag.admin.ch/bag/en/home/krankheiten/ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-epidemien/novel-cov/empfehlungen-fuer-reisende/quarantaene-einreisende.html|title=Coronavirus: Entering Switzerland|first=Federal Office of Public Health|last=FOPH|website=www.bag.admin.ch|access-date=12 November 2021|archive-date=24 July 2020|archive-url=https://web.archive.org/web/20200724080307/https://www.bag.admin.ch/bag/en/home/krankheiten/ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-epidemien/novel-cov/empfehlungen-fuer-reisende/quarantaene-einreisende.html}}
- The Netherlands{{cite web|url=https://www.government.nl/topics/coronavirus-covid-19/visiting-the-netherlands-from-abroad/requirements-for-proof-of-vaccination|title=Travelling to the Netherlands with proof of vaccination - Coronavirus COVID-19 - Government.nl|first=Ministerie van Algemene|last=Zaken|date=12 November 2021|website=www.government.nl}}
- Turkey{{cite web|url=https://www.visasturkey.com/vaccinations-for-turkey/|title=Vaccinations for Turkey: Do I need an Approved COVID Vaccine?|date=10 April 2019|access-date=16 November 2021|archive-date=16 November 2021|archive-url=https://web.archive.org/web/20211116191928/https://www.visasturkey.com/vaccinations-for-turkey/}}
- Ukraine{{cite web|url=https://visitukraine.today/|title=Visit Ukraine - Information and Rules|website=Visit Ukraine}}
- United Kingdom{{cite web|url=https://www.gov.uk/government/news/travel-updatenew-guidance-for-people-vaccinated-under-who-emergency-use-listing-and-under-18s|title=Travel update: new guidance for people vaccinated under WHO Emergency Use Listing and under 18s|website=GOV.UK}}
- United States{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/travelers/proof-of-vaccination.html|title=COVID-19 and Your Health|date=11 February 2020|website=U.S. Centers for Disease Control and Prevention (CDC)}}
- Uruguay{{cite web|url=https://www.gub.uy/ministerio-salud-publica/comunicacion/publicaciones/requisitos-para-ingreso-uruguay-personas-nacionales-extranjeras|title=Requisitos para el ingreso a Uruguay de personas nacionales o extranjeras|website=Ministerio de Salud Pública}} (only if approved in a person's country of origin)
{{div col end}}
{{Clear}}
Sputnik V
{{infobox
| image = {{Graph:Map|scale=65|defaultValue=gainsboro
|AE=dodgerblue|AG=dodgerblue|AM=dodgerblue|AO=dodgerblue|AR=dodgerblue|AU=turquoise|AZ=dodgerblue
|BA=dodgerblue|BD=dodgerblue|BH=dodgerblue|BO=dodgerblue|BR=dodgerblue|BY=dodgerblue
|CG=dodgerblue|CI=dodgerblue|CL=dodgerblue|CM=dodgerblue|CY=turquoise
|DJ=dodgerblue|DZ=dodgerblue
|EE=turquoise|EC=dodgerblue|EG=dodgerblue
|GA=dodgerblue|GH=dodgerblue|GM=dodgerblue|GN=dodgerblue|GR=turquoise|GT=dodgerblue|GY=dodgerblue
|HK=turquoise|HN=dodgerblue|HU=dodgerblue
|ID=dodgerblue|IL=turquoise|IN=dodgerblue|IQ=dodgerblue|IR=dodgerblue
|JO=dodgerblue
|KE=dodgerblue|KG=dodgerblue|KH=dodgerblue|KZ=dodgerblue
|LA=dodgerblue|LB=dodgerblue|LK=dodgerblue|LY=dodgerblue
|MA=dodgerblue|MD=dodgerblue|ME=dodgerblue|MK=dodgerblue|ML=dodgerblue|MM=dodgerblue|MN=dodgerblue|MU=dodgerblue|MV=dodgerblue|MX=dodgerblue|MY=turquoise
|NA=dodgerblue|NG=dodgerblue|NI=dodgerblue|NP=dodgerblue
|OM=dodgerblue|NZ=turquoise
|PA=dodgerblue|PE=dodgerblue|PH=dodgerblue|PK=dodgerblue|PS=dodgerblue|PY=dodgerblue
|RS=dodgerblue|RU=blueviolet|RW=dodgerblue
|SA=turquoise|SC=dodgerblue|SI=turquoise|SK=darkorange|SM=dodgerblue|SY=dodgerblue
|TH=turquoise|TJ=dodgerblue|TM=blueviolet|TN=dodgerblue|TR=dodgerblue
|UZ=blueviolet
|VC=dodgerblue|VE=dodgerblue|VN=dodgerblue
|ZA=red|ZW=dodgerblue
}}
| caption = {{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|darkorange|Authorization expired}}
{{leftlegend|turquoise|Allowed for travel}}
{{leftlegend|red|Rejected}}
}}
The Sputnik V COVID-19 vaccine is a viral vector vaccine{{cite journal|date=17 June 2020|title=An Open Study of the Safety, Tolerability and Immunogenicity of the Drug "Gam-COVID-Vac" Vaccine Against COVID-19|url=https://clinicaltrials.gov/ct2/show/NCT04436471|access-date=5 March 2021|website=ClinicalTrials.gov|publisher=United States National Library of Medicine|id=NCT04436471}} produced by the Russian Gamaleya Research Institute of Epidemiology and Microbiology.
;Full (3)
- Russia{{cite journal|vauthors=Burki TK|date=November 2020|title=The Russian vaccine for COVID-19|journal=The Lancet. Respiratory Medicine|volume=8|issue=11|pages=e85–e86|doi=10.1016/S2213-2600(20)30402-1|pmc=7837053|pmid=32896274|doi-access=free|title-link=doi}}{{cite news|date=4 February 2022|title=Sputnik V vaccine granted full permanent approval in Russia|work=PR Newswire|url=https://www.prnewswire.com/in/news-releases/sputnik-v-vaccine-granted-full-permanent-approval-in-russia-879907727.html|access-date=8 February 2022}}
- Turkmenistan{{cite news|date=18 January 2021|title=Turkmenistan is the first in Central Asia to have registered 'Sputnik V' vaccine|work=Orient|url=https://orient.tm/en/turkmenistan-is-the-first-in-central-asia-to-have-registered-sputnik-v-vaccine/|access-date=17 March 2021|archive-date=27 January 2021|archive-url=https://web.archive.org/web/20210127203020/https://orient.tm/en/turkmenistan-is-the-first-in-central-asia-to-have-registered-sputnik-v-vaccine/}}{{cite news|date=22 January 2021|title=Session of the Cabinet of Ministers of Turkmenistan |work=Turkmenistan today |url=https://tdh.gov.tm/en/post/25815/objectives-of-increasing-national-health-system%E2%80%99s-potential-discussed}}
- Uzbekistan{{cite news|date=17 February 2021|title=Uzbekistan Certifies Russia's Sputnik Vaccine For Mass Use|publisher=Agence France-Presse (Barron's)|url=https://www.barrons.com/news/uzbekistan-certifies-russia-s-sputnik-vaccine-for-mass-use-01613559912}}
{{Clear}}
;Emergency (76)
- Albania
- Algeria{{cite news|date=10 January 2021|title=Covid19: National Pharmaceuticals Agency registers Sputnik V vaccine|work=Algeria Press service|url=https://www.aps.dz/en/health-science-technology/37478-covid19-national-pharmaceuticals-agency-registers-sputnik-v-vaccine}}
- Angola
- Antigua and Barbuda{{cite press release|title=Antigua and Barbuda authorizes Sputnik V|url=https://sputnikvaccine.com/newsroom/pressreleases/antigua-and-barbuda-authorizes-sputnik-v/|website=sputnikvaccine.com|date=26 March 2021}}
- Argentina{{cite press release|title=Argentina has registered the Sputnik V vaccine based on Russian clinical trial data|url=https://sputnikvaccine.com/newsroom/pressreleases/argentina-has-registered-the-sputnik-v-vaccine-based-on-russian-clinical-trial-data-/|access-date=1 January 2021|publisher=Gamaleya Center}}
- Armenia{{cite news|date=1 February 2021|title=Armenia approves Russia's Sputnik V coronavirus vaccine -Russia's RDIF|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-russia-vaccine-armeni/armenia-approves-russias-sputnik-v-coronavirus-vaccine-russias-rdif-idUSR4N2J304T|access-date=1 February 2021}}
- Azerbaijan{{cite news|date=12 March 2021|title=Azerbaijan approves Russia's Sputnik V vaccine for use against COVID-19 -Azeri health ministry|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-russia-azerbaijan/azerbaijan-approves-russias-sputnik-v-vaccine-for-use-against-covid-19-azeri-health-ministry-idUSR4N2IW02L}}{{#invoke:Cite web||title=Russian Direct Investment Fund|url=https://rdif.ru/Eng_fullNews/6524/|access-date=1 April 2021|website=rdif.ru}}
- Bahrain{{cite news|date=10 February 2021|title=Bahrain authorises Sputnik V COVID-19 vaccine for emergency use – Bahrain TV|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-bahrain-vaccine-int-idUSKBN2AA1GW|access-date=19 February 2021}}
- Bangladesh{{cite news|date=27 April 2021|title=Bangladesh approves Russia's Sputnik V Covid-19 vaccine for emergency use|publisher=Dhaka Tribune|url=https://www.dhakatribune.com/bangladesh/2021/04/27/bangladesh-approves-russia-s-sputnik-v-vaccine-for-emergency-use|access-date=27 April 2021}}
- Belarus{{cite news|date=21 December 2020|title=Belarus registers Sputnik V vaccine, in first outside Russia – RDIF|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-vaccine-belarus/belarus-registers-sputnik-v-vaccine-in-first-outside-russia-rdif-idINKBN28V0ZG|access-date=22 December 2020}}
- Bolivia{{cite news|title=Ministerio de Salud de Bolivia – Bolivia y Rusia firman contrato para adquirir 5,2 millones de dosis de la vacuna Sputnik-V contra la COVID-19|work=minsalud.gob.bo|url=https://www.minsalud.gob.bo/5114-bolivia-y-rusia-firman-contrato-para-adquirir-5-2-millones-de-dosis-de-la-vacuna-sputnik-v-contra-el-covid-19|access-date=1 January 2021}}
- Bosnia and Herzegovina{{#invoke:Cite web||date=5 February 2021|title=Sputnik V vaccine registered in Bosnia and Herzegovina's Republika Srpska|url=https://tass.com/world/1253307|access-date=8 February 2021|agency=TASS}}
- Brazil{{cite news |title=Anvisa aprova, com restrições, a importação excepcional de doses da Covaxin e Sputnik V |trans-title=Anvisa approves import of doses of Covaxin and Sputnik V, with restrictions |url=https://g1.globo.com/bemestar/vacina/noticia/2021/06/04/anvisa-covaxin-sputnik-v.ghtml |access-date=4 June 2021 |work=G1 |agency=Globo |date=4 June 2021 |language=Portuguese}} (restricted)
- Cambodia{{cite web|title=Russian Direct Investment Fund|url=https://rdif.ru/Eng_fullNews/7138/|access-date=5 November 2021|website=rdif.ru|archive-date=5 November 2021|archive-url=https://web.archive.org/web/20211105013012/https://rdif.ru/Eng_fullNews/7138/}}
- Cameroon{{cite news|date=19 March 2021|title=Cameroon approves Russia's Sputnik V coronavirus vaccine for use – RDIF|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-vaccine-russia-camero-idUSR4N2HG02H}}
- Chile{{#invoke:Cite web||title=Instituto de Salud Pública de Chile|url=https://www.ispch.cl/noticia/isp-aprueba-uso-de-emergencia-e-importacion-de-la-vacuna-sputnik-v/|access-date=21 July 2021}}
- Congo-Brazzaville
- Djibouti{{cite news |title=Angola, Congo Republic and Djibouti approve Russia's Sputnik V vaccine |url=https://www.reuters.com/article/health-coronavirus-russia-vaccine-angola-idUSR4N2K301A |publisher=Reuters |date=3 March 2021 }}
- Ecuador{{cite news|title=Arcsa autoriza el ingreso al Ecuador de vacuna Sputnik V|work=www.controlsanitario.gob.ec|url=https://www.controlsanitario.gob.ec/arcsa-autoriza-el-ingreso-al-ecuador-de-vacuna-sputnik-v/|date=14 May 2021|access-date=15 May 2021}}
- Egypt{{cite news|title=COVID-19: Egypt authorises Sputnik V, AstraZeneca virus jabs|work=Gulf News|url=https://gulfnews.com/world/mena/covid-19-egypt-authorises-sputnik-v-astrazeneca-virus-jabs-1.1614189861208|access-date=24 February 2021}}
- Gabon{{cite press release|title=Sputnik V authorised in Gabon|url=https://sputnikvaccine.com/newsroom/pressreleases/sputnik-v-authorized-in-gabon/|access-date=17 February 2021|publisher=Gamaleya Center}}
- Gambia{{cite web|title=Farmacovigilancia de vacunas para COVID-19 - Gamaleya Sputnik V; Sputnik Light|url=https://covid-19pharmacovigilance.paho.org/|access-date=9 October 2021|website=Farmacovigilancia de vacunas para COVID-19}}
- Ghana{{cite news|date=20 February 2021|title=Ghana approves Russia's Sputnik V vaccine for emergency use – RDIF|agency=Reuters|url=https://news.trust.org/item/20210220072758-kzlw8/|access-date=17 March 2021|archive-date=19 March 2021|archive-url=https://web.archive.org/web/20210319084048/https://news.trust.org/item/20210220072758-kzlw8/|url-status=dead}}
- Guatemala{{#invoke:Cite web||title=Guatemala authorizes Sputnik V|url=https://www.pharmiweb.com/press-release/2021-02-26/guatemala-authorizes-sputnik-v|access-date=1 April 2021|website=PharmiWeb}}
- Guinea{{cite news|date=31 December 2020|title=Guinea Begins Administering Russia's Sputnik V Covid-19 Vaccine|work=Africa news|url=https://www.africanews.com/2020/12/31/guinea-begins-administering-russia-s-sputnik-v-covid-19-vaccine/}}
- Guyana{{cite news|date=3 March 2021|title=Russia's Sputnik V vaccine expands its reach in Latin America|publisher=CNN|url=https://edition.cnn.com/2021/03/03/americas/sputnik-latin-america-spreads-intl-latam/index.html}}
- Honduras{{cite news|date=25 February 2021|title=Honduras approves use of Sputnik V vaccine against COVID-19|publisher=Xinhuanet|url=http://www.xinhuanet.com/english/2021-02/25/c_139764745.htm}}
- Hungary{{cite news |title=Hungarian drug regulator approves Sputnik V vaccine: website |url=https://www.themoscowtimes.com/2021/02/07/hungary-approves-russias-sputnik-v-vaccine-a72853 |work=The Moscow Times |date=7 February 2021 }}{{cite news | last=Spike | first=Justin | title=Hungary approves 2 more vaccines from outside EU amid spike |agency=Associated Press |website=ABC News | date=22 March 2021 | url=https://abcnews.go.com/Health/wireStory/hungary-approves-vaccines-eu-amid-spike-76604743 | access-date=14 July 2021 }}
- India{{cite news |title=India approves Russia's 'Sputnik V' COVID-19 vaccine: Economic Times |url=https://www.reuters.com/article/health-coronavirus-india-vaccine/india-approves-russias-sputnik-v-covid-19-vaccine-economic-times-idUSKBN2BZ11Y |publisher=Reuters |date=12 April 2021 }}
- Indonesia{{cite web|date=25 August 2021|title=BPOM Terbitkan Izin Darurat Vaksin Rusia Sputnik-V|url=https://www.cnnindonesia.com/nasional/20210825111626-20-685041/bpom-terbitkan-izin-darurat-vaksin-rusia-sputnik-v|access-date=25 August 2021|website=CNN Indonesia|language=id-ID}}
- Iran{{cite news|date=26 January 2021|title=Iran approves Russian coronavirus vaccine Sputnik V|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-russia-iran/iran-approves-russian-coronavirus-vaccine-sputnik-v-for-use-idUSKBN29V1A8}}
- Iraq{{cite press release|title=Sputnik V authorized in Iraq|url=https://www.pharmiweb.com/press-release/2021-03-05/sputnik-v-authorized-in-iraq|publisher=PharmiWeb.com|date=4 March 2021}}
- Ivory Coast
- Jordan{{cite press release|title=Jordan approves Russia's Sputnik V vaccine for use against COVID-19|url=https://www.reuters.com/article/health-coronavirus-russia-jordan-vaccine/jordan-approves-russias-sputnik-v-vaccine-for-use-against-covid-19-idUSL1N2L8241|publisher=Reuters|date=10 March 2021}}
- Kazakhstan{{#invoke:Cite web||date=1 February 2021|title=Kazakhstan begins mass vaccination by Russian Sputnik V|url=https://www.neweurope.eu/article/kazakhstan-has-began-mass-vaccination-by-russian-sputnik-v/|access-date=19 February 2021}}
- Kenya{{cite news|date=10 March 2021|title=Morocco, Kenya approve Russian coronavirus vaccine for use – RDIF|url=https://www.reuters.com/article/uk-health-coronavirus-vaccine-russia-ken-idUSKBN2B2130|access-date=12 March 2021}}
- Kyrgyzstan{{cite press release|title=Sputnik V registered in Kyrgyzstan|url=https://sputnikvaccine.com/newsroom/pressreleases/sputnik-v-registered-in-kyrgyzstan/|website=Gamaleya Center|date=23 February 2021}}
- Laos{{#invoke:Cite web||title=Laos declares Covid-19 vaccinations safe, more to be inoculated next week |url=https://www.thestar.com.my/aseanplus/aseanplus-news/2021/01/06/laos-declares-covid-19-vaccinations-safe-more-to-be-inoculated-next-week|access-date=19 February 2021|website=The Star|location=Malaysia}}
- Lebanon{{cite news|date=5 February 2021|title=Lebanon authorises emergency use of Russia's Sputnik V vaccine|agency=Reuters|url=https://news.trust.org/item/20210205151526-w0bv2/|access-date=17 March 2021|archive-date=19 March 2021|archive-url=https://web.archive.org/web/20210319084134/https://news.trust.org/item/20210205151526-w0bv2/|url-status=dead}}
- Libya
- Maldives{{cite news|title=Maldives approves Russia's Sputnik V COVID-19 vaccine|url=https://www.reuters.com/article/health-coronavirus-vaccine-russia-maldiv/maldives-approves-russias-sputnik-v-covid-19-vaccine-idUSR4N2MN00D|website=reuters.com|date=13 May 2021|access-date=13 May 2021}}
- Mali{{cite news|date=30 March 2021|title=Mali approves Russia's Sputnik V vaccine – Russian sovereign wealth fund|publisher=Reuters|url=https://www.reuters.com/article/uk-health-coronavirus-russia-mali-vaccin/mali-approves-russias-sputnik-v-vaccine-russian-sovereign-wealth-fund-idUSKBN2BM0Y5}}
- Mauritius{{cite news|date=22 March 2021|title=Mauritius approves Russia's Sputnik V coronavirus vaccine – Russian RDIF fund|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-vaccine-russia-maurit/mauritius-approves-russias-sputnik-v-coronavirus-vaccine-russian-rdif-fund-idUSR4N2KP01G}}
- Mexico{{cite news|date=3 February 2021|title=Mexico, Germany warm to Russia's Sputnik V virus vaccine|work=The Jakarta Post|url=https://www.thejakartapost.com/news/2021/02/03/mexico-germany-warm-to-russias-sputnik-v-virus-vaccine-.html}}
- Moldova
- Mongolia{{cite news|date=9 February 2021|title=Mongolia Approves Russia's Sputnik V Coronavirus Vaccine – RDIF|publisher=Urdu Point|url=https://www.urdupoint.com/en/world/mongolia-approves-russias-sputnik-v-coronavi-1163730.html}}
- Montenegro{{cite news|date=12 February 2021|title=Montenegro and St. Vincent approve Russia's Sputnik V vaccine – RDIF|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-russia-vaccine-mon/montenegro-and-st-vincent-approve-russias-sputnik-v-vaccine-rdif-idUSKBN2AC0QZ}}
- Morocco{{cite news|date=11 March 2021|title=Morocco orders one million doses of Russia's Sputnik V vaccine|publisher=Yabiladi|url=https://en.yabiladi.com/articles/details/107075/morocco-orders-million-doses-russia-s.html}}
- Myanmar{{#invoke:Cite web||title=Myanmar registers Russia's Sputnik V COVID-19 vaccine|url=https://tass.com/world/1253415|access-date=19 February 2021|publisher=Tass}}
- Namibia{{#invoke:Cite web||title=Russian Direct Investment Fund|url=https://rdif.ru/Eng_fullNews/6520/|access-date=1 April 2021|website=rdif.ru}}
- Nepal{{cite news|date=20 April 2021|title=Nepal approves Russia's Sputnik V COVID-19 vaccine|work=Reuters|url=https://www.reuters.com/article/health-coronavirus-nepal-idINL4N2MD3KU|access-date=23 April 2021}}
- Nicaragua{{cite news|date=3 February 2021|title=Nicaragua approves Russian COVID-19 vaccine|work=Associated Press|url=https://apnews.com/article/nicaragua-europe-russia-health-coronavirus-pandemic-82f9744bcf62d1689683c56455ecf15a |access-date=2 June 2021}}
- Nigeria{{cite news |title=Sputnik V vaccine approved in Nigeria |url=https://rdif.ru/fullNews/6937/ |access-date=18 July 2021 |work=Russian Direct Investment Fund |date=15 July 2021 |archive-date=18 July 2021 |archive-url=https://web.archive.org/web/20210718122835/https://rdif.ru/fullNews/6937/ }}
- North Macedonia{{#invoke:Cite web||date=7 March 2021|title=NRussia's Sputnik V COVID 19 vaccine registered in North Macedonia|url=https://tass.com/coronavirus-outbreak-in-china/1263509|publisher=TASS}}
- Oman
- Pakistan{{cite news|date=24 January 2021|title=Govt okays Russian vaccine for 'emergency use'|work=Dawn|url=https://www.dawn.com/news/1603273}}
- Palestine{{cite news|date=11 January 2021|title=Palestine has become the first country in the Middle East to register Sputnik V vaccine|work=RFID|url=https://rdif.ru/Eng_fullNews/6279/}}
- Panama{{cite news |title=Panama approves use of Russian vaccine |url=https://www.newsroompanama.com/news/panama-approves-use-of-russian-vaccine |access-date=2 April 2021 |work=Newsroom Panama |date=1 April 2021}}
- Paraguay{{cite news|date=15 January 2021|title=Paraguay approves Russia's Sputnik V vaccine: RDIF|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-russia-vaccine-paragu/paraguay-approves-russias-sputnik-v-vaccine-rdif-idUSR4N2J303Y|access-date=15 January 2021}}
- Peru{{#invoke:Cite web||date=20 July 2021|title=Perú anuncia acuerdo para compra de 20 millones de dosis de la vacuna Sputnik V|url=https://elperuano.pe/noticia/125005-gobierno-firma-contrato-para-compra-de-20-millones-de-dosis-de-la-vacuna-sputnik-v|access-date=5 August 2021|website=El Peruano}}
- Philippines{{cite web |url=https://cnnphilippines.com/news/2021/3/19/Russia-Gamaleya-emergency-use-PH.html |title=Russia's Sputnik V approved for emergency use in PH |date=19 March 2021 |website=CNN Philippines |access-date=19 March 2021 |archive-date=19 March 2021 |archive-url=https://web.archive.org/web/20210319023615/https://cnnphilippines.com/news/2021/3/19/Russia-Gamaleya-emergency-use-PH.html |url-status=dead }}
- Rwanda
- Saint Vincent and the Grenadines{{#invoke:Cite web||date=11 February 2021|title=Public Health (Emergency Authorisation of COVID-19 Vaccine) Rules, 2021|url=https://www.gov.vc/images/pdf_documents/SRO-Public_Health_Emergency_Authorisation_of_Covid-19_Vaccine.pdf|access-date=12 February 2021|website=Government of Saint Vincent and the Grenadines}}
- San Marino{{cite news|date=20 February 2021|title=San Marino buys the Sputnik vaccine: "First doses already in the next few days"|work=Unioneonline|url=https://www.unionesarda.it/en/articolo/news/mondo/2021/02/19/san-marino-acquista-il-vaccino-sputnik-prime-dosi-gia-nei-prossim-137-1117575.html|access-date=17 March 2021|archive-date=19 March 2021|archive-url=https://web.archive.org/web/20210319083816/https://www.unionesarda.it/en/articolo/news/mondo/2021/02/19/san-marino-acquista-il-vaccino-sputnik-prime-dosi-gia-nei-prossim-137-1117575.html}}{{cite news|date=12 April 2021|title=San Marino reopens thanks to Sputnik covid vaccine from Russia |work=Wanted in Rome|url=https://www.wantedinrome.com/news/san-marino-reopens-thanks-to-sputnik-covid-vaccine-from-russia.html}}
- Serbia{{cite news|date=31 December 2020|title=Agencija odobrila uvoz ruske vakcine Sputnjik V u Srbiju|language=sr-RS|work=N1|url=https://rs.n1info.com/vesti/agencija-odobrila-uvoz-ruske-vakcine-sputnjik-v-u-srbiju/}}
- Seychelles{{cite news|date=19 March 2021|title=Sputnik V vaccine approved in Seychelles|agency=TASS|url=https://tass.com/world/1268131}}
- Sri Lanka{{cite news|date=4 March 2021|title=Sri Lanka approves Russia's Sputnik V vaccine|work=The Hindu|url=https://www.thehindu.com/news/international/sri-lanka-approves-russias-sputnik-v-vaccine/article33987742.ece}}
- Syria{{cite news|date=22 February 2021|title=Syria authorizes use of Sputnik-V|publisher=Roya|url=https://en.royanews.tv/news/25728/2021-02-22}}
- Tajikistan
- Tanzania{{cite news|last=Mohammed|first=Omar|date=17 June 2021|title=Tanzania poised to join COVAX vaccine-sharing facility - WHO|work=Reuters|url=https://www.reuters.com/world/africa/tanzania-submit-request-join-covax-vaccine-sharing-facility-2021-06-17/|access-date=13 January 2022}}
- Tunisia{{cite press release|title=Sputnik V vaccine authorized in Tunisia|url=https://sputnikvaccine.com/newsroom/pressreleases/sputnik-v-vaccine-authorized-in-tunisia/|access-date=30 January 2021|publisher=Gamaleya Center}}
- Turkey (limited use){{cite news|author=Merve Aydogan|date=30 April 2021|title=Turkey OKs emergency use of Sputnik-V vaccine|work=Anadolu Agency|url=https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/turkey-oks-emergency-use-of-sputnik-v-vaccine/2225824}}{{cite news|title=Erdogan unimpressed by Putin's COVID-19 antibodies, Sputnik V vaccine booster offer|url=https://english.alarabiya.net/coronavirus/2021/09/29/Erdogan-unimpressed-by-Putin-s-COVID-19-antibodies-Sputnik-V-vaccine-booster-offer|date=29 September 2021|access-date=11 January 2022|publisher=Al Arabiya English}}
- United Arab Emirates{{cite news|date=21 January 2021|title=UAE approves Russia's Sputnik vaccine for emergency use|work=Khaleej Times|url=https://www.khaleejtimes.com/coronavirus-pandemic/uae-approves-russias-sputnik-vaccine-for-emergency-use|access-date=21 January 2021}}
- Venezuela{{cite news|date=29 December 2020|title=Venezuela firma contrato para la adquisición de la vacuna rusa Sputnik V|language=es|publisher=Reuters|url=https://www.reuters.com/article/salud-coronavirus-venezuela-rusia-idLTAKBN2931X2}}
- Vietnam{{cite news|title=Vietnam approves Russia Covid-19 vaccine for emergency use|publisher=VnExpress|url=https://vnexpress.net/news/news/vietnam-approves-russia-covid-19-vaccine-for-emergency-use-4240528.html|access-date=2 April 2021}}
- Zimbabwe{{cite news|date=9 March 2021|title=Covid-19: Zimbabwe authorises Sputnik V, Sinovac vaccines for emergency use|publisher=news24.com|url=https://www.news24.com/news24/africa/news/covid-19-zimbabwe-authorises-sputnik-v-sinovac-vaccines-for-emergency-use-20210309}}
;Expired
- Slovakia{{cite news|date=1 March 2021|title=Povolenie na terapeutické použitie neregistrovaného lieku|url=https://www.health.gov.sk/Zdroje?/Sources/kategorizacia/doku_kl/ziad_lieky/sputnik.pdf|access-date=8 July 2021}}{{cite web|date=14 April 2021|title=Zmätky s vakcínami pokračujú. Aký Sputnik máme v skladoch?|url=https://spravy.pravda.sk/domace/clanok/584380-zmatky-s-vakcinami-pokracuju-aky-sputnik-mame-v-skladoch/|access-date=8 July 2021|website=Pravda.sk|language=sk-SK}}
;Rejected
- South Africa{{cite book |title=Update on the SAHPRA review of the Sputnik V vaccine |date=18 October 2021 |publisher=South African Health Products Regulatory Agency |url=https://www.sahpra.org.za/news-and-updates/update-on-the-sahpra-review-of-the-sputnik-v-vaccine/ |access-date=20 April 2022}}{{cite web|last=AfricaNews|date=20 October 2021|title=South Africa rejects Russian-made coronavirus vaccine Sputnik V|url=https://www.africanews.com/2021/10/20/south-africa-rejects-russian-made-coronavirus-vaccine-sputnik-v/|access-date=22 October 2021|website=Africanews}}
;Travel-only
- Australia{{cite web|title=Vaccines we recognise for the purpose of travel to Australia|url=https://www.tga.gov.au/international-covid-19-vaccines-recognised-australia|access-date=17 January 2022|website=Therapeutic Goods Administration}}
- Cyprus{{cite web|title=Vaccinated/Recovered Passengers|url=https://cyprusflightpass.gov.cy/en/vaccinated-passengers|access-date=16 November 2021|archive-date=16 November 2021|archive-url=https://web.archive.org/web/20211116185435/https://cyprusflightpass.gov.cy/en/vaccinated-passengers}}
- Estonia{{cite web|title=Questions and answers on coronavirus, related decisions and changes: Vaccines|url=https://kkk.kriis.ee/en/faq/covid-19-vaccination/vaccines#q10069311|access-date=24 November 2021|website=kkk.kriis.ee}}
- Greece{{cite web|date=11 August 2021|title=Greece Accepting Most Covid-19 Vaccines for Travel|url=https://news.gtp.gr/2021/08/11/greece-accepting-most-covid-19-vaccines-for-travel/|access-date=20 November 2021|website=GTP Headlines}}
- Hong Kong
- Israel{{cite web|title=Entry to Israel - Non-Israeli Citizens: Air Travel|url=https://corona.health.gov.il/en/directives/air-travel-covid19-green/?tab=by-air|access-date=24 November 2021|website=Corona Traffic Light Model (Ramzor) Website}}
- Malaysia{{cite web|title=Travellers must have MySejahtera to enter Malaysia|url=https://themalaysianreserve.com/2022/03/25/travellers-must-have-mysejahtera-to-enter-malaysia/amp/|date=25 March 2022|publisher=The Malaysian Reserve|access-date=25 March 2022|website=themalaysianreserve.com}}
- New Zealand
- Saudi Arabia{{cite web |title=Saudi Arabia has joined more than 100 countries accepting visitors vaccinated with Sputnik V following extensive work between Ministry of Health of Saudi Arabia and RDIF, supported by the Ministry of Investments of Saudi Arabia |url=https://sputnikvaccine.com/newsroom/pressreleases/saudi-arabia-has-joined-more-than-100-countries-accepting-visitors-vaccinated-with-sputnik-v/ |access-date=10 December 2021 |date=5 December 2021}}
- Slovenia{{cite web|title=Border Crossing |url=https://www.gov.si/en/topics/coronavirus-disease-covid-19/border-crossing/|access-date=24 November 2021|website=Portal GOV.SI}}
- St. Lucia{{cite web|title=NEW-FAQs|url=https://www.stlucia.org/en/covid-19/faqs/|access-date=24 November 2021|website=Saint Lucia Tourism Authority|archive-date=8 December 2022|archive-url=https://web.archive.org/web/20221208103421/https://www.stlucia.org/en/covid-19/faqs/}}
- Thailand{{cite web|title=THAILAND'S ENTRY REGULATIONS|url=https://thaiembassy.at/en/coe.html|access-date=20 December 2021|website=Royal Thai Embassy in Vienna}}
CoronaVac
{{infobox
| image = {{Graph:Map|scale=65|defaultValue=gainsboro
|AD=turqoise|AE=turqoise|AF=limegreen|AG=dodgerblue|AL=dodgerblue|AM=dodgerblue|AO=dodgerblue|AR=dodgerblue|AT=turquoise|AU=turquoise|AZ=limegreen
|BA=dodgerblue|BB=dodgerblue|BD=dodgerblue|BF=dodgerblue|BH=limegreen|BI=dodgerblue|BJ=limegreen|BN=dodgerblue|BO=dodgerblue|BR=dodgerblue|BS=limegreen|BT=dodgerblue|BW=dodgerblue|BZ=dodgerblue
|CA=turquoise|CD=limegreen|CF=limegreen|CG=dodgerblue|CH=turquoise|CI=dodgerblue|CL=dodgerblue|CM=dodgerblue|CN=blueviolet|CO=dodgerblue|CR=limegreen|CU=dodgerblue|CV=dodgerblue|CY=turquoise
|DJ=dodgerblue|DM=dodgerblue|DO=dodgerblue|DZ=dodgerblue
|EC=dodgerblue|EE=turquoise|EG=dodgerblue|ES=turquoise|ET=dodgerblue
|FI=turquoise|FJ=limegreen|FM=limegreen
|GA=dodgerblue|GB=turquoise|GD=limegreen|GE=dodgerblue|GH=limegreen|GM=dodgerblue|GN=dodgerblue|GQ=dodgerblue|GR=turquoise|GT=limegreen|GW=dodgerblue|GY=dodgerblue
|HK=limegreen|HN=limegreen|HR=turquoise|HT=limegreen|HU=dodgerblue
|ID=dodgerblue|IE=turquoise|IN=limegreen|IQ=dodgerblue|IR=limegreen|IS=turquoise
|JM=limegreen|JO=dodgerblue|JP=turquoise
|KE=dodgerblue|KG=dodgerblue|KH=dodgerblue|KI=dodgerblue|KM=dodgerblue|KN=limegreen|KP=limegreen|KR=turquoise|KW=dodgerblue|KZ=dodgerblue
|LA=dodgerblue|LB=dodgerblue|LC=limegreen|LI=turquoise|LK=dodgerblue|LR=limegreen|LS=dodgerblue|LY=dodgerblue
|MA=dodgerblue|MC=limegreen|MD=dodgerblue|ME=dodgerblue|MG=dodgerblue|MH=limegreen|MK=dodgerblue|ML=limegreen|MM=dodgerblue|MN=dodgerblue|MO=blueviolet|MR=dodgerblue|MU=dodgerblue|MV=dodgerblue|MW=dodgerblue|MX=dodgerblue|MY=dodgerblue|MZ=dodgerblue
|NA=dodgerblue|NE=dodgerblue|NG=dodgerblue|NI=limegreen|NL=turquoise|NO=turqoise|NP=dodgerblue|NR=limegreen|NZ=turquoise
|OM=dodgerblue
|PA=dodgerblue|PE=limegreen|PG=dodgerblue|PH=dodgerblue|PK=dodgerblue|PS=dodgerblue|PT=turquoise|PW=turquoise|PY=dodgerblue
|QA=dodgerblue
|RS=limegreen|RW=dodgerblue
|SA=dodgerblue|SB=dodgerblue|SC=blueviolet|SD=dodgerblue|SE=turquoise|SG=dodgerblue|SI=turquoise|SK=turquoise|SL=dodgerblue|SN=dodgerblue|SO=dodgerblue|SR=dodgerblue|SS=limegreen|ST=limegreen|SV=dodgerblue|SY=dodgerblue|SZ=limegreen
|TD=dodgerblue|TG=limegreen|TH=dodgerblue|TJ=limegreen|TL=limegreen|TM=dodgerblue|TN=dodgerblue|TO=limegreen|TR=dodgerblue|TT=dodgerblue|TV=limegreen|TZ=dodgerblue
|UA=dodgerblue|UG=limegreen|US=turquoise|UY=dodgerblue|UZ=dodgerblue
|VC=limegreen|VE=dodgerblue|VU=dodgerblue
|WS=limegreen
|XK=limegreen
|YE=dodgerblue|VN=turquoise|
|ZA=dodgerblue|ZM=dodgerblue|ZW=dodgerblue
}}
| caption = {{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
{{leftlegend|limegreen|Eligible COVAX recipient}}
}}
The CoronaVac COVID-19 vaccine is an inactivated virus vaccine{{#invoke:Cite web||date=12 May 2020|title=Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection (COVID-19) (Renqiu)|url=https://clinicaltrials.gov/ct2/show/NCT04383574|url-status=live|archive-url=https://web.archive.org/web/20201011084809/https://clinicaltrials.gov/ct2/show/NCT04383574/|archive-date=11 October 2020|access-date=14 July 2020|website=ClinicalTrials.gov|publisher=United States National Library of Medicine|id=NCT04383574}} produced by the Chinese company Sinovac Biotech.{{#invoke:Cite web||date=2 July 2020|title=Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals (PROFISCOV)|url=https://clinicaltrials.gov/ct2/show/NCT04456595|url-status=live|archive-url=https://web.archive.org/web/20201011084811/https://clinicaltrials.gov/ct2/show/NCT04456595/|archive-date=11 October 2020|access-date=3 August 2020|website=ClinicalTrials.gov|publisher=United States National Library of Medicine|id=NCT04456595}}{{cite journal|last1=PT. Bio Farma|date=10 August 2020|title=A Phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-COV-2 inactivated vaccine in healthy adults aged 18–59 years in Indonesia|url=https://www.ina-registry.org/index.php?act=registry_trial_detail&code_trial=16202009080721WXFM0YX|journal=Registri Penyakit Indonesia|access-date=15 August 2020}}
;Full (1)
- Hong Kong{{#invoke:Cite web||date=18 February 2021|title=Use of Sinovac vaccine authorised|url=https://www.news.gov.hk/eng/2021/02/20210218/20210218_111857_034.html|access-date=19 February 2021|publisher=Government of Hong Kong}}
{{Clear}}
;Emergency (71)
- Afghanistan
- Albania{{#invoke:Cite web||last=Semini|first=Llazar|title=Albania starts mass COVID vaccinations before tourist season|url=https://abcnews.go.com/Business/wireStory/albania-starts-mass-covid-vaccinations-tourist-season-76733128|access-date=29 March 2021|website=ABC News}}
- Algeria
- Argentina
- Armenia{{#invoke:Cite web||title=В Армению отправлена китайская вакцина от COVID-19|url=https://ru.armradio.am/2021/04/30/%d0%b2-%d0%b0%d1%80%d0%bc%d0%b5%d0%bd%d0%b8%d1%8e-%d0%be%d1%82%d0%bf%d1%80%d0%b0%d0%b2%d0%bb%d0%b5%d0%bd%d0%b0-%d0%ba%d0%b8%d1%82%d0%b0%d0%b9%d1%81%d0%ba%d0%b0%d1%8f-%d0%b2%d0%b0%d0%ba%d1%86%d0%b8/|access-date=9 May 2021|website=Общественное Радио Армении|language=ru-RU}}
- Azerbaijan{{#invoke:Cite web||last1=Aliyev|first1=Jeyhun|title=Azerbaijan kicks off COVID-19 vaccination|url=https://www.aa.com.tr/en/world/azerbaijan-kicks-off-covid-19-vaccination/2114591|access-date=7 February 2021|publisher=Anadolu Agency}}
- Bangladesh{{#invoke:Cite web||title=Bangladesh approves Sinovac Covid-19 vaccine for emergency use|date=6 June 2021|url=https://www.dhakatribune.com/bangladesh/2021/06/06/sinovac-covid-19-vaccine-approved-for-emergency-use|access-date=6 June 2021|publisher=Dhaka Tribune}}
- Benin{{#invoke:Cite web||last=Ayosso|first=Akpédjé|date=29 March 2021|title=Deux ministres vaccinés contre Covid-19|url=https://www.24haubenin.info/?Deux-ministres-vaccines-contre-Covid-19|access-date=7 April 2021|website=24haubenin.info|language=fr}}
- Bolivia{{#invoke:Cite web||title=Bolívia autoriza uso de vacinas Sputnik V e CoronaVac contra covid-19|url=https://noticias.uol.com.br/internacional/ultimas-noticias/2021/01/06/bolivia-autoriza-uso-de-vacinas-sputnik-v-e-coronavac-contra-covid-19.htm|access-date=6 January 2021|website=noticias.uol.com.br|language=pt-br}}
- Bosnia and Herzegovina{{#invoke:Cite web||last=Agency|first=Anadolu|date=28 March 2021|title=Turkey sends Chinese COVID-19 vaccines to Bosnia-Herzegovina|url=https://www.dailysabah.com/politics/diplomacy/turkey-sends-chinese-covid-19-vaccines-to-bosnia-herzegovina|access-date=14 April 2021|website=Daily Sabah}}
- Botswana{{#invoke:Cite web||title=Botswana Could Be First African Country to Vaccinate Entire Adult Population |url=https://www.voanews.com/covid-19-pandemic/botswana-could-be-first-african-country-vaccinate-entire-adult-population|access-date=21 May 2021|website=Voice of America|date=27 April 2021}}
- Brazil{{cite news|last1=McGeever|first1=Jamie|last2=Fonseca|first2=Pedro|date=17 January 2021|title=Brazil clears emergency use of Sinovac, AstraZeneca vaccines, shots begin|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-brazil-idUSKBN29M0M3|access-date=17 January 2021}}
- Cambodia{{#invoke:Cite web||last1=Chanritheara|first1=Torn|title=Cambodia Approves AstraZeneca and Sinovac Vaccines for COVID-19 Emergency Use|url=https://cambodianess.com/article/cambodia-approves-astrazeneca-and-sinovac-vaccines-for-covid-19-emergency-use|access-date=12 February 2021|publisher=Cambodianess}}
- Chile{{#invoke:Cite web||date=20 January 2021|title=Chile aprueba el uso de emergencia de la vacuna china de Sinovac contra covid-19|url=https://www.france24.com/es/minuto-a-minuto/20210120-chile-aprueba-el-uso-de-emergencia-de-la-vacuna-china-de-sinovac-contra-covid-19|access-date=30 January 2021|publisher=France 24}}
- Colombia{{#invoke:Cite web||last1=Aliyev|first1=Jeyhun|title=Colombia approves emergency use of CoronaVac vaccine|url=https://www.aa.com.tr/en/americas/colombia-approves-emergency-use-of-coronavac-vaccine/2134570|access-date=7 February 2021|publisher=Anadolu Agency}}
- Djibouti{{#invoke:Cite web||title=Djibouti Ministry of Health|url=https://twitter.com/minsantedj/status/1372948366137696270|access-date=30 March 2021|website=Twitter}}
- Dominica
- Dominican Republic{{#invoke:Cite web||title=Anticovid vaccines run out as Dominican Republic awaits arrival of more doses|url=https://dominicantoday.com/dr/covid-19/2021/03/08/anticovid-vaccines-run-out-as-dominican-republic-awaits-arrival-of-more-doses/|access-date=10 March 2021|publisher=DominicanToday}}
- East Timor{{#invoke:Cite news ||last=Martins|first=Filomeno|title=Government to launch Chinese Sinovac vaccine next week |work=TATOLI Agência Noticiosa de Timor-Leste|url=http://www.tatoli.tl/en/2021/06/11/government-to-launch-chinese-sinovac-vaccine-next-week/|access-date=15 June 2021}}
- Ecuador{{#invoke:Cite web||title=Ecuador signs agreement with Sinovac for 2 million COVID-19 vaccine: minister|url=https://nationalpost.com/pmn/health-pmn/ecuador-signs-agreement-with-sinovac-for-2-million-covid-19-vaccine-minister|access-date=26 February 2021|work=National Post}}
- Egypt{{#invoke:Cite web||title=Egypt approves Sinovac COVID-19 vaccine for emergency use|url=https://gulfnews.com/world/mena/egypt-approves-sinovac-covid-19-vaccine-for-emergency-use-1.1619472925063|access-date=27 April 2021|website=gulfnews|date=27 April 2021 }}
- El Salvador{{#invoke:Cite news ||title=Llegan a El Salvador un millón de dosis de la vacuna china CoronaVac contra el covid-19 de la farmacéutica Sinovac|url=https://www.laprensagrafica.com/elsalvador/Llegan-a-El-Salvador-un-millon-de-dosis-de-la-vacuna-china-contra-el-covid-19-de-la-farmaceutica-Sinovac-20210328-0004.html|access-date=29 March 2021|newspaper=La Prensa Gráfica |language=es-ES}}
- Equatorial Guinea
- Fiji{{#invoke:Cite web||title=China to donate Sinovac Vaccine to Fiji|url=https://www.fbcnews.com.fj/news/china-to-donate-sinovac-vaccine-to-fiji/|access-date=22 March 2021|website=Fiji Broadcasting Corporation}}
- Gabon
- Georgia{{#invoke:Cite web||title=Covid-19 vaccination with Sinovac to start on May 24 in Georgia|url=https://agenda.ge/en/news/2021/1336|access-date=21 May 2021|website=Agenda.ge}}
- Guinea{{#invoke:Cite web||title=Guinea receives purchase of 300,000 Sinovac COVID-19 vaccines|url=https://www.channelnewsasia.com/news/world/guinea-receives-purchase-of-300-000-sinovac-covid-19-vaccines-14649970|access-date=3 June 2021|website=CNA}}
- Guyana
- Hungary
- Indonesia{{cite news|last=Soeriaatmadja|first=Wahyudi|date=11 January 2021|title=Indonesia grants emergency use approval to Sinovac's vaccine, local trials show 65% efficacy|work=The Straits Times|url=https://www.straitstimes.com/asia/se-asia/indonesia-grants-emergency-use-approval-to-sinovac-vaccine-local-trials-show-65|access-date=11 January 2021}}{{cite news|date=11 January 2021|title=BPOM Grants Emergency Use Authorization for Sinovac Vaccine|work=Tempo|url=https://en.tempo.co/read/1422220/bpom-grants-emergency-use-authorization-for-sinovac-vaccine|access-date=11 January 2021}}
- Iraq
- Jordan
- Kazakhstan{{#invoke:Cite news ||title=В Казахстан доставили первую партию китайской вакцины CoronaVac |work=Kazakhstan Today|url=https://www.kt.kz/rus/covid-19/v_kazahstan_dostavili_pervuyu_partiyu_kitayskoy_vaktsiny_1377916469.html|access-date=7 June 2021 |language=ru}}
- Kuwait
- Laos{{cite news|last1=Liu|first1=Roxanne|date=6 February 2021|title=China approves Sinovac Biotech COVID-19 vaccine for general public use|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-vaccine-sinovac/china-approves-sinovac-biotech-covid-19-vaccine-for-general-public-use-idUSKBN2A60AY|access-date=7 February 2021}}
- Lebanon
- Libya{{#invoke:Cite web||date=9 May 2021|title=Libya begins administrating China's Sinovac vaccine in Tripoli|url=https://www.libyanexpress.com/libya-begins-administrating-chinas-sinovac-vaccine-in-tripoli/|access-date=21 May 2021|website=Libyan Express}}
- Malawi
- Malaysia{{cite news|date=2 March 2021|title=Malaysia approves Sinovac, AstraZeneca COVID-19 vaccines for use|publisher=Reuters|url=https://www.reuters.com/business/healthcare-pharmaceuticals/malaysia-approves-sinovac-astrazeneca-covid-19-vaccines-use-2021-03-02/ |access-date=21 November 2021}}
- Maldives
- Mexico{{cite news|last1=Barrera|first1=Adriana|date=11 February 2021|title=Mexico approves China's CanSino and Sinovac COVID-19 vaccines|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-mexico-cansino/update-2-mexico-approves-chinas-cansino-and-sinovac-covid-19-vaccines-idUSL1N2KG0NO|access-date=11 February 2021}}
- Moldova{{cite news|last=Tanas|first=Alexander|date=9 April 2021|title=Moldova to buy 400,000 doses of Sinovac COVID-19 vaccine|work=Reuters|url=https://www.reuters.com/article/health-coronavirus-moldova-sinovac-idUKL8N2M24JT|access-date=9 May 2021}}
- Morocco
- Myanmar{{#invoke:Cite web||last=Fishbein|first=Emily|title=Ethnic groups step in as Myanmar's COVID response falls apart|url=https://www.aljazeera.com/news/2021/5/10/ethnic-groups-step-in-as-myanmars-covid-response-falls-apart|access-date=23 July 2021|website=Al Jazeera}}
- Nepal{{#invoke:Cite web||title=Nepal gives emergency use approval to China's Sinovac Covid-19 vaccine|url=https://kathmandupost.com/health/2021/06/04/nepal-gives-emergency-use-approval-to-china-s-sinovac-covid-19-vaccine|access-date=7 June 2021|website=kathmandupost}}
- North Macedonia{{#invoke:Cite web||last=Testorides|first=Konstantin|date=27 June 2021|title=North Macedonia gets 500,000 doses of Sinovac vaccines|url=https://apnews.com/article/coronavirus-vaccine-coronavirus-pandemic-health-government-and-politics-business-1827f4b8b524449d72dd43e62a97ac63|access-date=28 June 2021|publisher=Associated Press}}
- Oman{{#invoke:Cite web||title=COVID-19: Oman approves use of Sinovac and Sputnik vaccines|url=https://gulfnews.com/world/gulf/oman/covid-19-oman-approves-use-of-sinovac-and-sputnik-vaccines-1.80173049|access-date=25 June 2021|website=gulfnews|date=24 June 2021 }}
- Pakistan{{#invoke:Cite web||title=DRAP allows emergency authorisation to fifth Covid-19 vaccine|url=https://www.thenews.com.pk/print/817278-drap-allows-emergency-authorisation-to-fifth-covid-19-vaccine|access-date=10 April 2021|website=The News International}}
- Palestine
- Panama{{cite news|date=9 April 2021|title=Panama approves emergency use of Chinese vaccine against COVID-19|publisher=Xinhuanet|url=http://www.xinhuanet.com/english/2021-04/10/c_139870805.htm|access-date=9 April 2021}}
- Paraguay{{#invoke:Cite web||title=CoronaVac, vacuna de alta eficacia|url=https://www.mspbs.gov.py/portal/22762/coronavac-vacuna-de-alta-eficacia.html|website=Ministerio de Salud Publica Y Bienestar Social (Paraguay)}}
- Philippines{{cite news|date=22 February 2021|title=Philippines approves Sinovac's COVID-19 vaccine for emergency use|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-philippines-vaccine/philippines-approves-sinovacs-covid-19-vaccine-for-emergency-use-idUSL4N2KL0UK}}
- Qatar
- Rwanda
- Saint Vincent and the Grenadines
- Saudi Arabia{{cite news|date=24 August 2021|title=MoH: Six COVID-19 vaccines approved in Saudi Arabia|work=Saudi Gazette|url=https://saudigazette.com.sa/article/610193|access-date=25 December 2021}}
- Singapore{{cite web|author=Matthew Mohan|date=23 October 2021|title=Sinovac COVID-19 vaccine to be included in Singapore's national vaccination programme|url=https://www.channelnewsasia.com/singapore/sinovac-covid-19-vaccine-national-vaccination-programme-three-dose-singapore-2263787|access-date=23 October 2021|website=CNA}}
- Somalia
- South Africa{{cite news|date=3 July 2021|title=SAHPRA authorises the CoronaVac vaccine with conditions|publisher=SAHPRA|url=https://www.sahpra.org.za/press-releases/sahpra-authorises-the-coronavac-vaccine-with-conditions/}}
- Sri Lanka{{#invoke:Cite web||title=Sri Lanka approves China's Sinovac COVID-19 vaccine for emergency use|url=http://www.colombopage.com/archive_21A/Jul17_1626497465CH.php|access-date=18 July 2021|website=ColomboPage}}
- Sudan
- Syria
- Tajikistan{{#invoke:Cite news ||script-title=ru:Китайской вакциной в Таджикистане первоначально будут прививать людей старше 60 лет |work=ASIA-Plus|url=https://asiaplustj.info/ru/news/tajikistan/society/20210621/kitaiskoi-vaktsinoi-v-tadzhikistane-pervonachalno-budut-privivat-lyudei-starshe-60-let|access-date=13 July 2021}}
- Tanzania{{#invoke:Cite web||date=13 July 2021|title=Vaccine-Holdout Tanzania Begins Inoculations With Sinovac Doses - BNN Bloomberg|url=https://www.bnnbloomberg.ca/vaccine-holdout-tanzania-begins-inoculations-with-sinovac-doses-1.1628276|access-date=13 July 2021|website=Bloomberg}}
- Thailand{{cite news|last1=Thepgumpanat|first1=Panarat|date=22 February 2021|title=Thailand allows emergency use of Sinovac's COVID-19 vaccine|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-thailand/thailand-allows-emergency-use-of-sinovacs-covid-19-vaccine-idUSKBN2AM1BX|access-date=23 February 2021}}
- Togo{{#invoke:Cite web||title=Le CoronaVac pour les étudiants du public|url=https://www.republicoftogo.com/Toutes-les-rubriques/Education/Le-CoronaVac-pour-les-etudiants-du-public|access-date=23 May 2021|website=République Togolaise|language=fr}}
- Trinidad and Tobago{{cite web|date=8 November 2021|title=Health Ministry: Covaxin vaccine approved use in Trinidad and Tobago|url=https://newsday.co.tt/2021/11/08/health-ministry-covaxin-vaccine-approved-use-in-trinidad-and-tobago/|access-date=30 November 2021|website=Trinidad and Tobago Newsday}}
- Tunisia{{#invoke:Cite web||date=5 March 2021|title=Tunisia approva vaccino cinese Sinovac|url=https://www.ansa.it/sito/notizie/mondo/dalla_cina/2021/03/05/covid-tunisia-approva-vaccino-cinese-sinovac_9ba5fbb3-4ee9-48de-9327-c37a3931f5d1.html|access-date=7 March 2021|publisher=Agenzia Nazionale Stampa Associata (in Italian)|language=it}}
- Turkey{{cite news|date=14 January 2021|title=Turkey grants emergency authorization to Sinovac's CoronaVac|url=https://www.reuters.com/article/us-health-coronavirus-turkey-vaccine-idUSKBN29I29F|access-date=9 January 2022|publisher=Reuters}}
- Turkmenistan{{#invoke:Cite web||last=turkmenportal|title=В Туркменистан поступила крупная партия китайской вакцины "CoronaVac" |url=https://turkmenportal.com/blog/36504/v-turkmenistan-postupila-krupnaya-partiya-kitaiskoi-vakciny-coronavac|access-date=7 June 2021|website=Туркменистан, интернет портал о культурной, деловой и развлекательной жизни в Туркменистане|language=ru}}
- Uganda
- Ukraine{{cite news|last1=Zinets|first1=Natalia|date=9 March 2021|title=Ukraine approves China's Sinovac COVID-19 vaccine|url=https://www.reuters.com/article/us-health-coronavirus-ukraine-vaccine-idUSKBN2B11H6|access-date=10 March 2021|publisher=Reuters}}
- United Arab Emirates
- Uruguay
- Uzbekistan{{#invoke:Cite web||title=Uzbekistan plans to obtain Sinovac coronavirus vaccine|url=https://akipress.com/news:658218:Uzbekistan_plans_to_obtain_Sinovac_coronavirus_vaccine/|access-date=21 May 2021|website=akipress}}
- Venezuela{{#invoke:Cite web||date=30 June 2021|title=COVID-19 Information|url=https://ve.usembassy.gov/covid-19-information/|access-date=23 August 2021|website=U.S. Embassy in Venezuela}}
- Yemen
- Zimbabwe
- Northern Cyprus
- World Health Organization{{cite news |last=Nebehay |first=Stephanie |title=WHO approves Sinovac COVID vaccine, the second Chinese-made dose listed |url=https://www.reuters.com/article/us-health-coronavirus-who-sinovac/who-approves-sinovac-covid-vaccine-the-second-chinese-made-dose-listed-idUSKCN2DD3V5 |access-date=1 June 2021 |work=Reuters |date=1 June 2021 |location=Geneva}}{{cite web | title=WHO recommendation Sinovac COVID-19 vaccine (Vero Cell [Inactivated]) – CoronaVac | website=World Health Organization (WHO) | date=1 May 2021 | url=https://extranet.who.int/pqweb/vaccines/who-recommendation-sinovac-covid-19-vaccine-vero-cell-inactivated-coronavac | access-date=1 June 2021 | archive-date=2 June 2021 | archive-url=https://web.archive.org/web/20210602213345/https://extranet.who.int/pqweb/vaccines/who-recommendation-sinovac-covid-19-vaccine-vero-cell-inactivated-coronavac }}{{cite press release | title=WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations | website=World Health Organization (WHO) | url=https://www.who.int/news/item/01-06-2021-who-validates-sinovac-covid-19-vaccine-for-emergency-use-and-issues-interim-policy-recommendations | access-date=1 June 2021}}
;Travel-only
{{div col|colwidth=18em}}
- Andorra
- Australia{{cite news|date=1 October 2021|title=Australia set to restart international travel in November, Scott Morrison says|work=The Guardian|url=https://www.theguardian.com/australia-news/2021/oct/01/australia-set-to-restart-international-travel-in-november-scott-morrison-says|access-date=21 November 2021}}
- Austria (only for entry)
- Canada
- Costa Rica
- Croatia
- Cyprus
- Estonia (only if approved in a person's country of origin)
- Finland
- Greece
- Grenada
- Iceland
- Ireland
- Japan
- Liechtenstein
- Norway{{cite web|url=https://www.helsenorge.no/en/coronavirus/international-travels/#who-can-travel-to-norway|title=CInternational travels to Norway|date=23 March 2020}}
- New Zealand
- Norway{{Cite web|url=http://www.police.hu/en/content/information-on-general-rules-of-border-crossing|title=INFORMATION ON GENERAL RULES OF BORDER CROSSING – National Police Headquarters of Hungary}}
- Palau{{Cite web|url=https://www.palaugov.pw/travel/|title=COVID-19 Pandemic Entry Requirements – PalauGov.pw}}
- Panama
- Portugal (only in Madeira)
- Slovakia
- Slovenia
- South Korea
- Spain
- St. Kitts and Nevis
- St. Lucia
- St. Vincent and the Grenadines
- Sweden
- Switzerland
- The Netherlands
- Ukraine
- United Arab Emirates{{cite web|url=https://www.mohap.gov.ae/en/services/travelers-vaccination|title=Travelers Vaccinations - Ministry of Health and Prevention - UAE|website=www.mohap.gov.ae|access-date=22 November 2021|archive-date=22 November 2021|archive-url=https://web.archive.org/web/20211122031706/https://www.mohap.gov.ae/en/services/travelers-vaccination|url-status=dead}}
- United Kingdom
- United States
- Vietnam{{cite news|date=21 October 2021|title=Việt Nam temporarily approves COVID-19 vaccine certificates by 72 countries, territories: Foreign ministry|work=Việt Nam News|url=https://vietnamnews.vn/politics-laws/1063197/viet-nam-temporarily-approves-covid-19-vaccine-certificates-by-72-countries-territories-foreign-ministry.html|access-date=8 January 2022}}
{{div col end}}
{{clear}}
{{Clear}}
Novavax
{{infobox
| image = {{Graph:Map|scale=65|defaultValue=gainsboro
|AF=limegreen|AG=limegreen|AL=limegreen|AM=limegreen|AO=limegreen|AR=limegreen|AT=dodgerblue|AU=blueviolet|AZ=limegreen
|BA=limegreen|BB=limegreen|BD=dodgerblue|BE=dodgerblue|BF=limegreen|BG=dodgerblue|BJ=limegreen|BN=limegreen|BO=limegreen|BR=limegreen|BS=limegreen|BT=limegreen|BZ=limegreen
|CA=blueviolet|CD=limegreen|CG=limegreen|CH=dodgerblue|CI=limegreen|CL=limegreen|CM=limegreen|CO=limegreen|CR=limegreen|CV=limegreen|CY=dodgerblue|CZ=dodgerblue
|DE=dodgerblue|DK=dodgerblue|DJ=limegreen|DM=limegreen|DO=limegreen|DZ=limegreen
|EC=limegreen|EE=dodgerblue|EG=limegreen|ES=dodgerblue
|FI=dodgerblue|FJ=limegreen|FM=limegreen|FR=dodgerblue
|GD=limegreen|GE=limegreen|GH=limegreen|GM=limegreen|GN=limegreen|GR=dodgerblue
|HN=limegreen|HR=dodgerblue|HT=limegreen|HU=dodgerblue
|ID=dodgerblue|IE=dodgerblue|IQ=limegreen|IS=dodgerblue|IT=dodgerblue
|JM=limegreen|JO=limegreen|JP=blueviolet
|KE=limegreen|KH=limegreen|KI=limegreen|KM=limegreen|KN=limegreen|KP=limegreen|KR=blueviolet|
|LA=limegreen|LB=limegreen|LC=limegreen|LR=limegreen|LS=limegreen|LT=dodgerblue|LU=dodgerblue|LV=dodgerblue|LY=limegreen
|MA=limegreen|MC=dodgerblue|MD=limegreen|ME=limegreen|MH=limegreen|MK=limegreen|ML=limegreen|MR=limegreen|MT=dodgerblue|MU=limegreen|MV=limegreen|MW=limegreen|MY=limegreen|MZ=limegreen
|NA=limegreen|NE=limegreen|NG=limegreen|NL=dodgerblue|NO=dodgerblue|NR=limegreen|NZ=dodgerblue
|PA=turquoise|PE=limegreen|PG=limegreen|PH=dodgerblue|PK=limegreen|PL=dodgerblue|PT=dodgerblue
|QA=limegreen
|RO=dodgerblue|RS=limegreen|RW=limegreen
|SB=limegreen|SD=limegreen|SE=dodgerblue|SG=dodgerblue|SI=dodgerblue|SK=dodgerblue|SL=limegreen|SN=limegreen|SO=limegreen|SR=limegreen|SS=limegreen|ST=limegreen|SV=limegreen|SY=limegreen|SZ=limegreen
|TD=limegreen|TG=limegreen|TH=dodgerblue|TJ=limegreen|TL=limegreen|TN=limegreen|TO=limegreen
|TR=turquoise|TV=limegreen
|UA=limegreen|UG=limegreen|GB=dodgerblue|UY=limegreen|UZ=limegreen
|VC=limegreen|VU=limegreen
|WS=limegreen|XK=limegreen|YE=limegreen|ZA=limegreen|ZM=limegreen|IN=dodgerblue
|US=dodgerblue|AE=turquoise|SA=limegreen|ET=limegreen|CF=limegreen|KG=limegreen
|BW=limegreen|ZW=limegreen|MX=limegreen|PY=limegreen|VE=limegreen|IR=limegreen|NI=limegreen|GY=limegreen|MM=limegreen|VN=limegreen|MG=limegreen|LK=limegreen|GT=limegreen
}}
| caption = {{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
{{leftlegend|limegreen|Eligible COVAX recipient}}
}}
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, is a subunit COVID-19 vaccine candidate developed by Novavax and the Coalition for Epidemic Preparedness Innovations.{{cite press release | title=WHO lists 9th COVID-19 vaccine for emergency use with aim to increase access to vaccination in lower-income countries | website=World Health Organization (WHO) | date=17 December 2021 | url=https://www.who.int/news/item/17-12-2021-who-lists-9th-covid-19-vaccine-for-emergency-use-with-aim-to-increase-access-to-vaccination-in-lower-income-countries | access-date=30 October 2022}}{{cite press release | title=WHO lists 10th COVID-19 vaccine for emergency use: Nuvaxovid | website=World Health Organization (WHO) | date=21 December 2021 | url=https://www.who.int/news/item/21-12-2021-who-lists-10th-covid-19-vaccine-for-emergency-use-nuvaxovid | access-date=30 October 2022}}
;Full (4)
- Australia{{cite web|title=TGA provisionally approves Novavax (Biocelect Pty Ltd's) COVID-19 vaccine NUVAXOVID|url=https://www.tga.gov.au/media-release/tga-provisionally-approves-novavax-biocelect-pty-ltds-covid-19-vaccine-nuvaxovid|access-date=20 January 2022|website=Therapeutic Goods Administration|date=20 January 2022}}
- Canada{{cite web | title=Novavax Nuvaxovid COVID-19 vaccine | website=Health Canada | date=7 June 2022 | url=https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/novavax.html | access-date=30 October 2022 }}{{cite news |date=17 February 2022|title=Canada approves Novavax's COVID-19 vaccine for adults|publisher=Reuters|url=https://www.reuters.com/business/healthcare-pharmaceuticals/canada-approves-novavaxs-covid-19-vaccine-2022-02-17/|access-date=17 February 2022}}
- Japan{{cite news|date=19 April 2022|title=Japan approves Novavax as 4th COVID vaccine amid new surge|work=ABC News|url=https://abcnews.go.com/Health/wireStory/japan-approves-novavax-covid-19-vaccine-84159564|access-date=21 April 2022}}
- South Korea{{cite news|date=12 January 2022|title=South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine|work=Novavax, Inc.|url=https://ir.novavax.com/2022-01-12-South-Korea-Ministry-of-Food-and-Drug-Safety-Approves-Novavax-COVID-19-Vaccine|access-date=22 January 2022}}
{{Clear}}
;Emergency (57)
- Bangladesh{{cite news |title=Novavax Reports First Quarter 2022 Financial Results and Operational Highlights |url=https://finance.yahoo.com/news/novavax-reports-first-quarter-2022-200200347.html |work=Novavax, Inc. |date=9 May 2022}}
- India{{cite news |last1=Achom |first1=Debasish |title=India Clears 2 New Vaccines And Merck's Covid Pill |url=https://www.ndtv.com/india-news/coronavirus-2-more-vaccines-covovax-and-corbevax-and-anti-viral-drug-molnupiravir-cleared-in-india-2675170 |work=NDTV.com |date=28 December 2021}}
- Indonesia{{cite news|last1=O'donnell|first1=Carl|last2=Nadeem|first2=Dania|date=1 November 2021|title=Novavax COVID-19 vaccine gets first authorization; expects more within weeks, CEO says|work=Reuters|url=https://www.reuters.com/business/healthcare-pharmaceuticals/novavax-covid-19-vaccine-receives-emergency-use-authorization-indonesia-2021-11-01/|access-date=1 November 2021}}
- Monaco
- New Zealand{{cite news|last1=The Associated Press Staff|date=3 February 2022|title=Novavax's COVID-19 shot receives provisional approval in New Zealand|agency=Associated Press|url=https://www.ctvnews.ca/world/novavax-s-covid-19-shot-receives-provisional-approval-in-new-zealand-1.5767524|access-date=4 February 2022}}
- Philippines{{cite news |title=Philippines approves emergency use of Novavax's COVID-19 vaccine |url=https://www.reuters.com/business/healthcare-pharmaceuticals/philippines-approves-emergency-use-novavaxs-covid-19-vaccine-2021-11-17/ |access-date=17 November 2021 |publisher=Reuters |date=17 November 2021}}
- Singapore{{cite web|author=Clara Chong|date=14 February 2022|title=Novavax Covid-19 vaccine approved for those aged 18 and above in Singapore|url=https://www.straitstimes.com/singapore/novavax-covid-19-vaccine-approved-for-those-aged-18-and-above-to-arrive-in-the-next-few-months|access-date=14 February 2022|website=The Straits Times}}
- South Africa
- Switzerland{{cite news |title=Swissmedic grants temporary authorisation for the Nuvaxovid COVID-19 vaccine from Novavax |url=https://www.swissmedic.ch/swissmedic/en/home/news/coronavirus-covid-19/zl-nuvaxovid-novovax.html |work=Swissmedic |date=13 April 2022}}
- Thailand{{cite web|title=Novavax and Serum Institute of India Receive Emergency Use Authorization for Novavax' COVID-19 Vaccine in Thailand|url=https://finance.yahoo.com/news/novavax-serum-institute-india-receive-130000777.html|access-date=11 April 2022|website=Yahoo! Finance}}
- Taiwan{{cite web |date=19 June 2022 |title=Novavax cleared for use by Taiwan FDA |url=https://www.taiwannews.com.tw/en/news/4574660 |access-date=24 June 2022 |website=Taiwan News}}
- United Kingdom{{cite web|title=Novavax COVID-19 vaccine Nuvaxovid approved by MHRA|url=https://www.gov.uk/government/news/novavax-covid-19-vaccine-nuvaxovid-approved-by-mhra|access-date=3 February 2022|website=GOV.UK}}
- United States{{cite press release |date=13 July 2022 |title=Coronavirus (COVID-19) Update: FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvanted |url=https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-emergency-use-novavax-covid-19-vaccine-adjuvanted |access-date=14 July 2022 |publisher=U.S. Food and Drug Administration }}{{cite web |title=FDA Authorizes Novavax's COVID-19 Vaccine—Here's What to Know About the New Shot |url=https://www.health.com/news/novavax-fda-emergency-use-authorization |access-date=14 July 2022 |website=Health |first=Meagan |last=Drillinger |date=13 July 2022}}
{{nowrap|EMA countries}}{{cite web|date=20 December 2021|title=EMA recommends Nuvaxovid for authorisation in the EU|url=https://www.ema.europa.eu/en/news/ema-recommends-nuvaxovid-authorisation-eu|publisher=European Medicines Agency (EMA)}}
- Austria
- Belgium
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Malta
- Netherlands
- Norway
- Poland
- Portugal
- Romania
- Slovakia
- Slovenia
- Spain
- Sweden
{{nowrap|CARPHA countries and entities}}
- Antigua and Barbuda
- Bahamas
- Barbados
- Belize
- Dominica
- Grenada
- Guyana
- Haiti
- Jamaica
- Saint Kitts and Nevis
- Saint Lucia
- Saint Vincent and the Grenadines
- Suriname
- Trinidad and Tobago
:* Anguilla
:* Aruba
:* British Virgin Islands
:* Bermuda
:* Caribbean Netherlands
:* Cayman Islands
:* Curaçao
:* Montserrat
:* Sint Maarten
:* Turks and Caicos Islands
- World Health Organization{{cite press release | title=WHO lists 9th COVID-19 vaccine for emergency use with aim to increase access to vaccination in lower-income countries | website=World Health Organization (WHO) | url=https://www.who.int/news/item/17-12-2021-who-lists-9th-covid-19-vaccine-for-emergency-use-with-aim-to-increase-access-to-vaccination-in-lower-income-countries | access-date=17 December 2021}}{{cite news |title=WHO issues emergency use listing to Novavax-Serum Institute's COVID-19 vaccine |url=https://www.reuters.com/business/healthcare-pharmaceuticals/who-issues-emergency-use-listing-novavax-serum-institutes-covid-19-vaccine-2021-12-17/ |work=Reuters |date=17 December 2021 }}
;Travel-only
- Hong Kong
- Palau
- Panama
- Switzerland
- Turkey
- United Arab Emirates
- United States (before emergency approval July 2022)
{{clear}}
Covaxin
{{infobox
| image = {{Graph:Map|scale=65|defaultValue=gainsboro
|AF=limegreen|AG=limegreen|AL=limegreen|AM=limegreen|AO=limegreen|AR=limegreen|AZ=limegreen|AU=turquoise
|BA=limegreen|BB=limegreen|BD=limegreen|BF=limegreen|BH=dodgerblue|BJ=limegreen|BN=limegreen|BO=limegreen|BR=limegreen|BS=limegreen|BT=limegreen|BW=dodgerblue|BZ=limegreen
|CD=limegreen|CF=dodgerblue|CG=limegreen|CI=limegreen|CL=limegreen|CM=limegreen|CO=limegreen|CR=limegreen|CV=limegreen
|DJ=limegreen|DM=limegreen|DO=limegreen|DZ=limegreen
|EC=limegreen|EE=turquoise|EG=limegreen|ET=dodgerblue|
|FJ=limegreen|FM=limegreen|FI=turquoise
|GD=limegreen|GB=turquoise|GE=limegreen|GH=limegreen|GM=limegreen|GN=limegreen|GR=turquoise|GT=dodgerblue|GY=dodgerblue
|HK=turquoise|HN=limegreen|HT=limegreen
|ID=limegreen|IN=blueviolet|IQ=limegreen|IR=dodgerblue|IS=turquoise
|JP=turquoise|JM=limegreen|JO=limegreen
|KE=limegreen|KG=turquoise|KH=limegreen|KI=limegreen|KM=dodgerblue|KN=limegreen|KP=limegreen|KR=limegreen|
|LA=limegreen|LB=limegreen|LC=limegreen|LK=turquoise|LR=limegreen|LS=limegreen|LY=limegreen
|MA=limegreen|MC=limegreen|MD=limegreen|ME=limegreen|MH=limegreen|MK=limegreen|ML=limegreen|MM=dodgerblue|MN=turquoise|MR=limegreen|MU=dodgerblue|MV=limegreen|MW=limegreen|MX=dodgerblue|MY=dodgerblue|MZ=limegreen
|NA=limegreen|NE=limegreen|NG=limegreen|NI=dodgerblue|NP=dodgerblue|NR=limegreen|NZ=turquoise
|OM=turquoise
|PA=limegreen|PE=limegreen|PG=limegreen|PH=dodgerblue|PK=limegreen|PS=turquoise|PY=dodgerblue
|QA=limegreen
|RS=limegreen|RW=limegreen
|SA=turquoise|SB=limegreen|SD=limegreen|SG=turquoise|SL=limegreen|SN=limegreen|SO=limegreen|SR=limegreen|SS=limegreen|ST=limegreen|SV=limegreen|SY=limegreen|SZ=limegreen
|TD=limegreen|TG=limegreen|TH=turquoise|TJ=limegreen|TL=limegreen|TN=limegreen|TO=limegreen|TT=dodgerblue|TV=limegreen
|UA=limegreen|UG=limegreen|US=turquoise|UY=limegreen|UZ=limegreen|CH=turquoise|TR=turquoise|
|VC=limegreen|VE=dodgerblue|VN=dodgerblue|VU=limegreen
|WS=limegreen
|XK=limegreen
|YE=limegreen
|ZA=limegreen|ZM=limegreen|ZW=dodgerblue
|AD=turquoise|AT=turquoise|CA=turquoise|HR=turquoise|CY=turquoise|IE=turquoise|LI=turquoise|NL=turquoise|SI=turquoise|SK=turquoise|ES=turquoise|SE=turquoise
}}
| caption = {{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
{{leftlegend|limegreen|Eligible COVAX recipient}}
}}
Covaxin is an inactivated virus vaccine produced by the Indian company Bharat Biotech in collaboration with the Indian Council of Medical Research–National Institute of Virology.
;Full (1)
;Emergency (50)
- Afghanistan
- Bahrain{{cite news|date=11 November 2021|title=Bahrain authorizes COVAXIN for emergency use|work=Bahrain News Agency|url=https://www.bna.bh/en/BahrainauthorizesCOVAXINforemergencyuse.aspx?cms=q8FmFJgiscL2fwIzON1%2bDvdCpVGdtuusfPwcuTv4D1k%3d|access-date=29 January 2022}}
- Botswana{{#invoke:Cite news||url=https://timesofindia.indiatimes.com/india/covid-19-bharat-biotech-ramps-up-covaxin-capacity-to-700-million-doses-per-annum/articleshow/82162467.cms|title=Covid-19: Bharat Biotech ramps up Covaxin capacity to 700 million doses per annum | India News |website=The Times of India|date=20 April 2021 }}
- Central African Republic
- Comoros
- Egypt
- Ethiopia
- Guatemala (not used){{cite web|url=https://ais.paho.org/imm/IM_DosisAdmin-Vacunacion.asp|title=COVID-19 vaccine doses administered in the Americas|website=ais.paho.org}}
- Iran{{cite news |title=Iran issues permit for emergency use for three other COVID-19 vaccines: Official |url=https://en.irna.ir/news/84233593/Iran-issues-permit-for-emergency-use-for-three-other-COVID-19 |work=IRNA English |date=17 February 2021 }}
- Iraq
- Jordan
- Kuwait
- Lebanon
- Libya
- Malaysia{{cite web|url=
https://www.nst.com.my/amp/news/nation/2022/02/770394/covaxin-given-conditional-approval-under-emergency-use-protocols|title=Covaxin given conditional approval under emergency use protocols|website=nst.com.my|publisher=New Straits Times|date=10 February 2021|access-date=10 February 2022}}
- Mauritius{{cite web|last=Livemint|date=1 November 2021|title=5 more countries recognise India's Covid vaccination certificate. Details here|url=https://www.livemint.com/news/india/five-more-countries-recognise-india-s-covid-vaccination-certificate-details-here-11635766929707.html|access-date=1 November 2021|website=mint}}
- Mexico{{#invoke:Cite web||url=https://www.excelsior.com.mx/nacional/mexico-autoriza-covaxin-vacuna-de-emergencia-india/1441874|title=México autoriza Covaxin, la vacuna india contra covid-19|publisher=Excelsior|date=6 April 2021}} (not used)
- Morocco
- Myanmar{{cite news |title=Myanmar sees over 130,000 Covid-19 recoveries, just over 7,000 still in hospital |url=https://elevenmyanmar.com/news/myanmar-sees-over-130000-covid-19-recoveries-just-over-7000-still-in-hospital |work=Eleven Media Group |date=19 February 2021}}
- Nepal{{cite news|last=Sharma|first=Gopal|date=19 March 2021|title=Nepal becomes third country to give emergency nod to Indian vaccine COVAXIN|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-nepal-india-idUSKBN2BB1KN|access-date=19 March 2021}}
- Nicaragua (not used)
- Oman
- Pakistan
- Paraguay{{#invoke:Cite web||url=https://www.hindustantimes.com/india-news/covid19-india-provides-100-000-doses-of-covaxin-vaccine-to-paraguay-101617057324587.html|title=India provides 100,000 doses of Covaxin vaccine to Paraguay|work=Hindustan Times|date=30 March 2021}}{{cite tweet|number=1376615865068752896|user=MaritoAbdo|title=Acaban de llegar 100.000 dosis de vacunas contra el Covid-19, provenientes de la India. La prioridad es avanzar hacia la inmunización de todo el personal de blanco y luego la población de riesgo. Gracias a la República de la India por el apoyo.|date=30 March 2021}}
- Philippines{{cite news |title=Philippine FDA issues full EUA to Bharat Biotech's Covaxin |url=https://mb.com.ph/2021/06/23/philippine-fda-issues-full-eua-to-bharat-biotechs-covaxin/ |publisher=Manila Bulletin |date=23 June 2021}}{{cite news |title=FDA grants full emergency use authorization for Covaxin |url=https://cnnphilippines.com/news/2021/6/25/COVAXIN-EUA-Philippines.html |publisher=CNN Philippines |date=25 June 2021 |access-date=25 June 2021 |archive-date=3 July 2021 |archive-url=https://web.archive.org/web/20210703070449/https://cnnphilippines.com/news/2021/6/25/COVAXIN-EUA-Philippines.html |url-status=dead }}
- Qatar
- Somalia
- Sudan
- Syria
- Tunisia
- United Arab Emirates
- Venezuela (not used)
- Vietnam{{cite news |title=Covid-19: Hong Kong, Vietnam latest to approve Covaxin for emergency use |url=https://www.hindustantimes.com/india-news/covid19-hong-kong-vietnam-latest-to-approve-covaxin-for-emergency-use-101636530349366.html |work=Hindustan Times |date=10 November 2021 }}
- Yemen
- Zimbabwe{{#invoke:Cite web||date=4 March 2021|title=Zimbabwe approves Covaxin, first in Africa to okay India-made Covid-19 vaccine|url=https://www.hindustantimes.com/world-news/zimbabwe-approves-covaxin-first-in-africa-to-okay-india-made-covid-19-vaccine-101614859597880.html|access-date=3 July 2021|website=Hindustan Times}}
{{nowrap|CARPHA countries and entities}}{{cite web |title=COVID-19 Vaccine Update Supplement, Week of 13th – 17th June, 2022 |url=https://carpha.org/Portals/0/Documents/COVID-19%20Vaccine%20Updates/CARPHA%20COVID-19%20Vaccine%20Update%20072%20June%2013%202022.pdf |publisher=CARPHA |access-date=20 November 2022 |page=9}}
- Antigua and Barbuda
- Bahamas
- Barbados
- Belize
- Dominica
- Grenada
- Guyana (not used)
- Haiti
- Jamaica
- Saint Kitts and Nevis
- Saint Lucia
- Saint Vincent and the Grenadines
- Suriname
- Trinidad and Tobago
:* Anguilla
:* Aruba
:* British Virgin Islands
:* Bermuda
:* Caribbean Netherlands
:* Cayman Islands
:* Curaçao
:* Montserrat
:* Sint Maarten
:* Turks and Caicos Islands
- Palestine
- World Health Organization{{cite news |title=India's first homegrown COVID-19 shot wins WHO emergency use listing |url=https://www.reuters.com/world/india/whos-advisory-group-recommends-emergency-listing-indias-first-homegrown-covid-19-2021-11-03/ |work=Reuters |date=3 November 2021 }}{{cite press release | title=WHO issues emergency use listing for eighth COVID-19 vaccine | website=World Health Organization (WHO) | url=https://www.who.int/news/item/03-11-2021-who-issues-emergency-use-listing-for-eighth-covid-19-vaccine | access-date=3 November 2021}}
;Travel-only
{{div col|colwidth=18em}}
- Andorra
- Australia
- Austria (only for entry)
- Canada
- Costa Rica
- Croatia
- Cyprus
- Estonia (only if approved in a person's country of origin)
- Finland
- Greece
- Hong Kong
- Iceland
- Ireland
- Japan
- Kyrgyzstan
- Liechtenstein
- Mongolia
- New Zealand
- Norway
- Oman
- Palestine
- Palau
- Panama
- Portugal (only in Madeira)
- Saudi Arabia{{cite web |url=https://keralakaumudi.com/en/news/mobile/news.php?id=701543&u= |title=Relief for expatriates: Saudi Arabia approves four more vaccines, including Covaxin |date=6 December 2021 |publisher=Kerala Kaumudi}}
- Singapore
- Slovakia
- Slovenia
- South Korea
- Spain
- Sri Lanka{{cite news |title=Sri Lanka green light for Covaxin: Opens quarantine free for fully jabbed Indian tourists |url=https://timesofindia.indiatimes.com/business/international-business/sri-lanka-green-light-for-covaxin-opens-quarantine-free-for-fully-jabbed-indian-tourists/articleshow/85594554.cms |newspaper=The Times of India |date=24 August 2021}}
- Sweden
- Switzerland
- Thailand{{cite web |title=Thailand Pass FAQs |url=https://consular.mfa.go.th/th/content/thailand-pass-faqs-2 |website=Department of Consular Affairs |access-date=11 January 2022}}
- The Netherlands
- Turkey
- Ukraine
- United Kingdom
- United States
{{div col end}}
{{clear}}
VLA2001
{{infobox|image={{Graph:Map|scale=65|defaultValue=gainsboro
|AE=dodgerblue|AT=dodgerblue
|BE=dodgerblue|BG=dodgerblue
|CY=dodgerblue|CZ=dodgerblue
|DE=dodgerblue|DK=dodgerblue
|ES=dodgerblue|EE=dodgerblue
|FI=dodgerblue|FR=dodgerblue
|GB=blueviolet|GR=dodgerblue
|HR=dodgerblue|HU=dodgerblue
|IE=dodgerblue|IS=dodgerblue|IT=dodgerblue
|LI=dodgerblue|LT=dodgerblue|LU=dodgerblue|LV=dodgerblue
|MT=dodgerblue|MY=turquoise
|NL=dodgerblue|NO=dodgerblue|NZ=turquoise
|PL=dodgerblue|PT=dodgerblue
|RO=dodgerblue
|SE=dodgerblue|SI=dodgerblue|SK=dodgerblue
|TR=turquoise
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
VLA2001 is an inactivated vaccine developed by Valneva SE and Dynavax Technologies.
;Full (1)
- United Kingdom{{Cite news |date=14 April 2022 |title=Valneva Covid vaccine approved for use in UK |url=https://www.bbc.co.uk/news/health-61104594 |work=BBC News}}
{{div col|colwidth=18em}}
;Emergency (32)
- Bahrain{{Failed verification | date = June 2024}}
- United Arab Emirates{{cite web |date=17 May 2022 |title=Valneva receives EUA from UAE for its inactivated COVID-19 vaccine |url=https://www.expresspharma.in/valneva-receives-eua-from-uae-for-its-inactivated-covid-19-vaccine/ |access-date=20 June 2022 |website=Express Pharma }}
{{nowrap|EMA countries}}{{cite web |date=20 June 2022 |title=COVID-19 Vaccine (inactivated, adjuvanted) Valneva EPAR |url=https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-inactivated-adjuvanted-valneva |url-status=live |archive-url=https://web.archive.org/web/20220628005530/https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-inactivated-adjuvanted-valneva |archive-date=28 June 2022 |access-date=28 June 2022 |website=European Medicines Agency (EMA)}}
- Austria
- Belgium
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Malta
- Netherlands
- Norway
- Poland
- Portugal
- Romania
- Slovakia
- Slovenia
- Spain
- Sweden
{{div col end}}
;Travel-only
Sanofi–GSK
The Sanofi–GSK COVID-19 vaccine, sold under the brand name VidPrevtyn Beta, is a subunit vaccine developed by Sanofi Pasteur and GSK plc. It is based on the SARS-CoV-2 Beta variant.
{{nowrap|EMA countries}} (as booster only){{cite web |last1=Kansteiner |first1=Fraiser |title=Sanofi, GSK crash the COVID-19 vaccine party late with a world-first nod for their next-gen booster |url=https://www.fiercepharma.com/pharma/sanofi-and-gsk-crash-covid-19-vaccine-late-world-first-nod-next-gen-booster-vidprevtyn-beta |website=Fierce Pharma |access-date=18 November 2022 |language=en |date=10 November 2022}}
- Austria
- Belgium
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Malta
- Netherlands
- Norway
- Poland
- Portugal
- Romania
- Slovakia
- Slovenia
- Spain
- Sweden
Sputnik Light
{{infobox|image={{Graph:Map|scale=65|defaultValue=gainsboro
|AO=dodgerblue|AE=dodgerblue|AR=dodgerblue
|BH=dodgerblue|BJ=dodgerblue|BY=dodgerblue
|CG=dodgerblue
|EG=dodgerblue
|IR=dodgerblue
|IN=dodgerblue
|KG=dodgerblue|KH=dodgerblue|KZ=dodgerblue
|LA=dodgerblue
|MN=dodgerblue|MU=dodgerblue|MY=turquoise
|NI=dodgerblue|NZ=turquoise
|PH=dodgerblue|PS=dodgerblue
|RU=dodgerblue
|SM=dodgerblue|SY=dodgerblue
|TM=dodgerblue|TN=dodgerblue|TR=turquoise|TZ=dodgerblue
|VC=dodgerblue|VE=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
Sputnik Light is a viral vector vaccine,{{cite news|last=Ryumin|first=Alexander|date=20 February 2021|title=Russia registers its third COVID-19 vaccine CoviVac|publisher=TASS|location=Moscow|url=https://tass.com/society/1258859|access-date=6 March 2021}} produced by the Russian Gamaleya Research Institute of Epidemiology and Microbiology. It consists of the first dose of the Sputnik V vaccine, which is based on the Ad26 vector.{{cite press release |date=6 May 2021 |title=Single dose vaccine, Sputnik Light, authorized for use in Russia |url=https://rdif.ru/Eng_fullNews/6763/ |publisher=Russian Direct Investment Fund |access-date=11 May 2021}}
;Full (0)
;Emergency (28)
- Angola{{cite news |title=Sputnik Light Vaccine Approved For Use In Angola |url=https://sputnikvaccine.com/newsroom/pressreleases/sputnik-light-vaccine-approved-for-use-in-angola/ |access-date=13 May 2021 |publisher=Sputnik V vaccine |date=12 May 2021}}
- Argentina{{cite web|title=BOLETIN OFICIAL REPUBLICA ARGENTINA - MINISTERIO DE SALUD - Resolución 3451/2021|url=https://www.boletinoficial.gob.ar/detalleAviso/primera/253978|access-date=7 December 2021|website=www.boletinoficial.gob.ar}}
- Armenia{{cite web|title=Armenia approves Russian one-dose Sputnik Light vaccine|url=https://en.armradio.am/2021/09/06/armenia-approves-russian-one-dose-sputnik-light-vaccine/|access-date=8 December 2021|website=Public Radio of Armenia}}
- Bahrain{{cite news|date=11 May 2021|title=Bahrain authorizes emergency use of one-shot Sputnik-Light COVID-19 vaccine|publisher=Reuters|url=https://www.reuters.com/world/middle-east/bahrain-authorizes-emergency-use-one-shot-sputnik-light-covid-19-vaccine-2021-05-11/|access-date=12 May 2021}}
- Belarus{{cite news |title=Belarus registers Russia's Sputnik Light vaccine for use |url=https://www.reuters.com/business/healthcare-pharmaceuticals/belarus-registers-russias-sputnik-light-vaccine-use-2021-06-03/ |access-date=4 June 2021 |date=3 June 2021}}
- Benin{{cite news|date=14 January 2022|title=Sputnik Light vaccine authorized in Benin, says Russian Direct Investment Fund|work=TASS|url=https://tass.com/world/1388289|access-date=7 February 2022}}
- Cambodia
- Congo-Brazzaville{{cite web |title=Single-dose Sputnik Light vaccine approved for use in the Republic of the Congo |url=https://rdif.ru/Eng_fullNews/6878/ |publisher=Russian Direct Investment Fund |website=rdif.ru |date=7 June 2021 |access-date=7 June 2021 |archive-date=7 June 2021 |archive-url=https://web.archive.org/web/20210607175016/https://rdif.ru/Eng_fullNews/6878/ }}
- Egypt{{cite web|title=The single-component Sputnik Light vaccine authorized in Egypt|url=https://sputnikvaccine.com/newsroom/pressreleases/the-single-component-sputnik-light-vaccine-authorized-in-egypt/|access-date=1 October 2021|website=sputnikvaccine}}
- Iran
- India{{cite web|title=Sputnik Light: DCGI nod to emergency use of single-dose Covid vaccine|url=https://www.livemint.com/news/india/sputnik-light-dcgi-nod-to-emergency-use-of-single-dose-covid-vaccine-11644160096963.html|website=Livemint|date=2 February 2022}}
- Kazakhstan{{cite news |title=Kazakhstan approves Russia's single-dose Sputnik Light vaccine |url=https://www.reuters.com/world/asia-pacific/kazakhstan-approves-russias-single-dose-sputnik-light-vaccine-rdif-2021-07-15/ |access-date=15 July 2021 |work=Reuters |date=15 July 2021 |location=Moscow}}
- Kyrgyzstan{{#invoke:Cite web||title=Single-dose Sputnik Light vaccine registered in Kyrgyzstan|url=https://sputnikvaccine.com/newsroom/pressreleases/single-dose-sputnik-light-vaccine-registered-in-kyrgyzstan/|access-date=25 June 2021|website=sputnikvaccine}}
- Laos
- Mauritius{{cite news |title=Russia's Sputnik Light vaccine approved for use in Mauritius |url=https://www.reuters.com/business/healthcare-pharmaceuticals/russias-sputnik-light-vaccine-approved-use-mauritius-rdif-2021-06-02/ |access-date=4 June 2021 |work=Reuters |date=2 June 2021}}
- Mongolia{{cite press release |title=Single-dose Sputnik Light vaccine registered in Mongolia |url=https://rdif.ru/Eng_fullNews/6907/ |location=Moscow |publisher=Russian Direct Investment Fund |access-date=25 June 2021 |date=11 June 2021 |archive-date=29 June 2021 |archive-url=https://web.archive.org/web/20210629205823/https://rdif.ru/Eng_fullNews/6907/ }}
- Nicaragua{{cite news |title=Single-dose Sputnik Light vaccine approved for use in Nicaragua |url=https://rdif.ru/Eng_fullNews/6846/ |publisher=Russian Direct Investment Fund |date=20 May 2021 |access-date=1 June 2021 |archive-date=3 June 2021 |archive-url=https://web.archive.org/web/20210603092124/https://rdif.ru/Eng_fullNews/6846/ }}
- Palestine{{cite news |title=Russia's Sputnik Light vaccine approved for use in Palestinian territories |url=https://www.reuters.com/article/health-coronavirus-russia-israel-palesti-idUSR4N2NB01F |access-date=4 June 2021 |work=Reuters |date=31 May 2021}}
- Philippines{{cite news|title=Philippines approves emergency use of Russia's Sputnik Light vaccine|url=https://www.reuters.com/world/asia-pacific/philippines-approves-emergency-use-russias-sputnik-light-vaccine-2021-08-23/ |access-date=23 August 2021 |work=Reuters |date=23 August 2021}}
- Russia{{cite news |title=Russia Approves Single-Dose Sputnik Light Covid Vaccine For Use |url=https://www.ndtv.com/world-news/russia-approves-single-dose-sputnik-light-covid-19-vaccine-for-use-2436470 |publisher=NDTV Coronavirus |date=6 May 2021}}
- Saint Vincent and the Grenadines
- San Marino{{cite web|title=Russian Direct Investment Fund|url=https://rdif.ru/Eng_fullNews/7171/|access-date=30 November 2021|website=rdif.ru|archive-date=30 November 2021|archive-url=https://web.archive.org/web/20211130200937/https://rdif.ru/Eng_fullNews/7171/}}
- Syria{{cite news |title=Batch of Russia's Sputnik Light vaccine delivered to Syria |url=https://tass.com/world/1317383 |access-date=31 July 2021 |work=TASS |date=24 July 2021 |location=Damascus}}
- Tanzania
- Tunisia
- Turkmenistan{{Cite web|url=https://turkmenportal.com/blog/42752/turkmenistan-zaregistriroval-oblegchennyi-variant-rossiiskoi-vakciny-sputnik-v|title=Туркменистан зарегистрировал облегченный вариант российской вакцины «Спутник V» | Здоровье}}
- United Arab Emirates{{cite web|date=6 October 2021|title=UAE authorises Sputnik Light COVID-19 vaccine -Russia's RDIF|url=https://www.reuters.com/world/middle-east/uae-authorises-sputnik-light-covid-19-vaccine-russias-rdif-2021-10-06/|access-date=23 October 2021|website=Reuters}}
- Venezuela{{cite press release|title=Single-dose Sputnik Light vaccine approved for use in Venezuela |url=https://sputnikvaccine.com/newsroom/pressreleases/single-dose-sputnik-light-vaccine-approved-for-use-in-venezuela/|access-date=15 May 2021|publisher=Gamaleya Center}}
Non-country entities
- Abkhazia{{cite news|date=28 October 2021|title=In Abkhazia, 3,638 People Were Covid-19 Vaccination With Satellite Light |url=https://minzdrav.apsny.land/novosti/item/801-v-abkhazii-privivku-ot-covid-19-sputnikom-lajt-sdelali-3638-chelovek}}
- Donbass Region (unofficially){{cite web|url=https://warsawinstitute.org/moscow-plays-donbas-part-ukraine-conflict/ |title=Moscow Plays Up Donbas As Part Of The Ukraine Conflict |publisher=Warsaw Institute |date=30 July 2021 |access-date=4 March 2022}}
;Travel-only
{{clear}}
Convidecia
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|AR=dodgerblue
|CL=dodgerblue
|CN=blueviolet
|EC=dodgerblue
|HK=turquoise
|HU=dodgerblue
|ID=dodgerblue
|JP=turquoise
|MD=dodgerblue
|MX=dodgerblue
|MY=dodgerblue
|NZ=turquoise
|PK=dodgerblue
|TR=turquoise
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
Convidecia is a viral vector vaccine{{cite journal|vauthors=Zhu FC, Guan XH, Li YH, Huang JY, Jiang T, Hou LH, Li JX, Yang BF, Wang L, Wang WJ, Wu SP, Wang Z, Wu XH, Xu JJ, Zhang Z, Jia SY, Wang BS, Hu Y, Liu JJ, Zhang J, Qian XA, Li Q, Pan HX, Jiang HD, Deng P, Gou JB, Wang XW, Wang XH, Chen W|date=August 2020|title=Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial|journal=Lancet|volume=396|issue=10249|pages=479–88|doi=10.1016/s0140-6736(20)31605-6|pmc=7836858|pmid=32702299|doi-access=free|title-link=doi}} produced by the Chinese company CanSino Biologics and the Beijing Institute of Biotechnology of the Academy of Military Medical Sciences.
;Full (1)
;Emergency (9)
- Argentina{{#invoke:Cite web||date=11 June 2021|title=Argentina issues emergency approval to China's single-dose Cansino COVID-19 vaccine|url=https://www.reuters.com/world/americas/argentina-issues-emergency-approval-chinas-single-dose-cansino-covid-19-vaccine-2021-06-11/|access-date=11 June 2021|website=Reuters}}
- Chile{{#invoke:Cite web||title=ISP Approves Emergency Use And Importation Of Cansino Vaccine To Fight COVID-19|url=https://www.ispch.cl/noticia/isp-aprueba-uso-de-emergencia-e-importacion-de-la-vacuna-covid-19-de-laboratorio-cansino/|access-date=8 April 2021|website=Institute of Public Health of Chile}}
- Ecuador{{#invoke:Cite web||date=15 June 2021|title=Ecuador authorizes use of China's CanSino vaccine against COVID-19|url=https://www.reuters.com/world/americas/ecuador-authorizes-use-chinas-cansino-vaccine-against-covid-19-2021-06-15/|access-date=16 June 2021|website=Reuters}}
- Hungary{{cite web | title=China's CanSino Biologics COVID-19 vaccine receives emergency use approval in Hungary | publisher=MSN | date=22 March 2021 | url=https://www.msn.com/en-xl/europe/top-stories/china-s-cansino-biologics-covid-19-vaccine-receives-emergency-use-approval-in-hungary/ar-BB1eOIEV | access-date=22 March 2021}}
- Indonesia
- Malaysia{{#invoke:Cite web||title=Govt approves Pfizer jabs for 12-year-olds and above, CanSino and Johnson & Johnson vaccines get conditional registration, says Health DG|url=https://www.thestar.com.my/news/nation/2021/06/15/govt-approves-pfizer-jabs-for-12-year-olds-and-above-conditional-approval-for-cansino-and-johnson--johnson-vaccines-says-health-dg|access-date=15 June 2021|website=The Star}}
- Mexico
- Moldova
- Pakistan{{cite news | last1=Shahzad |first1=Asif |title=Pakistan approves Chinese CanSinoBIO COVID vaccine for emergency use |url=https://www.reuters.com/article/us-health-coronavirus-pakistan-vaccine/pakistan-approves-chinese-cansinobio-covid-vaccine-for-emergency-use-idUSKBN2AC1FG |publisher=Reuters |access-date=12 February 2021 |date=12 February 2021}}
- World Health Organization{{cite press release | title=WHO validates 11th vaccine for COVID-19 | website=World Health Organization | date=19 May 2022 | url=https://www.who.int/news/item/19-05-2022-who-validates-11th-vaccine-for-covid-19 | access-date=30 October 2022}}
;Travel-only
{{clear}}
Sinopharm WIBP
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|AE=dodgerblue
|CN=blueviolet
|HK=turquoise
|MK=dodgerblue
|MY=turquoise
|NZ=turquoise
|PE=dodgerblue
|PH=dodgerblue
|TR=turquoise
|VE=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
The Sinopharm WIBP COVID-19 vaccine is an inactivated virus vaccine produced by the China National Pharmaceutical Group (Sinopharm) and its Wuhan Institute of Biological Products.
;Full (1)
;Emergency (5)
- Armenia
- North Macedonia
- Peru
- Philippines{{cite news |author1=De Vera, Analou |title=FDA grants EUA to COVID-19 vaccine Sinopharm manufactured by Wuhan affiliate |url=https://mb.com.ph/2021/08/25/fda-grants-eua-to-covid-19-vaccine-sinopharm-manufactured-by-wuhan-affiliate/ |publisher=Manila Bulletin |date=25 August 2021}}
- United Arab Emirates
- Venezuela
;Travel-only
{{clear}}
Abdala
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|CU=dodgerblue
|GY=turquoise
|KH=turquoise
|LC=turquoise
|MX=dodgerblue
|MY=turquoise
|NI=dodgerblue
|NZ=turquoise
|TR=turquoise
|UY=turquoise
|VC=turquoise
|VE=dodgerblue
|VN=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
Abdala is a subunit vaccine developed by the Center for Genetic Engineering and Biotechnology in Cuba.
;Full (0)
;Emergency (6)
- Cuba{{cite news|date=9 July 2021|title=COVID: Cuba approves emergency use of own Abdala vaccine|work=Deutsche Welle|url=https://www.dw.com/en/covid-cuba-approves-emergency-use-of-own-abdala-vaccine/a-58222105|access-date=9 July 2021}}{{#invoke:Cite web||title=Aprueba el CECMED el Autorizo de Uso de Emergencia del candidato vacunal cubano ABDALA |website=CECMED|url=https://www.cecmed.cu/noticias/aprueba-cecmed-autorizo-uso-emergencia-candidato-vacunal-cubano-abdala|access-date=9 July 2021|language=es}}
- Mexico{{cite web|date=29 December 2021|title=Cofepris emite autorización para uso de emergencia de vacuna Abdala|url=https://www.gob.mx/cofepris/articulos/cofepris-emite-autorizacion-para-uso-de-emergencia-de-vacuna-abdala|access-date=29 December 2021|website=www.gob.mx/cofepris|language=es}}
- Nicaragua{{cite news|title=Nicaragua authorises two COVID-19 vaccines from Cuba, Cuban firm says|url=https://www.reuters.com/business/healthcare-pharmaceuticals/nicaragua-authorises-two-covid-19-vaccines-cuba-cuban-firm-says-2021-10-02/ |access-date= 4 October 2021|publisher=Reuters |date=2 October 2021}}
- St. Vincent and the Grenadines{{cite news |title=Vincentians have access to Cuban Abdala vaccine |url=https://caribbean.loopnews.com/content/vincentians-have-access-cuban-abdala-vaccine|access-date=28 December 2021|work=Loop News}}{{cite news|date=28 December 2021|title=St Vincent, The Grenadines to use Cuba's Abdala vaccine|work=Political Lore|url=https://www.politicallore.com/st-vincent-the-grenadines-to-use-cubas-abdala-vaccine/27626|access-date=13 January 2022}}
- Venezuela{{cite news |title=Venezuela receives first shipment of Cuban coronavirus vaccine |url=https://www.reuters.com/world/americas/venezuela-receives-first-shipment-cuban-coronavirus-vaccine-2021-06-24/ |access-date=3 July 2021 |publisher=Reuters |date=25 June 2021}}
- Vietnam
;Travel-only
- Cambodia{{cite web|url=https://www.khmertimeskh.com/50971131/list-of-covid-19-vaccines-recognised-by-cambodia-for-quarantine-free-international-entry/|title = List of COVID-19 vaccines recognised by Cambodia for quarantine free international entry - Khmer Times|date = 15 November 2021}}
- Colombia{{cite web|title=Conozca las 20 vacunas aceptadas para el ingreso de viajeros a Colombia|url=https://www.cali.gov.co/publicaciones/165988/conozca-las-20-vacunas-aceptadas-para-el-ingreso-de-viajeros-a-colombia/|access-date=15 December 2021|website=www.cali.gov.co|language=es}}
- Guyana{{cite web |date=November 2021 |title=Requirements for Port Entry into Guyana |url=https://www.health.gov.gy/images/travel_requirement.pdf#page=2 |access-date=2 March 2022 |website=www.health.gov.gy/index.php/component/k2/item/304-travel-guidelines}}{{cite web |date=19 January 2022 |title=Travel Restrictions Entering Guyana from Cuba |url=https://airheart.com/travel-bans/from/cuba/to/guyana |access-date=2 March 2022 |website=airheart.com/travel-bans |archive-date=2 March 2022 |archive-url=https://web.archive.org/web/20220302141904/https://airheart.com/travel-bans/from/cuba/to/guyana }}
- Malaysia
- New Zealand
- St. Lucia
- Turkey
- Uruguay (only if accepted in the country of the person's origin)
{{clear}}
EpiVacCorona
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|TM=blueviolet|TR=turquoise
|RU=dodgerblue
|BY=dodgerblue
|NZ=turquoise
|KH=dodgerblue
|VE=dodgerblue
|MY=turquoise
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
EpiVacCorona is a peptide vaccine produced by the Russian State Research Center of Virology and Biotechnology VECTOR.{{#invoke:Cite web||date=22 September 2020|title=Study of the Safety, Reactogenicity and Immunogenicity of "EpiVacCorona" Vaccine for the Prevention of COVID-19 (EpiVacCorona)|url=https://clinicaltrials.gov/ct2/show/NCT04527575|access-date=16 November 2020|website=ClinicalTrials.gov|publisher=United States National Library of Medicine|id=NCT04368988}}
;Full (1)
- Turkmenistan{{cite news |title= Turkmenistan registers vaccines for the prevention of infectious diseases |url=https://tdh.gov.tm/en/post/25911/turkmenistan-registers-vaccines-prevention-infectious-diseases |work=Turkmenistan Today |date=29 January 2021 }}{{cite news |title=Russian vaccine "EpiVacCorona" was registered in Turkmenistan |url=https://www.en24news.com/e/2021/01/russian-vaccine-epivaccorona-was-registered-in-turkmenistan.html |work=EN24 |date=29 January 2021 |access-date=17 March 2021 |archive-date=19 March 2021 |archive-url=https://web.archive.org/web/20210319140314/https://www.en24news.com/error }}
;Emergency (4)
- Belarus{{#invoke:Cite web||date=3 February 2021|title=Belarus receives Russia's EpiVacCorona vaccine|url=https://eng.belta.by/society/view/belarus-receives-russias-epivaccorona-vaccine-137131-2021/|access-date=5 April 2021|website=Belta}}
- Cambodia
- Russia{{cite web | title = О регистрации вакцины ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора "ЭпиВакКорона" | website = Rospotrebnadzor | url = https://www.rospotrebnadzor.ru/region/rss/rss.php?ELEMENT_ID=15660 | date = 14 October 2020 | language = ru | access-date = 17 March 2021 | archive-date = 1 November 2020 | archive-url = https://web.archive.org/web/20201101010437/https://www.rospotrebnadzor.ru/region/rss/rss.php?ELEMENT_ID=15660 | url-status = dead }}{{cite web | title = Russia's EpiVacCorona vaccine post-registration trials started | publisher=The Pharma Letter |url = https://www.thepharmaletter.com/article/russia-s-epivaccorona-vaccine-post-registration-trials-started |date=18 November 2020 }}
- Venezuela
;Travel-only
{{clear}}
Zifivax
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|CN=dodgerblue
|HK=turquoise
|ID=dodgerblue
|MY=turquoise
|NZ=turquoise
|PK=dodgerblue
|TR=turquoise
|UZ=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
Zifivax is a subunit vaccine produced by the Chinese company Anhui Zhifei Longcom Biopharmaceutical.{{#invoke:Cite web||date=1 March 2021|title=COVID-19 vaccine development pipeline (Refresh URL to update)|url=https://vac-lshtm.shinyapps.io/ncov_vaccine_landscape/|access-date=10 March 2021|publisher=Vaccine Centre, London School of Hygiene and Tropical Medicine}}
;Full (0)
;Emergency (5)
- China{{cite news|last=Liu|first=Roxanne|date=15 March 2021|title=China IMCAS's COVID-19 vaccine obtained emergency use approval in China|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-china-vaccine-idUSL4N2LD3BZ|access-date=15 March 2021}}
- Colombia{{cite web |title=Invima recomienda el uso de emergencia de Zifivax, otra vacuna anticovid producida en China |url=https://www.infobae.com/america/colombia/2022/01/27/invima-recomienda-el-uso-de-emergencia-de-zifivax-otra-vacuna-anticovid-producida-en-china/ |access-date=24 June 2022 |website=infobae |date=27 January 2022 |language=es-ES}}
- Indonesia{{cite web|date=7 October 2021|title=BPOM Setujui Penggunaan Dalam Kedaruratan Vaksin Zifivax|url=https://republika.co.id/berita/nasional/umum/r0ljxq436/bpom-setujui-penggunaan-dalam-kedaruratan-vaksin-zifivax|access-date=7 October 2021|work=Republika.co.id|language=id}}
- Pakistan{{cite web|title=Pakistan gears up for China's "ZF-2001 vaccine"--China Economic Net|url=http://en.ce.cn/Insight/202111/08/t20211108_37068436.shtml|access-date=30 November 2021|website=en.ce.cn}}
- Uzbekistan{{cite news | last1=Mamatkulov |first1=Mukhammadsharif |title=Uzbekistan approves Chinese-developed COVID-19 vaccine |url=https://www.reuters.com/article/uzbekistan-china-coronavirus-vaccine/uzbekistan-approves-chinese-developed-covid-19-vaccine-idUSS0N2IK00P |publisher=Reuters |access-date=2 March 2021 |date=1 March 2021}}
;Travel-only
{{clear}}
Soberana 02
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|CU=dodgerblue
|GY=turquoise
|HU=turquoise
|IR=dodgerblue
|MY=turquoise
|NI=dodgerblue|NZ=turquoise
|TR=turquoise
|VE=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
Soberana 02, is a conjugate vaccine developed by the Finlay Institute in Cuba.{{cite web |title=Autorizo de emergencia SOBERANA 02 en Irán |url=https://www.finlay.edu.cu/blog/autorizo-de-emergencia-soberana-02-en-iran/ |website=finlay.edu.cu |publisher=Instituto Finlay de Vacunas |access-date=6 July 2021 |date=1 July 2021}}
;Full (0)
;Emergency (4)
- Cuba{{cite news |title=Cuba grants emergency approval to second homegrown COVID-19 vaccine |url=https://www.gmanetwork.com/news/scitech/science/800262/cuba-grants-emergency-approval-to-second-homegrown-covid-19-vaccine/story/ |publisher=GMA News |date=21 August 2021}}
- Iran
- Nicaragua{{cite news |title=Nicaragua authorises two COVID-19 vaccines from Cuba, Cuban firm says|url=https://www.reuters.com/business/healthcare-pharmaceuticals/nicaragua-authorises-two-covid-19-vaccines-cuba-cuban-firm-says-2021-10-02/|publisher=Reuters |date =2 October 2021}}
- Venezuela
;Travel-only
CoviVac
{{infobox
| image = {{Graph:Map|scale=50|defaultValue=gainsboro
|BY=dodgerblue
|KH=dodgerblue
|MY=turquoise
|NZ=turquoise
|RU=dodgerblue
|TR=turquoise
}}
| caption = {{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
CoviVac is an inactivated virus vaccine produced by the Chumakov Centre at the Russian Academy of Sciences.{{#invoke:Cite web||date=18 January 2021|title=Briefing with Deputy Prime Minister Tatyana Golikova, Health Minister Mikhail Murashko and Head of Rospotrebnadzor Anna Popova|url=http://government.ru/en/news/41342/|access-date=20 February 2021|publisher=Government of Russia}}
;Full (0)
;Emergency (3)
- Belarus{{#invoke:Cite web||date=16 December 2021|title=Минздрав выдал разрешение на ввоз и применение вакцины КовиВак|url=http://minzdrav.gov.by/ru/novoe-na-sayte/minzdrav-vydal-razreshenie-na-vvoz-i-primenenie-vaktsiny-kovivak/|publisher=Ministry of Health of the Republic of Belarus|language=RU}}
- Cambodia
- Russia{{cite news |date=20 February 2021 |title=Russia approves its third COVID-19 vaccine, CoviVac |publisher=Reuters |url=https://www.reuters.com/article/us-health-coronavirus-russia-vaccine/russia-approves-its-third-covid-19-vaccine-covivac-idUKKBN2AK07H}}
; Travel-only
QazCovid-in
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|KZ=dodgerblue
|KG=dodgerblue
|MY=turquoise
|NZ=turquoise
|TR=turquoise
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
QazCovid-in, also known as QazVac, is an inactivated virus vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan.{{cite web |title=A new vaccine on the scene: Kazakhstan begins rollout of homegrown QazVac |date=26 April 2021 |url=https://fortune.com/2021/04/26/new-covid-19-vaccine-kazakhstan-qazvac/ |website=Fortune}}
;Full (0)
;Emergency (2)
- Kazakhstan
- Kyrgyzstan{{cite news | title=Vaccination against COVID-19: QazVac registered in Kyrgyzstan
|url=https://24.kg/english/204508_Vaccination_against_COVID-19_QazVac_registered_in_Kyrgyzstan/ |publisher=24.kg |date=19 August 2021 }}{{cite news | title=Kyrgyzstan to start using Kazakh-made QazVac after expert review|url=https://www.eureporter.co/world/kazakhstan/2021/08/19/kyrgyzstan-to-start-using-kazakh-made-qazvac-after-expert-review/ |publisher=Eureporter |date=19 August 2021 }}{{cite news | title=The Covid-19 Vaccine Qazvac Is Firstly Registrated[sic] Abroad |url=https://www.biosafety.kz/en/uncategorized/%d0%b2%d0%b0%d0%ba%d1%86%d0%b8%d0%bd%d0%b0-qazvac-%d0%bf%d1%80%d0%be%d1%82%d0%b8%d0%b2-covid-19-%d0%bf%d0%be%d0%bb%d1%83%d1%87%d0%b8%d0%bb%d0%b0-%d0%bf%d0%b5%d1%80%d0%b2%d1%83%d1%8e-%d1%80%d0%b5%d0%b3/ |publisher=Biosafety.kz |date=18 August 2021 }}
;Travel-only
{{Clear}}
Minhai
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|CN=dodgerblue
|ID=dodgerblue
|MY=turquoise
|NZ=turquoise
|TR=turquoise
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
Minhai COVID-19 vaccine, is an inactivated virus vaccine developed by Minhai Biotechnology Co. and Shenzhen Kangtai Biological Products Co. Ltd. in China.{{cite news|date=14 May 2021|title=Kangtai Biological's COVID-19 vaccine gets emergency use approval in China|work=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-vaccine-kangtai-idUSKBN2CV1F6|access-date=20 May 2021}}
;Full (0)
;Emergency (2)
- China
- Indonesia{{cite press release|author=Shenzhen Kangtai Biological Products Co., Ltd|title=BioKangtai's adenovirus vector COVID-19 vaccine obtained EUA in Indonesia|url=https://www.prnewswire.com/news-releases/biokangtais-adenovirus-vector-covid-19-vaccine-obtained-eua-in-indonesia-301415162.html|access-date=30 November 2021|website=PR Newswire}}
;Travel-only
Medigen
{{infobox
| image = {{Graph:Map|scale=50|defaultValue=gainsboro
|BZ=turquoise
|ID=turquoise
|MY=turquoise
|NZ=turquoise
|PW=turquoise
|PY=dodgerblue
|SOMALILAND=dodgerblue
|TH=turquoise
|TR=turquoise
|TW=dodgerblue
}}
| caption = {{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|turquoise|Allowed for travel}}
}}
MVC-COV1901, is a protein subunit vaccine developed by Taiwan's Medigen Vaccine Biologics and Dynavax Technologies.{{cite web |date=19 July 2021 |title=Taiwan approves Medigen's COVID-19 vaccine candidate |url=https://www.reuters.com/world/asia-pacific/taiwan-approves-production-medigens-covid-19-vaccine-candidate-2021-07-19/ |access-date=19 July 2021 |publisher=Reuters}}
;Full (0)
;Emergency (3)
- Eswatini
- Taiwan
- Paraguay{{cite news |date=14 February 2022 |title=Paraguay aprueba vacuna taiwanesa Medigen para uso de emergencia |agency=Diario HOY |url=https://www.hoy.com.py/nacionales/paraguay-aprueba-vacuna-taiwanesa-medigen-para-uso-de-emergencia}}
;Non-country entities
;Travel-only
- Belize{{cite web |date=30 November 2021 |title=MOHW Approves Entry for Persons with the Taiwanese Medigen Jab |url=https://lovefm.com/mohw-approves-entry-for-persons-with-the-taiwanese-medigen-jab/ |access-date=8 January 2022 |website=Love FM News |archive-date=7 January 2022 |archive-url=https://web.archive.org/web/20220107161153/https://lovefm.com/mohw-approves-entry-for-persons-with-the-taiwanese-medigen-jab/ }}
- Indonesia{{cite web |date=16 November 2021 |title=Negara yang mengakui vaksin Medigen menjadi 4 negara |url=https://news.pts.org.tw/article/554169 |access-date=8 January 2022 |website=PTS news}}
- Malaysia
- New Zealand
- Palau{{cite web |title=COVID-19 Pandemic Entry Requirements – PalauGov.pw |url=https://www.palaugov.pw/travel/ |access-date=24 December 2021}}
- Thailand
- Turkey
Corbevax
Corbevax is a protein subunit vaccine developed by Texas Children's Hospital at the Baylor College of Medicine in Houston, Texas, and licensed to Indian biopharmaceutical firm Biological E. Limited (BioE) for development and production.{{cite news |last=Raghavan |first=Prabha |date=10 June 2021 |title=Explained: How is Biological E's Corbevax different? |website=The Indian Express |url=https://indianexpress.com/article/explained/corbevax-vaccine-biological-e-india-7344928/ |access-date=29 December 2021}}
;Full (0)
;Emergency (2)
- India
- Botswana{{cite news |date=28 March 2022 |title=Botswana Approves Corbevax Covid Vaccine, Plans Local Output |work=Bloomberg.com |url=https://www.bloomberg.com/news/articles/2022-03-28/botswana-approves-corbevax-covid-vaccine-plans-local-output |access-date=29 June 2022}}
;Travel-only
COVIran Barekat
COVIran Barekat, is an inactivated virus vaccine developed by Shifa Pharmed Industrial Co. in Iran.{{#invoke:Cite web||date=14 June 2021|title=Iran issues license on its coronavirus vaccine|url=https://en.trend.az/iran/society/3439812.html|access-date=14 June 2021|website=Trend.Az}}
;Full (0)
;Emergency (2)
- Iran
- Nicaragua{{cite web |title=Nicaragua recibe 200 mil dosis de la vacuna Coviran donadas por Irán |url=https://www.el19digital.com/articulos/ver/titulo:129361-nicaragua-recibe-200-mil-dosis-de-la-vacuna-coviran-donadas-por-iran |access-date=12 July 2022 |website=El 19 Digital |language=es}}
;Travel-only
;
- Malaysia
- New Zealand
- Hungary{{cite web|date=16 December 2021|title=Iran and Hungary to Mutually Honour Immunity Certificates|url=https://hungarytoday.hu/hungary-iran-immunity-certificate-szijjarto/|access-date=18 December 2021|website=Hungary Today}}
- Turkey{{cite web|date=10 April 2019|title=Vaccinations for Turkey: Do I need an Approved COVID Vaccine?|url=https://www.visasturkey.com/vaccinations-for-turkey/|access-date=26 December 2021|website=Turkey Visa|archive-date=16 November 2021|archive-url=https://web.archive.org/web/20211116194536/https://www.visasturkey.com/vaccinations-for-turkey/}}
Chinese Academy of Medical Sciences
Chinese Academy of Medical Sciences COVID-19 vaccine, is an inactivated virus vaccine developed by Chinese Academy of Medical Sciences.{{cite news |last1=Liu |first1=Roxanne |last2=Woo |first2=Ryan |title=China builds new plant for IMBCAMS COVID-19 vaccine -state media |url=https://www.reuters.com/world/asia-pacific/china-builds-new-plant-imbcams-covid-19-vaccine-state-media-2021-06-09/ |access-date=15 June 2021 |work=Reuters |date=9 June 2021}}
;Full (0)
;Emergency (1)
;Travel-only
ZyCoV-D
ZyCoV-D, is a DNA plasmid based COVID-19 vaccine developed by the Indian pharmaceutical company Cadila Healthcare with support from the Biotechnology Industry Research Assistance Council.{{cite news |title=India gives emergency approval for world's first COVID-19 DNA vaccine |url=https://www.reuters.com/business/healthcare-pharmaceuticals/india-approves-zydus-cadilas-covid-19-vaccine-emergency-use-2021-08-20/ |work=Reuters |date=20 August 2021 }}
;Full (0)
;Emergency (1)
;Travel-only
FAKHRAVAC
FAKHRAVAC (or MIVAC), is an inactivated virus vaccine developed in Iran by the Organization of Defensive Innovation and Research, an organization of Iran's Ministry of Defense.{{cite web|date=9 September 2021|title=Iran Authorizes Emergency Use of Third Homegrown Vaccine - Defense news|url=https://www.tasnimnews.com/en/news/2021/09/09/2568712/iran-authorizes-emergency-use-of-third-homegrown-vaccine|url-status=live|archive-url=https://web.archive.org/web/20210909123956/https://www.tasnimnews.com/en/news/2021/09/09/2568712/iran-authorizes-emergency-use-of-third-homegrown-vaccine|archive-date=9 September 2021|access-date=9 September 2021|website=Tasnim News Agency}}
;Full (0)
;Emergency (1)
;Travel-only
COVAX-19
COVAX-19, also known as SpikoGen, is a protein subunit vaccine jointly developed by Australian-based company Vaxine and Iran-based company CinnaGen.{{cite news |title=Iran issues emergency permit for new local Covid-19 vaccine |url=https://en.mehrnews.com/news/179432/Iran-issues-emergency-permit-for-new-local-Covid-19-vaccine |access-date=12 October 2021 |publisher=Mehr News Agency |date= 6 October 2021}}
;Full (0)
;Emergency (1)
;Travel-only
Razi Cov Pars
Razi Cov Pars is a protein subunit vaccine developed by Razi Vaccine and Serum Research Institute.{{cite web|date=1 November 2021|title=Two homegrown vaccines receive emergency use license|url=https://www.tehrantimes.com/news/466570/Two-homegrown-vaccines-receive-emergency-use-license|access-date=27 November 2021|website=Tehran Times}}
;Full (0)
;Emergency (1)
;Travel-only
Turkovac
Turkovac is an inactivated vaccine developed by Health Institutes of Turkey and Erciyes University.{{cite news |last1=Aliyev |first1=Jeyhun |last2=Nur Duz |first2=Zehra |title=Turkey's domestic COVID-19 vaccine Turkovac approved for emergency use |url=https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/turkeys-domestic-covid-19-vaccine-turkovac-approved-for-emergency-use/2454638 |access-date=26 December 2021 |agency=Anadolu Agency |date=22 December 2021}}
;Full (0)
;Emergency (1)
;Travel-only
Sinopharm CNBG
Sinopharm CNBG COVID-19 vaccine (NVSI) is a recombinant protein subunit vaccine developed by the National Vaccine & Serum Institute (NVSI, 中生研究院), a subsidiary of China National Biotec Group (CNBG), which in turn is a subsidiary of Sinopharm.{{cite news|date=27 December 2021|title=Emergency use of Sinopharm's new CNBG protein vaccine approved in UAE|work=Gulf News|url=https://gulfnews.com/uae/emergency-use-of-sinopharms-new-cnbg-protein-vaccine-approved-in-uae-1.84628476|access-date=27 December 2021}}
;Full (0)
;Emergency (1)
;Travel-only
Soberana Plus
Soberana Plus is a single-dose of conjugate vaccine developed by the Finlay Institute in Cuba.{{cite news | vauthors = Dönmez BB |title=Cuba grants emergency use to 2 virus vaccines |url=https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/cuba-grants-emergency-use-to-2-virus-vaccines/2341850 |access-date=23 September 2021 |agency=Anadolu Agency |date=21 August 2021}}
;Emergency (2)
- Belarus{{cite web |date=27 July 2022 |title=Cuban COVID-19 vaccine registered in Belarus |url=https://eng.belta.by/society/view/cuban-covid-19-vaccine-registered-in-belarus-152088-2022/ |access-date=27 July 2022 |website=eng.belta.by }}
- Cuba{{cite news |date=21 August 2021 |title=Cuba grants emergency use to 2 virus vaccines |agency=Anadolu Agency |url=https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/cuba-grants-emergency-use-to-2-virus-vaccines/2341850 |access-date=23 September 2021 |vauthors=Dönmez BB}}
;Travel-only
CoVLP
CoVLP is a virus-like particle vaccine grown in an Australian weed, Nicotiana benthamiana. It was developed by Medicago, and is marketed under the name [https://medicago.com/en/press-release/covifenz/ Covifenz] {{Webarchive|url=https://web.archive.org/web/20220224161443/https://medicago.com/en/press-release/covifenz/ |date=24 February 2022 }}.
;Full (1)
- Canada{{cite web | title=Medicago Covifenz COVID-19 vaccine | website=Health Canada | date=7 June 2022 | url=https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/medicago.html | access-date=30 October 2022 }}
;Emergency (0)
;Travel-only
Noora
Noora is a protein-based vaccine developed by the Baqiyatallah University of Medical Sciences.
;Full (0)
;Emergency (1)
- Iran{{cite news |date=1 March 2022 |title="Noora" vaccine receives emergency use license |work=Tehran Times |url=https://www.tehrantimes.com/news/470601/Noora-vaccine-receives-emergency-use-license |access-date=2 March 2022}}
;Travel-only
SKYCovione
Walvax
Walvax COVID-19 vaccine is an RNA vaccine developed by Walvax Biotechnology, Suzhou Abogen Biosciences, and the PLA Academy of Military Science.{{cite web |title=SARS-CoV-2 mRNA vaccine |url=https://go.drugbank.com/drugs/DB15855 |access-date=2021-04-10 |website=go.drugbank.com}}
;Full (0)
;Emergency (1)
iNCOVACC
iNCOVACC, also called BBV154 is an adenovirus vector vaccine developed by Bharat Biotech, Precision Virologics, and Washington University School of Medicine.
;Full (0)
;Emergency (1)
- India{{cite web |title=Emergency-use approval for Bharat Biotech's iNCOVACC intranasal vaccin |url=https://www.thepharmaletter.com/article/emergency-use-approval-for-bharat-biotech-s-incovacc-intranasal-vaccine-in-india |website=www.thepharmaletter.com |access-date=20 November 2022 |date=2022-09-14}}
Gemcovac
Gemcovac, or GEMCOVAC-19, is a self-amplifying mRNA vaccine manufactured by Gennova Biopharmaceuticals.
;Full (0)
;Emergency (1)
- India{{cite web |last1=Haseltine |first1=William A. |title=Self-Amplifying mRNA Vaccine Receives EUA Nod From Indian Regulators |url=https://www.forbes.com/sites/williamhaseltine/2022/10/14/self-amplifying-mrna-vaccine-receives-eua-nod-from-indian-regulators/?sh=4931ed615aaf |website=Forbes |access-date=20 November 2022 |language=en}}
V-01
V-01 is a protein subunit vaccine developed by Livzon Mabpharm.
;Full (0)
;Emergency (1)
- China{{cite web |title=Livzon Pharma's COVID vaccine gets approval as booster in China |url=https://www.reuters.com/business/healthcare-pharmaceuticals/livzon-pharmas-covid-19-vaccine-gets-emergency-use-approval-china-2022-09-02/ |website=Reuters |access-date=20 November 2022 |language=en |date=2 September 2022}}
IndoVac
IndoVac is a protein subunit vaccine developed by Indonesian pharmaceutical company Bio Farma and Baylor College of Medicine.
;Full (0)
;Emergency (1)
Notes
{{reflist|group=lower-alpha}}
References
{{reflist}}
{{COVID-19 pandemic}}
{{Vaccines}}
{{Portal bar|COVID-19|Medicine|Modern history|Viruses|Current events}}